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Abstract
Abstract
Neuronal viability and connectivity is essential for neuronal function in heath 
and disease. The aim of this study was to elucidate factors and mechanisms 
that govern the maintenance and remodelling of RGC dendrites, as well as 
neuronal cell death in ageing and neurodegenerative diseases. Using PCR 
technique, the expression pattern of caspases 3,6-9 and inhibitors of 
apoptosis (lAPs), namely neuronal IAP (NIAP), cellular IAP1 and 2 (clAP1 
and 2), X-chromosome linked IAP (XIAP), Survivin, Bruce and Livin was 
determined in young adult (6 weeks), mature (24-52 weeks), old (88 weeks) 
and diseased retinae of Wistar albino and Brown Norway (BN) rats. Caspase 
expression was not altered during maturation and ageing in both strains. In 
ageing Wistar, NIAP, clAP2 and XIAP and clAP1 were decreased in 88 
compared to 24-52 weeks, while Survivin, Bruce and Livin were slightly 
increased with age. lAPs expression was generally decreased in mature (24- 
52 weeks) BN retinae compared to younger (6 weeks). Furthermore, 
validation of the expression of these molecules at protein level was carried 
out using western blotting and immunofluorescence techniques. clAP1 
protein levels were downregulated in RGCL of BN rats. Reduction of clAP1 
did not alter caspase activity but led to impairment in the survival pathway. 
Older BN retinae demonstrated compromised RGC morphology, but there 
was no retinal cell loss. Microbead experimental glaucoma model 
demonstrated no alteration in caspase expression upon induction of 
glaucoma. NIAP, clAP2, Survivin and Livin were up-regulated, while Bruce 
was down-regulated in glaucomatous eyes. clAP1 and XIAP expression 
remain similar between control and experimental eye. In conclusion, 
reduction in lAPs, which may lead to impairment in survival pathways might 
be the underlaying cause of reduction in dendrite complexity. Compromised 
RGC morphology makes a preparatory platform for neurodegenerative 
process observed in glaucoma disease where age is a major risk factor.
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Chapter 1 General Introduction
1.1 General introduction
The viability of the cell body and interneuronal connections are required 
for neural function in health and disease. Work performed by various 
group, including ours has emphased the importance of the viability of the 
neuronal cell body and interneuronal connections in neuronal 
pathologies. Neurons receive and processes incoming signals through 
the dendritic tree and convey the information to other neurons or parts of 
the body via axons (Brown, 2001). Dendrites are unique because they 
occupy a large three-dimensional space in a relationship to the cell body 
and axon and are highly plastic (Stuart, 2008), which increases 
susceptibility to any changes. In many neurodegenerative diseases 
(Alzheimer’s disease (AD),Parkinson’s disease (PD) and glaucoma), 
changes in the dendritic tree are taken as an early sign of disease. In AD 
remodelling of the dendritic tree is seen as a foundation of the disease 
etiology (Knobloch and Mansuy, 2008). Changes in the dendritic tree also 
occur in PD, where the loss of dopaminergic neuron input induces 
changes in the dendrites in the affected striatal regions (Deutch, 2006, 
Zaja-Milatovic et al., 2005).
In retinal pathologies such as glaucoma, dendrite remodelling occurs as 
an early event (Liets et al., 2006). Studies carried out in primates and 
murine models of glaucoma confirm that the changes have functional 
consequences (Weber and Harman, 2005). Despite this, the molecular 
mechanisms that control these changes are still unclear. The rapid 
development of non-invasive bio-imaging techniques as such ocular 
coherence tomography (OCT) and Optophysiology gives a promising sign 
of providing a way to detect these changes in the early stages of disease 
in the near future (Bizheva et al., 2006). That is why it is very important to 
elucidate the molecular mechanisms that modulate the changes in the 
dendrite during ageing and disease. The knowledge that will be obtained 
from this study might be essential for design of more effective therapeutic 
drugs for neuroprotection.
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1.2 Neuronal cell death
Cell death is defined by failure of a cell to maintain crucial life functions. 
One of the early sign of cell death is irreversible damage to the plasma 
membrane (Golstein and Kroemer, 2007). There are three types of cell 
death based on morphological criteria: Type I programmed cell death 
(apoptosis) that is a cell intrinsic mechanism for suicide; Type II cell death 
(autophagy) is characterised by the accumulation of double-membrane 
autophagic vacuoles in the cytoplasm; and Type III cell death (necrosis) 
is defined by the absences of the features observed in type I and type II 
cell death and is adenosine-5'-triphosphate (ATP)-independent (Edinger 
and Thompson, 2004). In addition to these modes of cell death, cells can 
be eliminated by other mechanisms including mitotic catastrophe, dark 
cell death, paraptosis, chondroptosis and autoschizis. Mitotic catastrophe 
is a type of cell death that occurs during mitosis (Castedo et al., 2004). 
Dark cell death is death usually observed in Huntington’s disease 
(Wolszon et al., 1994). It is defined by strong cytoplasmic condensation, 
chromatin lumping and ruffling of the cell membrane, but blebbling of the 
nucleus or plasma membrane is not observed (Turmaine et al., 2000).
Paraptosis is a variant of apoptosis that is characterised by formation of 
cytoplasmic vacuoles and mitochondrial swelling (Yamashima, 2004); 
(Sperandio et al., 2004). This kind of cell death is observed in 
amyotrophic lateral sclerosis (Sperandio et al., 2004). Similar to 
paraptosis, chondroptosis is a variant of classical apoptosis with features 
such as cell shrinkage, chromatin and involvement of apoptosis but is 
phagocytosis-independent (Roach et al., 2004). In autoschizis, the cell 
membrane splits allowing the cytoplasma to leak (Gilloteaux et al., 1998, 
Gilloteaux et al., 1995, Jamison et al., 2002). The aim of this introduction 
is to briefly summarise the literature on necrosis and autophagic cell 
death and to discuss apoptosis in detail, its components and involvement 
in dendrite remodelling because it is becoming apparent that regulated 
apoptosis signalling has a role in dendrite remodelling (Williams et al., 
2006). The links between the three types of cell death in the context of 
neurodegenerative disease will also be discussed, focusing on glaucoma.
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1.2.1 Necrosis
Necrosis occurs as a consequence of pathological insults secondary to 
toxin exposure or physical damage (Edinger and Thompson, 2004). It is 
defined by disruption of the plasma membrane and spillage of 
intracellular contents into the surrounding milieu with the consequence of 
initiating inflammation around the necrotic cell. The physiological 
importance of necrotic cell death has yet to be determined. Necrosis can 
be triggered by an apoptotic signal, such as activation of tumour necrosis 
factor (TNF) receptor; cells will die even in the presence of anti-apoptotic 
molecules and the cell will display all the morphological hallmarks of a 
necrotic cell (Jaattela and Tschopp, 2003). Indeed, Chan et al., studied 
cell death in Vaccinia infected cells to demonstrate the physiological 
significance of necrosis (Chan et al., 2003). Vaccinia encodes for anti- 
apoptotic proteins to preserve host cell viability. Addition of the 
proinflammatory cytokine, TNF to Vaccinia infected cells resulted in 
necrosis in the face of inhibition of apoptotic pathways (Chan et al.,
2003).
1.2.2 Autophagy
Autophagy means ueat oneself. Most cells have a basal level of active 
autophagy where it has a housekeeping role in maintaining the integrity of 
intracellular organelles and proteins (Jin, 2006). However, nutrients 
deprivation strongly induces activation of autophagy and this has been 
postulated to be an adaptive response of cells to starvation that promotes 
survival (Glick et al., Levine and Klionsky, 2004). Autophagic cell death 
involves formation of double membrane vesicles in the cytosol in which 
whole organelles and bulk cytoplasm are encapsulated. The vesicles are 
then fused with the lysosome in which the contents of the 
autophagosome is degraded and recycled (Edinger and Thompson,
2004). Thus, physiologically, autophagy is thought to play a role in 
degeneration of damaged organelles and long-lived proteins in order to 
provide energy in times of starvation.
4
Chapter 1 General Introduction
There are three modes of autophagy, namely macro-, micro- and 
chaperone-mediated autophagy, all of which promote proteolytic 
degradation of organelles and proteins in the lysosomes. Marco- 
autophagy transfers cytoplasmic cargo to the lysosomes through 
autophagosomes (double membrane bound vesicles) that fuses to 
lysosomes and forms an autolysosome. In micro-autophagy, on the other 
hand, the organelles and proteins are directly taken up by the lysosome 
itself. In chaperone-mediated autophagy (CMA), targeted cytoplasmic 
components are bound to chaperone proteins (such as heat shock 
(HSP)-70) forming a complex that is translocated across the lysosomal 
membrane. This is facilitated by the recognition of HSPs by lysosomal 
membrane receptors such as lysosomal associated membrane protein 
(LAMP-2A) leading to unfolding and degradation cytoplasmic cargo 
(Saftig et al., 2008).
1.2.3 Apoptosis
1.2.3.1 Introduction to apoptosis
Apoptosis is a type programmed cell death, which is orchestrated by a 
series of biochemical occurrences as part of signalling cascade (Fig 1.1). 
The biochemical and morphological hallmarks of apoptotic cells are 
chromatin condensation, cell shrinkage, plasma membrane blebbling, 
mitochondrial disruption, DNA fragmentation, and formation of apoptotic 
bodies (Kerr et al., 1972). In contrast to necrotic cell death, apoptosis is 
an active, energy consuming process carried out in an ordered manner. 
Apoptosis is essential for the development and viability of a healthy 
organism. The initiation of the apoptotic process may occur extrinsically 
or intrinsically. The extrinsic pathway involves the activation of death 
receptors such as Fas, a member of the TNF receptor superfamily,on the 
cell membrane (Ashkenazi and Dixit, 1998). The activation of death 
receptors leads to activation of Fas activated death domain (FADD), 
which in turn activates initiator caspases. Active, initiator caspases then 
activate effector caspases (see next paragraph for details on initiator and
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effector caspases). Once the effector caspases are activated (“point of no 
return”), the cell is designated to die (Guerin et al., 2006).
The key organelle for the intrinsic pathway is the mitochondrion. In 
addition to being the energy station for the cell, the mitochondrion houses 
a proapoptotic molecule including the members of the B cell lymphoma 2 
(Bcl-2) family (such as Bax and Bim) and cytochrome c. Bcl-2 family 
members controls mitochondrial integrity which, if compromised results in 
the release of cytochrome c to the cytosol resulting in its association with 
the adaptor molecule apoptosis protease activated factor (Apaf-1). The 
outcome is formation of a multimeric complex called the apoptosome that 
recruits caspase 9 and builds an active holoenzyme (Jiang and Wang,
2004). Once activated, caspase 9 is then capable of activating the 
effector caspase (Slee et al., 1999). It is important to note that crosstalk 
between the two pathways is possible and is mediated by truncated Bid 
molecules that are activated by caspase 8. Activated Bid promotes 
release of cytochrome c through activation of Bax (Li et al., 1998).
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Fig. 1.1. Apoptosis cascade. Programmed cell death can be activated via 
extrinsic factors (TNF receptor activation) or intrinsically by the relise of 
cytochrome c release from mitochondria. Both pathways lead to 
activation of effector caspases (including caspases 3, 6 and 7) that 
activate apoptotic protein cleavage. The IAP family of proteins inhibit, 
both initiator and effector caspases activation, but they in turn can be 
inhibited by smac/Diablo relise from damaged mitochondria. It is 
hypothesis for this project that lAPs may have a role in activation of 
NFkB, which is survival pathway. This activation in turn has an inhibitory 
effect on apoptotic pathway. Figure adapted with modification from 
Kisiswa et al., (2009). Picture courtesy of Dr. Adrian G Dervan.
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1.2.3.2 Caspases
Caspases, a family of cysteine aspartyl-specific proteases are essential 
for the execution of apoptosis. The proteases were first recognised in 
Caenorhabditis elegance (C. elegance) as playing an importantrole in 
apoptosis (Liu and Hengartner, 1999) and as a class, named C. elegance 
defective (CED). There are 15 CED genes identified to date. Mammalian 
caspases consist of 15 members and their presence is variable in the 
different stages of neuronal life-span (Earnshaw et al., 1999). In any 
given healthy cell, caspases are held in an inactive zymogenic state as 
pro-caspases and become active by proteolytic processing or induced 
proximity (Earnshaw et al., 1999).
The organisation of pro-caspases generally starts with the N-terminal pro­
domain followed by sequence encoding first a large subunit and then a 
small subunit (Fig. 1.2). Some pro-caspases have a spacer between the 
large and small subunits, which is removed during the activation process 
(Greenberg, 1996, Pham and Ley, 1997, Thornberry et al., 1997). 
Caspases posses additional domains including the death effector domain 
(DED; (Chinnaiyan et al., 1995) and caspase recruitment domain (CARD; 
(McArdle et al., 2002:Hofmann et al., 1997). DED, found in caspases 8 
and 10 interacts with signalling adaptor proteins such as FADD and 
Tumor necrosis receptor assossiated death domain (TRADD, Fig. 1.2). 
Caspases 1, 2, 4 and 9 each have a CARD domain, which facilitates 
interaction between different caspases and between caspases and other 
regulatory and adaptor proteins (Earnshaw et al., 1999). There are two 
categories of caspases, namely initiator caspases (caspase 1, 2, 6, 8 and 
9) and effector caspases comprising caspase 3, 4 and 7 in mammalian 
cells (Table 1.1). Initiator caspases tends to have large pro-domain and 
require oligomerisation and conformational change in order to be 
activated. Activation of effector caspases (caspases with a smaller pro­
domain) involves cleavage on the carboxyl side of aspartate residues and 
assembly of peptide fragments that gives rise to an activated enzyme 
(Prunell and Troy, 2004).
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Once activated, caspases induce cell death by cleaving cytoskeletal and 
associated proteins including kinases, members of the Bcl-2 family of 
apoptosis-related proteins, presinilins, amyloid precursor protein and 
DNA repair enzymes as well as by indirectly activating chromosomal 
endonucleases (Guerin et al., 2006). The expression of caspases varies 
depending on age of the organism. Recently, it has been shown that 
older mouse retinas are more resistant to apoptosis in vitro. This is due to 
lower expression of proapototic factors, such as caspase 3 and 9 in the 
older compared to the younger animals (McKernan et al., 2006). This 
clearly indicates that the caspase profile differs during development and 
adulthood.
Figure 1.2. Structure of mammalian caspase family. Caspases 2,8-10 
containes a pro-domain followed by a large and small subunit while 
caspases 3,6and 7 lacks pro-domain. The pro-domain, which varies in 
length may consists of two DEDs (found in caspase 8 and 10) and CARD 
(found in caspase 2 and 9). Both DED and CARD are absent in caspases 
3, 6 and 9. Figure, a courtesy of Dr. Adrian G Dervan was adapted from 
Kisiswa et al., (2009).
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Table 1.1. Structural and functional characteristic of mammalian neuronal 
caspases8
Active Caspases
Size of pro- subunit proteolytic
Caspase caspase (kDa) Prodomain type (kDa) specificities
ADODtotic initiator casDase
Caspase-2 51 Long with CARD domain 19/12 VDVAD3
Caspase-8 55 Long with two DED domains 18/11 (L/V/D)E(T/V/l)Db
Caspase-9 45 Long with CARD domain 17/10 (L/V/I)EHD
Caspase-10 55 Long with two DED domains 17/12 (l/V/L)EXD
AooDtotic effector casoase
Caspase-3 32 Short 17/12 DE(V/I)D
Caspase-6 34 Short 18/11 (T/V/I)E(H/V/I)D
Caspase-7 35 Short 20/12 DE(V/I)D
aAdapted from Philchenkov (2004) and Kisiswa et al., (2009) with 
modifications.
bThe proteolysis occurs after aspartic acid residues in the Pi position 
cEach amino acid in parentheses is possible
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Table 1.2. Protein substrate of caspases3
Protein substrates Caspases Cleavage
motif
Function of substrate
PARP 3,7 DEVDjG DNA repair enzyme
U1-70kDa 3 DGPDjG Splicing of RNA
DNA-PKcs 3 DEVDjN DNA double-strand-break 
repair
Gas2 3,7b SRVDjG Component of microfilament 
system
Protein kinase C 6 3 DMQDjN Cleaved to active form in 
apoptosis
Pro-IL-1(3 3 DELDjS Regulator of Rho GTPases
Lamin A 6 VEIDJ.N Assist in maintaining nuclear 
shape
Heteroribonuclear 
C1 and C2
proteins 3,7 ? Process of pre-RNA
Huntingtin 3 DXXD Huntington disease gene 
product
Frodin 3C DEADjS Membrane associated 
cytosketal protein
aTable adapted from (Cohen, 1997)and Kisiswa et al., (2009) with
modifications
b(Sgorbissa et al., 1999)
c(Tahzib et al., 2004)
1.2.3.3 Inhibitors of apoptosis (lAPs)
To prevent unnecessary cell death, cells are equipped with molecules 
called lAPs, which are the only known endogenous proteins that 
modulate the activity of both initiator and effector caspases. lAPs are 
members of a protein family characterised by the presence of one or 
more 70-80 amino-acids baculoviral IAP repeats (Vonsattel et 
al.)domains (Fig 1.3). The BIR domains are defined by cysteine and 
histidine-rich protein folding domain that chelates zinc and forms a
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compact globular structure consisting of four to five alpha helices and 
variable number of anti-parallel beta-pleated sheets (Liston et al., 2003). 
There are two types of BIR domains: Type I domains posses a high 
homology with the BIR domains in baculovirus lAPs and are capable of 
binding and inhibiting caspase; by contrast type II domains bind to 
caspases but affect the cell cycle i.e, they are expressed only during 
mitosis where they regulate cell division (Verhagen et al., 2001).
lAPs exert their functions either by binding to pro-caspases and 
preventing their activation, or by binding activated caspases to block their 
activity. Eight mammalian lAPs has been identified, namely, X- 
chromosome-linked IAP (XIAP), cellular IAP (clAP) 1 and 2, testis- 
specific IAP (TsIAP), neuronal IAP (NAIP), Survivin Bruce and Livin have 
been characterised (Prunell and Troy, 2004). With the exception of 
Survivin and Bruce, all mammalian lAPs contain type I BIR domains. 
Different lAPs may contain additional domains, such as the caspase 
recruitment domain (McArdle et al. 2002), which is found in clAP1 and 2, 
and the RING finger domain, which is present in XIAP, clAP1 and clAP2 
(Uren et al., 1996). In addition to their apoptosis inhibition properties, 
lAPs can also function as caspase substrates. In this case, caspases 
cleave lAPs in order to enhance their activity. For example, full-length 
XIAP is a less potent inhibitor of caspase 9 compared to the BR3-RING 
portion (Deveraux et al., 1997). Furthermore, there are a number of 
factors that are able to suppress the IAP activity.
Three mammalian negative IAP regulators have been identified; Smac 
[second mitochondria activator of caspase; known as DIABLO (direct IAP 
binding protein with low pi) in mouse], XIAP-associated factor 1 (XAF1) 
and Omi, a mitochondrial lAP-binding protein. Smac/Diablo positively 
regulates caspase activity by binding lAPs which results in the 
dissociation of lAPs from caspases, which in turn primes the execution 
phase of apoptosis (Duckett, 2005).XAF1 and Omi negatively regulated 
XIAP function by directly binding to XIAP preventing caspase 3 
inhibition(Liston et al., 2001). Interestingly, Omi is also involved in
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caspase-indipendent cell death (Liston et al., 2003). A summary of all 
mammalian lAPs, caspase activity and identified bonding protein can be 
seen in table 3
XIAP
C-IAP2
C-IAP1
NAIP
ML-JAP/Livln
TslAP/ILP-2
Survivin
Bruce/Apollon
Figure 1.3 The mammalian lAPs structure. The lAPs contain one or more 
BIR domains of either type I or II. In addition to the BIR domains, some 
IAP contains a RING zinc-finger domain, which employs E3 ubiquitin 
ligase activity and enables the IAP to catalyze ubiquitination, and a CARD 
domain that allows for homotypic protein-protein interaction. The 
“survivin-like” lAPs (Survivin and Bruce) are the simplest lAPs containing 
only one BIR domain. Figure adapted from Kisiswa et al., (2009) and is a 
courtesy of Dr. Adrian G Dervan.
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Tabel 1.3. lAPs normenclature and their properties. Table adapted from 
Liston et al., (2003).
IAP Alternative Domains Caspase Identified binding
names specificity proteins
NIAP BIRC1 BIR
(Kalloniatis 
et al.)
NOD
LRR
Caspase-3 and -7 Hippocalcin
XIAP BIRC4 BIR Caspase-3 , -7 Smac/DIABLO
API3 (Kalloniatis and -9 Omi/HtrA2
MIHA et al.) XAF1
ILP-1 RING TAB1
NRAGE
C-IAP1 BIRC2 BIR Caspase-3 , -7 Smac/DIABLO
API1 (Kalloniatis and -9 Omi/HtrA2
MIHB et al.) TRAF1
HIAP1 CARD
RING
TRAF2
C-IAP2 BIRC3 BIR Caspase-3 , -7 Smac/DIABLO
API2 (Kalloniatis and -9 Omi/HtrA2
MIHB et al.) TRAF1
HIAP2 CARD
RING
TRAF2
Bc110
Survivin BIRC5 BIR Caspase-3 and -7 B-tubulin
API4 Coiled coil Smac
TIAP (mouse)
Livin BIRC7 BIR Caspase-3 , -7 Smac
KIAP RING and -9
ML-IAP
Ts-IAP BIRC8
ILP-2
BIR
RING
Caspase-9
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1.2.3.4 Non-Apoptotic role of caspases
It is important to emphasise that caspase activation does not always have 
lethal consequences. A large body of literature has documented that 
caspases are involved in various cellular process, including cell 
proliferation and differentiation (Sadowski-Debbing et al., 2002, Schwerk 
and Schulze-Osthoff, 2003).
1.2.3.4.1 Role of caspases in cell proliferation
Several reports suggest that caspases are essential for proliferation of 
immune cells. Utilising caspase inhibitors, it was demonstrated that 
caspase 8 is required for T lymphocyte proliferation (Kennedy et al., 
1999, Alam et al., 1999). In line with this, work carried out on patients 
bearing inactivation mutations in caspase 8 revealed that these patients 
had abnormal proliferation of several immune cells including T and B 
lymphocytes and natural killer (NK) cells (Chun et al., 2002).
1.2.3.4.2 Role of caspases in cell differentiation
The first studies linking caspases to cell differentiation were perfomed in 
lens fibre cells (Ishizaki et al., 1998, Wride et al., 2006). Based on these 
observations it was hypothesised that caspases are involved in cell 
differentiation in various cells including erythrocytes, platelets, osteocytes 
and keratinocytes in addition to lens fibre cells (Oliver and Vallette, 2005). 
In keratinocyte differentiation, Okuyama and colleagues demonstrated 
that caspase 3 is required (Okuyama et al., 2004), while it was also 
reported that caspase 3 is important for efficient erythropoiesis (Carlile et 
al., 2004). Caspases 3 and 9 are also been suggested to be crucial for 
maturation of monocytes to macrophages but not to dendritic cells 
(Sordet et al., 2002). In osteoblast differentiation, caspases 8, 2 and 3 are 
required (Mogi and Togari, 2003)
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1.3 Retina
The retina represents the critical first stage for the transduction of visual 
signals. It is a highly organised multilayered part of the central nervous 
system (CNS) and maintains a high level of metabolic activity. A fully 
developed normal retina is approximately 500 microns thick in human and 
250 microns thick in rat. Morphologically, the retina is composed of RGCs 
which are the output neurons of the retina, photosensors, consisting of 
the rods and cones, horizontal, bipolar, amacrine cells and Muller glia 
(Masland, 2001, Becker et al., 1998). RGCs are located closest to the 
lens, while the photoreceptors are situated against to the epithelium and 
choroid (Guerin et al., 2006).Alteration in viability in RGCs and 
interneuronal connections plays an important role in retinal disorders. 
Investigations performed on the retina over the past few years have 
elucidated the importance of a viable cell body, but little is know about the 
significance of neuronal connectivity in maintaining retinal function
16
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Figure 1.4. Mammalian retinal structure. Retina comprises of different 
cells including photoreceptors, horizontal cells, bipolar cells, amacrine 
cells, ganglion cells and glial cell (not shown on the picture). Picture 
adapted from www.owlnet.rice.edu/-psvc351/imaqelist.htm. Accessed on 
1.6 .2010.
1.4 Retinal ganglion cells (RGCs)
RGCs represent 1% of the total number of retinal cells in the adult retina 
(Young, 1985) and comprise up to 70% of the cells in the ganglion cell 
layer (RGCL; (Isenmann et al., 2003). They are the only retinal neurons 
that project their axons through the optical nerve (ON), optic chiasm (OC) 
and the optic tract (OT) to their main targets, the superior colliculus (SC) 
and lateral geniculate nucleus (LGN) in the midbrain (Isenmann et al.,
2003). Other RCGs targets in the brain include suprachiasmatic nucleas 
(SCN), intergeniculate leaflet (IGL), olivary pretectal nucleas (OPN),
17
Chapter 1 General Introduction
lateral hypothalamus and preoptic regions, which are classified as “non 
imaging structures in the brain” (Hattar et al., 2006, Hattar et al., 2002, 
Morin et al., 2003). In the rat, RGCs are the first cells in the retina to 
differentiate and they start to appear from embryonic day 13 (E13) to E19 
(Dallimore et al., 2002). Genes, such as Pax 6, math 5, sonichedgehog 
(Ashhab et al., 2001) and notch are crucial for the specification of RGCs 
(Guerin et al., 2006). After specification, they migrate to the marginal 
zone of the primitive retina to form the inner neuroblastic layer. During 
migration, RGCs terminates differentiation under the influence of the 
bm36 gene (Gan et al., 1999). They then extend their axons to the ON 
before development of the dendritic tree (Maslim et al., 1986).
Over 90% of RGCs project to the SC, with 10% projecting to the LGN in 
the thalamus in rodents and in primates 90% of RGCs project to LGN. It 
is noteworthy that the primary visual centre is located in the thalamus in 
mammals (Dreher et al., 1985). The projection of the retina is 
topographically well organised and this organisation is highly preserved 
between species. After two weeks of postnatal development, the 
development and fine-tuning of the retino-tectal projections is completed 
and is in the adult state (Isenmann et al., 2003). The retino-tectal map is 
defined by the presence of both an anterior-posterior and a nasal- 
temporal orientation. Axons from the temporal retina project to the rostral 
SC, while the axons from the nasal retina innervate the caudal SC. Axons 
from the ventral retina project to the dorsal SC, while axons from the 
dorsal retina project to the ventral SC (Isenmann et al., 2003).
Morphologically, RGCs are classified into different types based on soma 
size and the architecture of the dendrite arbour (Fig. 1.5). These include 
two major groups: monostratified cells and bistratified cells. The groups 
are further subdivided into subtypes and have different nomenclature 
depending on the species (Sun et al., 2002). In the primate retina, the 
monostratified cells class consists of midget and parasol cells. The vast 
majority of RGCs in primates are the midget cells, which represents 80% 
of the RGCs. They have a medium-sized soma and a fairly small but
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compact and bushy dendritic tree. The second biggest population is 
comprised of the parasol cells that represent 10% of RGCs in the primate 
retina. They have the largest soma and dendritic field among the neurons 
in the ganglion cell layer (Weber et al., 1998). Bistratified cells in the rat 
are small in size with recursive and loop-forming dendrites (Sun et al., 
2002).
Recently, a small number of RGCs that contain an opsin-like protein 
called melanopsin (Opn4) were identified and named melanopsin RGC 
(pRGC; Berson et al., 2002, Sekaran et al., 2005, Semo et al., 2003, 
Hattar et al., 2002). These cells represent approximately 1% of the RGCs 
population in rodents (Hattar et al., 2002, Sollars et al., 2003). It was 
suggested that these cells may serve as photoreceptors that provides the 
SCN of the hypothalamus with photic information (Provencio et al., 2000). 
Further studies demonstrated that this was indeed the case, where it was 
demonstrated that most of the RGCs that project to the SCN were Opn4 
positive(Gooley et al., 2001, Sollars et al., 2003). There are several 
central sites that receive input from the pRGCs. Among these are the 
SCN, IGL, OPN, lateral hypothalamus and preoptic regions (Hattar et al., 
2006, Hattar et al., 2002, Morin et al., 2003). These sites are known to be 
involved in determination of light levels. The Opn4-containing RGCs also 
project to the ventral subparaventricular region and the ventrolateral 
preoptic zone, compartments that participate in acute modulation of 
behaviour and sleep (Gooley et al., 2003). Thus, pRGCs are involved in 
circadian rythme (Barnard et al., 2004, Freedman et al., 1999), 
suppression of pineal melatonin (Lucas et al., 1999), pupil construction 
(Lucas et al., 2001), negative masking behaviour (Thompson et al., 2008) 
and modulation of sleep (Altimus et al., 2008, Lupi et al., 2008).
19
Chapter 1 General Introduction
■ ■ o r
B1
(41%)
/;_;U/ \
\  \ .
C3
(77%)
\S ^ \  k $A
■'*( i V 1 /  /  f  J
■• J V \  V , |  •; 1 / f t
A2 outer
j (»% )
A2 inner
(78%)
i. f
„ ' : //A^ l~-'
v o 7 'V ifX'
B3 inner B3 outer, >
(81%) (41% ) '
W s' B4
(38%)
k' 'v .f<
-^Sr-/! U-" 
• < -,;uV ^1-
v J V-A.V*
v__r~
\\ \
C2 inner
(78%) 02  outer(48%) i*— -J-
A  0 4  inner
-■ ^  7" /
■ i^ T ,-^C 4  outer
- ' • (49%)- \ -% L 
AiH*' v<
(w%>7
- ^ r , . - «&$%{*
r  D ^5Ser D1 outer, (38%)
J
^ T t^ v a  X
>j D2 inner
> (84%)
< /  I f ; , /
> ^ f'C C  *  (HS.
-■>-. ■-
■-^ c/1,/ ! / / / ; . '
^* a : f^c-
D2 outer
(38%)
Figure 1.5. Types of RGC found in the rat retina. Four groups and 12 
subtypes have been identified to date. Percentile in the parenthesis 
indicates average depth of dendritic stratification in the inner plexiform 
layer of the particular subtype. Figure adapted form Sun et al., (2002).
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1.5 RGC death during development
In common with other parts of the CNS, RGCs undergo a substantial 
phase od cell death during development. There are two phases of RGC 
death during development. The first one, an early phase occurs 
immediately after neuronal birth, differentiation and migration, while the 
second one, a late phase, involves physiological cell death, which 
coincides with target innervations (Guerin et al., 2006). The late phase 
has been suggested to occur as a “fine-tuning” cell death, which ensures 
that only target-innervated cells survive. It has been estimated that 90% 
of RGCs undergo apoptosis during development (Galli-Resta and Ensini, 
1996). Interestingly, it has been shown that pRGC population is not 
affected by developmentalcel death, suggesting that the absolute number 
remain the same(Gonzalez-Menendez et al., 2010, Sekaran et al.,
2005).Sekaran and colleagues suggested that the high number of light- 
responsive neurons in eary postnatal days in RGCL in mice is a result of 
overproduction of pRGC (Sekaran et al., 2005).Neurotrophic factors are 
crucial for RGC survival, differentiation and regeneration and are 
expressed by RGCs themselves and other cells in the primary visual 
centre (Herzog and von Bartheld, 1998).
Other factors that are involved in RGC death during development are gap 
junctions. Gap junctions are intracellular channels that allow the cell to 
exchange small molecules including, inositol phosphatidyl 3 (IP3), Ca 2+ 
and second messengers such as cyclic nucleotide. Due to the small size 
of the channels, transfer of proteins and nucleic acid is excluded (Bennett 
et al., 1991). The channels are formed through each cell providing a 
hemichannel, which unites and form a two hemichannels called 
connexons. Each connexon consist of six subunits termed connexins 
(Cx’s) (Sohl et al., 1998). Gap junctions, found throughout the CNS are 
involved in different processes including neurogenesis (Becker and 
Mobbs, 1999), cell death (Lin et al., 1998), pattern formation (Paul et al., 
1995), synaptogenesis (Allen and Warner, 1991, Walton and Navarrete, 
1991) and the synchronization of impulses essential for the sharpening
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ofthe central visual projection (Cook, 1991). Most cells in the retina are 
coupled to each other via gap junctions (Becker et al., 1998).
During early development of chick retina the coupling is heterogenous 
and by E14 only cells with the same morphology are coupled to each 
other (Becker et al., 2002). It has been suggested that Cx43 mediates 
communication between RGCs during development, which may influence 
cell proliferation (Becker and Mobbs, 1999, Ilia and Jeffery, 1996). 
However, the expression decline during mid embryonic stages correlates 
with the end of proliferation and the beginning of the apoptotic period 
(Becker et al., 1998). In other regions of the developing CNS, the 
junctions have been suggested to be utilised for signalling apoptosis to 
the neighbouring cells by permitting the spreading of calcium waves 
suggesting involvement of calpains in cell death (Wolszon et al., 1994). 
The same might applies to RGCs.
1.6 Neurodegenerative diseases
Neurodegenerative diseases are classically defined by the presence of 
neuronal cell death. The group includes AD, which is characterised by 
death of neurons in cerebral cortex (Wenk, 2003), PD where the 
dopaminergic midbrain neurons are deceased (Isenmann et al., 2003), 
HD where neurons in the basal ganglia and cerebral cortex are 
degenerated (Vonsattel et al., 1985) and glaucoma (which will be 
discussed in detail below). In these diseases, neurons die predominately 
through apoptotic mechanisms though other cell death types cannot be 
exclusively ruled out. Terminal deoxynucleotidyl transferas-mediated 
deoxyuridine triphosphate (dUTP) nick end-labelling (TUNEL), which has 
been used for detection of apoptosis in neurodegenerative diseases, is a 
technique used to determine apoptosis by labelling fragmented DNA, but 
this method does not detect alterations in cell morphology. There is 
substantial evidence suggesting that this technique also positively labels 
cell that are undergoing necrosis. Thus, the TUNEL assay is not specific 
for detection of apoptosis. Additionally, there are many reports concluding
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that caspases are required for necrotic death (Yamashima, 2004) and 
activation of other proteases, in particular calpains and cathepsins are 
detected in necrosis (Golstein and Kroemer, 2007).
Calpains are calcium-dependent neutral proteases that are found in two 
isozymes, m- and p-calpains. Calpain is synthesised as an inactive 
heterodimer comprising 30 kDa and 80 kDa subunits. Upon activation, 
the 30 kDa subunit is cleaved to a final active fragment of 17 kDa while 
the 80 kDa is converted to 76 kDa enzymatic active form (Yamashima,
2004). Calpains are activated both during physiological and pathological 
conditions, such as phosphorylation (Melloni et al., 1996), muscular 
dystrophy (Kinbara et al., 1998), AD (Lee et al., 2000) and PD (Mouatt- 
Prigent et al., 1996). Once activated, calpains target cytoskeletal and 
associated proteins, kinases andphosphatases, membrane receptors and 
transporters and steroid receptors (Yamashima, 2004). In neurons, 
calpains are located in the somatodendritic area and in the axons. 
Increased free Ca2+ leads to overactivation of calpains and this result in 
loss of neuronal cell structure integrity and alterations in axonal transport 
(Yamashima, 2004).
Lysosomes house 80 different types of hydrolytic enzymes including 
various isoforms of cathepsins (cathepsins D (aspartyl), B, H and L 
(cysteine)) proteases. In neurons, sustained calpain activation may lead 
to disruption of the lysosome, releasing its contents. Cathepsin D 
mediates neuronal death, which is induced by ageing (Adamec et al., 
2000), while cathepsins B and L execute hippocampal neuronal death 
after global ischemia (Yamashima, 2000). Moreover, in AD and PD in 
particular, cells in an advanced stage of autophagy are frequently 
observed (Yuan et al., 2003).
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1.7 Glaucoma
1.7.1 Introduction to glaucoma
Glaucoma comprises a collection of eye diseases that commonly features 
cupping of the optical nerve head and death of RGCs (Quigley, 1999), 
which in turn leads to blindness in patients. It is the second commonest 
cause of blindness in the world and the leading cause of irreversible 
blindness. Various factors contribute to development of glaucoma 
including age, race, myopia, central cornea thickness and genetics (Pang 
and Clark, 2007). However, the major symptom frequently associated 
with glaucoma is elevated intraocular pressure (IOP), which is influenced 
by the balance between aqueous humoral production inside the eye and 
the aqueous drainage out of the eye through the trabecular meshwork 
(TM). Healthy individuals have IOP between 10-21 mm Hg while some 
individuals may have hypotony low pressure in the eye that can drop to 
0mm Hg. In some glaucoma patients the IOP can exceed 70 mm Hg 
(Khaw et al., 2004).
Different mechanisms have been proposed to contribute to RGC death. 
These include withdrawal of neurotrophic factors, vascular insufficiency, 
immune abnormality, glutamine toxicity and glial activation (Pang and 
Clark, 2007). While there are many dictinct subtypes in human, glaucoma 
can broadly be divided into two groups, namelyprimary open angle 
glaucoma and acute angle closure glaucoma
1.7.2 Primary open angle glaucoma
Primary open andgle glaucoma is defined by the increases resistant of 
the aqueous outflow in the trabecular meshwork or in Schlemm’s canal. It 
is important to note that the precise anomarlity in this type of glaucoma is 
yet to be elucidated. Patients suffering from primary open angle 
glaucoma lose their vision gradually and the manifestation of the clinical 
symptoms usually occurs after severe damage to the retinal ganglion cell
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layer (RGCL). Primary open angle glaucoma has been estimated to be 
the third cause of blindness in the UK (Khaw et al., 2004).
1.7.3 Acute angle closure glaucoma
In acute angle closure glaucoma is characterised by the blockade of the 
aqueous flow from the posterior chamber to the anterior chamber. The 
patients’ eyes become red and painful and they may also experience 
nausea and severe pain or headache (Khaw et al., 2004).
1.8 Experimental models of glaucoma
1.8.1 Introduction
The genetic and pathophysiological complexity of glaucoma has led to 
the need to employ a diverse range of experimental approaches and 
models to understand the molecular mechanisms involved in the disease. 
Several experimental animal models for glaucoma exist including 
monkey, mice and rat each with distinct advantages and pitfalls. The 
disease is induced in these animals by either surgical or genetic elevation 
of IOP (Weinreb and Lindsey, 2005, Morrison et al., 1995, Morrison et al., 
1997, John et al., 1999). Although the animal glaucoma models may not 
reflect the pathophysiology of human glaucoma, they enable the 
comparison of the prosess leading RGC death caused by elevated IOP, 
which may highlight pathways that are specific to increased IOP related 
guacoma versus glaucoma that occurs in absence of elated IOP. 
Elevated IOP causes structural, biochemical and functional changes that 
resemble the changes in the human disease. These modifications include 
disorganisation and compositional alterations in the optic nerve head 
(Bonhoeffer and Yuste, 2002), RGC death and visual deficit (Kuehn et al.,
2005).
25
Chapter 1 General Introduction
1.8.2 Experimental glaucoma in monkeys
Glaucoma can be induced in monkeys in different ways. The most useful 
method is by argon laser photocoagulation treatment to the TM, but the 
most effective technique is diode laser photocoagulation (Wang et al., 
1998, Gaasterland and Kupfer, 1974). Treatment results in whitening of 
the TM and also formation of bubbles. The treated eyes in this model 
develop moderately elevated IOP similar to that one observed in humans, 
varying between 25-60 mmHg (Quigley et al., 1995, Quigley, 1983). The 
elevated IOP can last for weeks to years. Damage to the RGCL can be 
assessed by RGC loss, but there are other ways of evaluating the 
damage in this model (Levkovitch-Verbin, 2004). Quigley and Addicks 
developed another model for producing chronic experimental glaucoma in 
monkeys. They injected autologous, fixed red blood cells into the anterior 
chamber in order to maintain elevated IOP. This model however, has a 
disadvantage of poor visibility of the retina and the ONH (Quigley and 
Addicks, 1980b, Quigley and Addicks, 1980a).
1.8.3 Experimental glaucoma in rats
In rats, experimental glaucoma is induced by translimbal laser 
photocoagulation. This model is postulated to be more reliable, simple to 
produce, reproduce and inexpensive (Levkovitch-Verbin et al., 2002, 
Levkovitch-Verbin, 2004). The treatment is carried out using a diode laser 
to damage the venous drainage from the TM of the animal, which is 
under general anaesthesia. This procedure is very quick; therefore more 
animals can be treated in a short period of time. It is important to 
measure the IOP before the treatment and every 3 days in the first two 
weeks and weekly thereafter. More than two measurements are 
performed and the final IOP value is obtained from the mean calculated 
from all measurements. Immediately after the laser treatment the retina 
and the choroidal blood vessels are observed focusing attention for signs 
of retina oedema and haemorrhage.
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The IOP peak in this model is between 34-40mm Hg, but unfortunately 
IOP goes up and then tends to drop. The axonal loss is gradual with a 
mean loss of axons of approximately 20% at the third week, 25% at the 
sixth week and 50% at the ninth week. Despite the closure of the intra- 
becular spaces and the major out flow channels, the retina and choroid 
continues to appear normal at all times (Levkovitch-Verbin, 2004, 
Levkovitch-Verbin et al., 2002).
The second rat model of experimental glaucoma, which is established in 
our group, was developed by Morrison and colleagues in which they 
increased outflow resistant by microinjecting hyperosmotic saline into the 
episcleral vein of Brown Norway rats (Johnson et al., 1996, Morrison et 
al., 1995, Morrison et al., 1997, Sohl et al.). Initially, the technique was 
effective in half of the animals treated and repetitive injections were 
required in order to increase IOP, but the method has been improved 
notably. The advantage of using BN rats is that the IOP can be measured 
on awake animals (Moore et al., 1995) since anaesthetic has been shown 
to decrease IOP (Jia et al., 2000). Two other models were also 
developed. In the first model, the limbus-draining veins were exposed by 
incising the conjunctiva in order to obtain increased IOP. The elevated 
IOP observed was twice normal and was maintained for a long time and 
at 6 months the loss of RGCs was 40% (Sawada and Neufeld, 1999, 
Shareef et al., 1995). In the second model, the increase in IOP was 
achieved by injecting India ink into the anterior chamber one week prior to 
laser photocoagulation treatment (Ueda et al., 1998).
1.8.4 Experimental glaucoma in mice
The most valuable mouse model of glaucoma is the genetically 
manipulated DBA/2J mouse strain (John et al., 1999). This strain 
develops glaucoma as a result of changes in the anterior chamber. The 
advantage of this model is that it exhibits similar features to pigmentary 
dispersion glaucoma in humans. These DBA/2J mice develop pigment 
dispersion, iris transillumination, iris atrophy, anterior synechiae and
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elevated IOP. Older animals are more likely to get glaucoma and the 
severity also increases with age. The RGC death in these animals is 
mainly by an apoptotic process and the degeneration of the RGCL is 
observed. The genes that contribute to glaucoma in this model are linked 
to chromosome 4 and 6 (John et al., 1998); (John et al., 1999).The 
disadvantage of DBA/2J model is that axon loss in these mice is not 
observed until 9 months, which requires housing the animals for long 
periods increasing experimental cost.
Furthermore, Mabuchi et al induced elevated IOP in mice employing a 
limbal laser photocoagulation technique. The IOP increased by 1.5 fold 
and was maintained for 2 to 12 weeks (Mabuchi et al., 2003). The 
magnitude and duration of elevated IOP correlated with axonal damage. 
Reitsamer developed an acute model by injected hyperosmatic saline in 
the mice limbal to induce glaucoma. At 8 weeks 20% of the axons were 
degenerated (Reitsamer et al., 2004)
1.9 RGCs in glaucoma
A large body of data demonstrates that RGCs in glaucoma undergo 
apoptosis (Cecconi et al., 1998, Neufeld and Gachie, 2003, Quigley et al., 
1995, Spear, 1993). Whether these cells die in a selective or random 
manner is still debatable. There are reports showing that in human and 
monkey glaucoma the large RGCs are more susceptible to apoptosis. 
These findings are based on histological results (Kalloniatis et al., 1993). 
However, findings from psychophysical investigations do not support 
histological data since magnocellular and parvocellular pathway deficits 
lead to similar results (Johnson, 1994, Graham et al., 1996). Morgan and 
colleagues challenged the hypothesis that there is a selective cell loss in 
the RGCs in primates (Morgan, 1994, Morgan, 2002, Morgan et al.,
2000). The authors demonstrated using cell soma analysis that both 
parasol and midget RGCs undergo cell shrinkage to the same extend 
prior to apoptosis (Morgan, 2002).
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Several mechanisms have been suggested to be involved in initiation and 
progression of RGC death. Axonal damage is one of the well recognised 
clinical features of glaucoma (Osborne et al., 1999). The axonal damage 
in the animal model is caused by elevated IOP, but it is important to 
acknowledge that in some glaucoma patients, RGC death occurs despite 
normal IOP. An estimation showed that a third of glaucoma patients do 
not show any defects in IOP (Douglas, 1998, Gupta and Weinreb, 1997). 
Insults to the vascular supply to the ONH can lead to ischemia/hypoxia­
like effects on the RGC axons. Due to the complexity of the vascular 
supply, this can easily be achieved. It has been shown that the blood flow 
to the ONH is altered in glaucoma. These findings clearly support the 
notion that axonal damage in glaucoma is a result of defective vascular 
supply (Osborne et al., 1999). Once the axon injury has occurred, the 
retrograde transport of growth factors is inhibited. In fact, it is suggested 
that the RGCs die because the soma is deprived of growth factors, such 
as brain derived neurotrophic factor (BDNF) that are provided by 
postsynaptic neurons (Jacobson, 1991). Thus, degeneration of RGCs in 
glaucoma occurs as a result of insufficient supply of trophic factors. This 
theory is also supported by studies performed in the rat ONL 
demonstrating that RGCs show a high capacity for axon regrowth and 
survival after treatment with BDNF (Osborne et al., 1999).
The retina contains three different kinds of glial cells; astrocytes, 
microglia and muller cells (Kuehn et al., 2005). Glial cell function under 
normal conditions is to support neurons. Excessive activation of glial cells 
has been suggested to contribute to RGC death. This was shown by the 
increased expression of glial fibrillary acidic protein (GFAP) in astrocytes 
and muller cells in glaucoma (Wang et al., 2000). The decreased glial cell 
support of neuronal function was proposed to be a mechanism underlying 
activated glial-dependent RGC death (Kuehn et al., 2005). This can be 
mediated by decreased biosynthesis of glutamate receptors (Martin et al., 
2002) or increased synthesis of harmful substances such us pro- 
inflammatory cytokines, TNF-alpha (TNF-a; (Tezel et al., 2001), reactive
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oxygen species or nitric oxide (Morgan et al., 1999a). Down-regulation of 
synthesis of glutamate receptors may result in increased glutamate 
concentrations. Excessive amounts of glutamate are toxic to neurons. 
Investigations carried out on cultured RGCs showed that these cells are 
more susceptible to glutamate excitoxicity (Caprioli et al., 1996).
Interestingly, recent discovered pRGCs has been suggested to have a 
preferential survival in glaucoma compared to the rest of RGCs (Li et al., 
2006, Robinson and Madison, 2004, Wang et al., 2008a). The injury- 
resistant feature of pRGC in glaucoma is yet to be eludidated but there 
has been suggestion that the non-uniform immediate early gene 
espression of pRGCs might contribute to the injury-resistant phenotype 
(Robinson and Madison, 2004, Semo et al., 2003). The sparsely 
branching dendritic field property of pRGC may also contribute to their 
increased survival (Berson et al., 2002). Li and colleagues showed after 
ONT and OH, the surviving pRGCs expressed activated Akt (Li et al., 
2008). Previous work from other groups demonstrated that delayed RGC 
death is a result of injury-mediated activation of PI3/Akt signalling 
pathway (Cheung et al., 2004, Huang et al., 2008, Nakazawa et al., 
2002). In contrary, there other reports suggesting that mRGCs are 
equally affect by axotomy as the rest of RGC population (Drouyer et al., 
2008, Jakobs et al., 2005). This discrepancy account for different models, 
survival periods and method of mRGCs quantification has been imployed 
in the different studies.
1.10 Dendrites in development
Neurons are polarised cells consisting of a cell body (also known as 
soma), axons and dendrites. The dendrites are extensions of neurons 
and the collective name for dendrites is the dendritic tree. While the axon 
is the important part of the neuron for transmission of information, in the 
form of action potentials, dendrites are essential for receiving the 
information from the surrounding milieu. For proper function of a neuron, 
the presence of a healthy dendritic tree is essential.
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The development of dendrites is divided into five stages which are: 1) 
polarisation, in which the dendrite attains characteristics such as 
diameter, length, growth rate and molecular composition almost similar to 
those found in the axon (Craig and Banker, 1994); 2) elongation, in which 
they extend in a defined direction and increase their diameter; 3) 
branching, involving the elaboration of the dendritic tree and formation of 
dendritic spines; 4) tiling, involving the spatial segregation of dendrite 
arbours into non-overlapping spatial territories observed in some classes 
of neurons; and 5) synapse formation (Jan and Jan, 2003, Scott and Luo,
2001).
Actin and the microtubule cytoskeleton are the major components that 
regulate dendritic development. In the cortex, filamentous actin (F-actin) 
is ubiquitously expressed in the dendrites, but is enriched in the dendritic 
spines. Microtubulin on the other hand, fills the interior of the dendrites 
(Fischer et al., 1998). Similar to the axon growth cone, dendritic growth 
cones consist of filopodia containing densely packed F-actin bundles. The 
filopodia allows the dendrites to sense the signals in the environment 
(Dailey and Smith, 1996). Thus, the molecules that regulate the actin 
cytoskeleton are also important in dendritic development. These 
molecules includes Rho small family guanosine triphosphate-ase 
(GTPase; Rac, Rho, Cdc42; (Hall, 1998). In their active form (GTP- 
bound), they function as molecular switches and signal transducers (Scott 
and Luo, 2001). Microtubules provide structural integrity for the dendrite. 
It was demonstrated that by silencing microtubule-associated protein 
(MAP2) utilising antisence oligonucleotides, the cultured neurons failed to 
form dendrites (Caceres et al., 1992). Moreover, microtubules in 
dendrites have a bi-directional orientation; they have both a plus-end- 
distal and minus-end-distal orientation (Craig and Banker, 1994). This 
has been suggested to be important for the differentiation and 
maintenance of dendritic structure (Scott and Luo, 2001).
Dendrite pruning is essential for development of neurons of both the CNS 
and peripheral nervous system (PNS). In general, an increased dendrite
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complexity is thought to enhance the number of synapses made on the 
neuron. Thus, a neuron with a highly complex dendritic tree is more 
susceptible to changes in its input structure from a variety of sources 
(Hickmott and Ethell, 2006, Kolb and Whishaw, 1998). Different factors 
can influence dendrite structure. These include external factors such as 
neurotrophins, Semaphorin 3A (Sema3A) and dendrites arborisation and 
synapsematurationl (Dasmi) as well as internal factors, including 
synaptic activity among others (Hickmott and Ethell, 2006).
1.10.1 External factors
Neurotrophins. Neurotrophins are a group of growth factors that comprise 
of nerve growth factor (NGF), Brain-derived neurotrophic factor (BDNF), 
neurotrophin-3 (NT-3) and neurotrophins-4 (NT-4) in mammals. They are 
involved in diverse cellular processes, such as neuronal survival, 
proliferation, axonal and dendrite growth, membrane trafficking, synapses 
formation and plasticity (Herzog and von Bartheld, 1998). Neurotrophins 
mediate their effects though interaction with a high affinity receptor 
tyrosine kinases (Trk receptors) and a low affinity receptor p75 (Guerin et 
al., 2006). NGF was first shown to mediate axonal growth in the PNS, but 
later it was demonstrated to induce dendritic growth and maintain 
dendrites in the PNS (Huang and Reichardt, 2003). Other studies 
demonstrated that neurotrophins control dendritic growth and 
arbourisation in the CNS, in particular pyramidal neurons in the 
developing visual cortex. BDNF increases the length and complexity of 
basal dendrites in pyramidal neurons of layer IV, whereas NT-4 exerts its 
effect on neurons in layers V and VI. On the other hand, apical dendrites 
respond to all four neurotrophins (McAllister et al., 1995).
Sema 3A. Sema3A is a soluble protein that belongs to the Semaphorin 
family, which consists of 20 membrane-bound and soluble proteins. 
Sema3A was characterised as an axonal guidance protein, but this 
protein is also directly involved in growth of apical dendrites of pyramidal 
neurons towards layer 1 in the cerebral cortex (Polleux et al., 2000). The 
mechanism behind the changes of Sema3A status (i.e. from being an
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axonal growth factor dendrite growth factor) is thought to involve cyclic 
nucleotide gunosine 3'/5'-monophosphate (cGMP). When the 
concentration of cGMP is increased in the axon, Sema3A becomes 
axonal repulsive and converts to a dendrite attractant (Song et al., 1998). 
It was shown that the enzyme that produces Sema3A is asymmetrically 
localised to the apical dendrite and it seems to be essential for dendrite 
attraction (Polleux et al., 2000). Sema3A knockout mice showed impaired 
orientation of pyramidal axons and dendrites in the cortex. Moreover, 
others investigations performed on Sema3A demonstrated reduced 
dendrite length and branching in Sema3A null mice. The authors 
postulated that the protein is required for development of dendrite arbours 
in the neocortex (Fenstermaker, 2003). The promiscuous effect of 
Sema3A is mediated by neuropilin-plexin receptor complex (He et al.,
2002) but the mechanism remains elusive.
Dasm 1. Dendrite arborization and synapse maturation 1 (Dasml) has 
also been suggested to be involved in dendrite remodelling (Shi et al., 
2004b). Although still uncharacterised, its resemblance to Robo, a cell- 
surface receptor involved in axonal guidance, suggested Dasm 1 to be a 
receptor (Falls, 2005). The receptor was shown to regulate dendrite 
elongation and branching and also strengthen the glutamergic synapses. 
Downregulation of Dasm 1 using RNA interference inhibited the 
elongation and branching of dendrites but had no effect on axons in 
cultured hippocampal neurons. Furthermore, reduction of Dasm 1 leads 
to a decreased number of a-amino-3-hydroxy-5-methylisoxazole-4- 
propionic acid receptors (AMPAR) receptors (a type of glutamergic 
receptors). Overall, Dasm 1 is involved in controlling neuronal input and 
might also be involved in neuronal plasticity throughout life (Shi et al., 
2004a, Shi et al., 2004b).
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1.10.2 Internal factors
Synaptic activity, NMDAR, Calcium (Ca2+), CaMII and CaMIV. Changes 
in intracellular Ca2+ have been suggested to regulate dendrite 
morphology (Wong and Ghosh, 2002). Increased intracellular Ca2+ 
following activation of N-methyl D aspartate (NMDAR) receptors or 
voltage-gated Ca2+ channels leads to activation of Ca2+s-dependent 
kinases; calcium calmodulin kinase II (CaMII) and CaMIV. CaMII induces 
Ras- and mitogen-activated kinase (MAPK)-mediated structural changes 
in dendritic morphology, whereas CaMIV activates cyclic adenosine 
monophosphate (Balosso et al.)response element binding protein 
(CREB)-mediated transcription (Redmond and Ghosh, 2005). In 
hippocampal neurons, it was shown that constant changes in dendritic 
architecture following multiple depolarisation was dependent on Ras and 
MAPK activation inducing local cytoskeletal changes (Wu et al., 2001). 
Activation of CaMIV and CREB-mediated gene expression in cortical 
neurons in vitro play a role in calcium-induced dendritic growth (Redmond 
et al., 2002). The overexpression of active CaMIV induces dendritic 
growth while a kinase-dead form of CaMIV or dominant-negative form of 
CREB suppressed calcium-dependent dendritic growth (McAllister, 2000).
1.11 Dendritic spines
Dendritic spines are small protrusions on dendrites that receive over 90%  
of excitatory input and are highly dynamic. Generally spines consist of a 
head attached to a dendrite through a stalk. They are morphologically 
divided into several types namely; stubby, thin, mushroom-shaped and 
cup-shaped (Dunaevsky et al., 1999). The formation of a spine is 
believed to involve dendrite filopodia and growth of presynaptic elements, 
although all dendrite filopodia seen at early stages do not transform to 
spines in adults. This suggests that both extrinsic and intrinsic factors 
regulate spine formation (Bonhoeffer and Yuste, 2002). The motility of the 
spines is highly dependent on the polarisation of actin filament. Various 
molecular families are known to regulate actin dynamics which in return 
plays a crucial role in dendritic spine morphogenesis (Fischer et al.,
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1998). These include receptors, scaffolding proteins and regulators of the 
cytoskeleton (Lippman and Dunaevsky, 2005). Changes in spine number 
and morphology are associated with changes in neuronal activity 
(Bonhoeffer and Yuste, 2002) while the size of the spine head correlates 
with synaptic strength (Lippman and Dunaevsky, 2005).
1.12 Dendrite remodelling of RGCs
All neurodegenerative diseases exhibit alterations in dendrite structure. In 
AD, progressive loss of dendritic spines is observed (Fiala et al., 2002). 
Fewer dendritic spines are observed in PD (McNeill et al., 1988), while in 
moderate HD, the striatal neurons show an increased in the density of 
dendritic spines, progressing to a marked loss of spines in advanced 
disease (Ferrante et al., 1991)
Dendrite atrophy and remodelling have been revealed to be the earliest 
sign of glaucoma in primates (Liets et al., 2006, Morgan, 2002) and also 
in a feline model of glaucoma (Shou et al., 2003). Dendrite atrophy 
occurs primarily due to axotomized RGCs. This axonal damage deprives 
the RGCs of neurotrophin support and the first part to be affected by the 
insufficient nutrients supply is the dendritic tree (Brannstrom et al., 1992, 
Thanos, 1988, Yawo, 1987). There is evidence pointing to a reduction of 
axonal thickness occurring at the same time as changes in the soma, but 
after alterations in dendrite structure. The structural changes include 
slimming of both proximal and distal dendrites and generally decreased 
complexity of the dendritic tree (Weber et al., 1998).
Morgan and colleagues showed that dendrite remodelling also occurs in 
the experimental rat glaucoma model (Morgan, 2002). The authors 
postulated that this observation suggests that global remodelling takes 
place prior to cell loss in glaucoma. Primate and mouse studies confirmed 
that alteration of the dendritic structure results in alterations in neuronal 
function; in particular, the action potential becomes more randomly 
(Jakobs et al., 2005, Weber and Harman, 2005) and contrast sensitivity
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and receptive field size are reduced, contributing to decreased efficient 
spatial summation. These alterations correlate with the symptoms seen in 
glaucoma in which variability in visual field sensitivity is manifested as an 
early feature of disease.
To date, very little attention has been paid to elucidating the molecular 
mechanisms that are involved in dendrite self-destruction. Whitmore 
suggested that the possible mechanisms could BCL-2 proteins, which are 
critical for regulation of apoptosis and appear not to be involved in axonal 
degeneration. This was demonstrated by experiments on explants culture 
in the absence of pro-apoptotic BCL-2 family members, where Bax and 
Bak did not show axonal degeneration (Whitmore et al., 2005).
1.13 Caspases and lAPs in dendrite remodelling
Alpha-Fodrin (a-fodrin) is a neuronal cytoskeleton protein that is targeted 
by caspase 3 (Tahzib et al., 2004). It is the first protein to be cleaved 
during apoptosis. a-Fodrin has been shown to co-localise with 
neurofibrillary tangle in AD. Recent research found a large accumulation 
of abnormal deposits of caspase 3 cleaved a-fodrin in many viable 
neurons (Tahzib et al., 2004). Furthermore, a significant investigation 
carried out by Williams and colleagues revealed that in Drosophila 
neurons during development, dendrite pruning was modulated by local 
caspase activity. The authors also reported that overexpression of 
Drosophila inhibitor of apoptosis 1 (DIAP1), which is a negative regulator 
of the Drosophila effector caspase DRONC, resulted in suppressed 
removal of the dendrites (Williams et al., 2006).
Moreover, other additional caspase regulation levels have been proposed 
(Montell, 2006). A mutation in the ubiquitin activation enzyme (Uba1) and 
the proteasome complex protein (mov34) is capable of hindering efficient 
remodelling of Drosophila C4da peripheral sensory neuron in larval 
metamorphosis (Kuo et al., 2005). A follow up study carried out by the 
same group revealed that the ubiquitin proteasome system (UPS)
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activation of the C4da neurons likely results in E2 ubiquitin-conjugating 
enzyme (UbcD1) mediated degradation of DIAP (Kuo et al., 2006). 
Additionally, another mechanism for degradation of DIAP has been 
discovered in which a newly described kinase called Drosophila IKK- 
related kinase (DmIKKs) is involved. Elimination of DmIKKs in sensory 
organelle precursor (SOP) development resulted in stabilisation of 
endogenous DIAP and this had a negative effect on Drosophila SOP 
development (Kuranaga et al., 2006). Furthermore, Oshima and 
colleagues revealed that IKKe regulates F-actin assembly, which plays an 
important role in cell morphogenesis. F-actin is required for maintenance 
of polarised elongation of the cell during morphogenesis (Oshima et al.,
2006).
Taken together, these data indicate that tight regulation of local caspase 
activity is very important for dendrite pruning in Drosophila development. 
How this process is restricted to dendrites without affecting the other 
parts of the cell may be explained by the dendrite-specific trafficking of 
UPS components resulting in the local degradation of dendritic lAPs and 
activation of caspases (Kuo et al., 2006). The other possibility is that 
activated DRONC cleaves a dendrite-specific substrate (Kuo et al., 2006). 
It is still unclear as to whether the same mechanisms as those in 
Drosophila apply to vertebrates and also whether similar mechanisms for 
dendrite remodelling occur during development and disease. However, 
elevated IOP in glaucoma leads to drastic environmental changes. 
Dendrites are susceptible to these changes and this leads to the 
remodelling and subsequent removal of dendrites prior to cell death.
Moreover, there is accumulating evidence supporting the role of 
apoptosis in regulating synaptic plasticity (Gilman and Mattson, 2002, 
Mattson and Duan, 1999). Mitochondria are key organelles that control 
synaptic plasticity through various mechanisms, including regulation of 
apoptosis signalling pathways (Mattson, 2006). Activation of caspase 3 
has been shown to cleave glutamate receptor or associated protein,
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which, in turn, leads to synaptic plasticity (Glazner et al., 2000, Lu et al., 
2002, Lu et al., 2006).
1.14 Summary
Generally, neural function in health and disease is dependent on a viable 
cell body and inteneuronal connections. Recent studies have made it 
clear that the changes in the dendritic tree occur as an early event in 
most neurodegenerative diseases including AD, PD and glaucoma 
(Deutch, 2006, Knobloch and Mansuy, 2008, Liets et al., 2006, Morgan et 
al., 2006, Zaja-Milatovic et al., 2005).And yet our understanding of the 
molecular mechanisms that modulate this changes is limited. The rapid 
development of non-invasive imaging techniques such as ocular 
coherence tomography (OCT) and Optophysiology shows a promising 
future in detecting changes in dendrites in the near future (Bizheva et al.,
2006).
There is a possibility of rescuing cells yet to undergo apoptosis; i.e. 
before they reach the point of no return, which is characterised by 
activation of effector caspases. Removal of dendrites results in the cell 
losing its support from the surrounding cellular milieu and this can 
facilitate cell death. The possibility of detecting the changes in dendritic 
structure associated with early stages of disease provides a window of 
opportunity for rescuing the cell from undergoing apoptosis. Attempts to 
rescue the cell by manipulation of the neurotrophin axis (Chen and 
Weber, 2001); (Martin et al., 2002) and cognate receptor trkB6 (Cheng et 
al., 2002) have shown low efficiency and clearly additional therapeutic 
strategies are required. Therefore, it is important to elucidate the 
molecular mechanisms underlying dendrite pruning in neurodegenerative 
diseases because this could provide insights into which molecules to 
target in order to obtain efficient therapeutic effects for neuroprotection.
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1.15 Hypothesis and aims of the study
1.15.1 Hypothesis
It is hypothesised that lAPs are differently expression in RGC which leads 
to differential modulation of caspase activity in these neurons, thereby 
providing molecular control of dendrite maintenance and remodelling as 
well as neuronal cell death in ageing and neurodegenerative diseases.
1.15.2 Aims
1. To characterise the expression pattern of caspases and lAPs At 
RNA level during maturation and ageing of BN and Wistar albino 
rat retinae.
2. To determine wether the expression pattern at RNA level 
correlates with expression pattern at protein level.
3. To evaluate the involvement of differently expressed IAP in 
maintenance of the cells in the BN RGCL.
4. To investigate whether there is any alteration in retinal cell density 
during retina maturation of BN rat.
5. To determine when dendrite pruning starts and the extent to which 
dendrite pruning occurs in adult rat retina.
6. To characterise the expression profile of pro-apoptotic and survival 
pathway molecules in glaucomatous eyes in order to identify 
molecules that could be targeted for therapeutic purposes in order 
to rescue RGC death.
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2.1 Animal husbandry
Adult BN rats (retired male breeders) of age range: mature (male, 24-52 
weeks), young adults (male, age 6 weeks), adult (male, age 10 and 16 
weeks) and adult Wistar albino (male and female) rats 16-24 and 88 
weeks in this study were fed rodent global diet pellet (Harlan, UK) and 
given water ad libitum. All experiments were conducted in accordance 
with Home Office (UK) regulations and ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research.
2.2 Retina dissection
2.2.1 Retina dissection for RNA analysis
Retinae were dissected before noon in order reduce variation that are 
caused by Circadiam rythme. BN rats (n = 3 for RT-PCR and n=6 for real 
time PCR in each group) and Wistar albino rats 16-24 months (n=4) and 
88 months (n=5) were sacrificed using an overdose of CO2. The eyes 
were immediately removed and stored in cold sterile RNA-free phosphate 
saline buffer (PBS), pH 7.4 (Sigma-Aldrich, Dorset, UK) awaiting 
dissection (2-5 minutes). The retina was dissected, removing the anterior 
chamber, the lens and vitreous (Kretz et al., 2007) in cold PBS under cold 
conditions and placed in RNase-later (Qiagen, West Sussex,UK) 
immediately after dissection. The samples were stored at 4°C until further 
analysis.
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Figure2.1.A schematic diagram showing retina dissection.A. The cornea 
is cut along the corneo-scleral rim as indicated by the red dotted line. B. 
The iris and the lens are then removed. C. The vitreous is removed using 
fine forceps. The retina is then detached from the eye cup by insertion of 
forceps branches between retina and eye cup and shearing forceps and 
eye cup in opposite directions (red arrows). Figure adapted from Kretz et 
al., (2007).
2.2.2 Retina dissection for protein isolation and 
immunofluorescence
Animals (n = 6 for each experiment) were sacrificed using an overdose of 
CO2. The eyes were immediately removed and stored in sterile PBS pH 
7.4. The retina for protein isolation was dissected in sterile PBS under 
cold conditions and stored in sterile PBS immediately after dissection at - 
20°C. The eyes used for immunofluorescence were dissected and the 
eye-cups were stored in 4% paraformaldehyde solution for further 
analysis (see appendix). All samples were stored at 4°C for further 
analysis.
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2.2.3 Retina dissection for explants culture
Eyes were immediately removed from CO2 overdosed animals and stored 
in cold sterile PBS. The retina was dissected immediately under cold 
conditions and transferred to a millicell nitrocellulose insert (Millipore, 
Hertfordshire, UK) with RGC side facing upwards.
2.3 Retina shavings
The retina is a multi-layered tissue where each layer contains different 
cell types. This facilitates enrichment of cells in a particular layer. Retinal 
shaving is a technique, first developed by Sokolov and colleagues 
(Sokolov et al., 2002)which can be usedto enrich the harvesting of 
selected cell types in the retina (Fig 2.2). Retinal flat-mounts were 
transferred with ganglion cell side facing up to a millicell nitrocellulose 
insert (Millipore, Hertfordshire, UK). The nitrocellulose membrane with 
overlying retina was then flat mounted on a glass coverslip and frozen 
immediately frozen by putting the sample in the cryostat set at -20°C. The 
retina was aligned with the cutting surface of the cryostat and 20 microns 
of RGCL shaved from the retina and transferred directly to ice cold 0.1M 
PBS pH 7.4. Both retinae from a single animal were processed in this 
way to provide a single sample. The remaining retina was immediately 
thawed and washed off the membrane using PBS and retained for further 
analysis.
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Figure 2.2. A schematic imaging showing retina shaving as done by 
Sokolov et al., (2002). A. The shaving technique. B. Staining of different 
photoreceptors markers. C. Schematic drawing of photoreceptors
2.4 Reverse transcriptase -PCR (RT-PCR)
2.4.1 Principle
The polymerase chain reaction (PCR) is a method that allows logarithmic 
amplification of a gene of interest (Fig. 2.3A-B). This is important because 
it generates enough starting material for subsequent analysis, such as 
gene sequencing and quantification of gene expression. PCR is divided 
into different sub-categories including RT- PCR, also known as 
conventional PCR, which is a semi quantitative PCR and real time-PCR, 
which is considered more quantitative (see section 2,4 for further details). 
The basic principle in both sub-categories is that a DNA template from 
the gene of interest is exponentially amplified over several (usually 20-35) 
cycles.
The three major steps of PCR are denaturation, annealing and extension 
(Fig 2.3B). Denaturation, which is usually performed at 94°C, is when the 
double stranded DNA is heated up, disrupting hydrogen bonds (a type of
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attractive intermolecular force that exists between two partial electric 
charges of opposite polarity, thus the weak positive charge property of 
hydrogen attracting an electronegative atom of molecules such as oxygen 
and nitrogen) between the strands leading to single stranded DNA. There 
is no enzymatic reaction at this temperature. During annealing, the 
primers are moving around and ionic bonds are constantly formed 
between single stranded primers and DNA. Since the primers are small 
they will bind first before the single strands gets a chance to bind to each 
other. When the primers find their complementary sequence they bind 
and form stable ionic bonds (very strong bonds with high melting 
temperature that are formed between two ions (ions are atoms with 
unequal number of protons and electrons)) and this generate a small 
segment of double stranded DNA. This facilitates the attachment of 
polymerase (an enzyme used for creating a new DNA/RNA strand using 
an existing DNA/RNA strand as a templet so that the templet can be 
copied).
The annealing temperature (Ta) is usually 5-10°C below the melting 
temperature (Tm) of the primers. Ta describes the temperature at which 
50% of the oligonucleotide-target duplexes have formed. The third step of 
PCR is extension, which takes place at 72°C. This is the ideal working 
temperature for the tag polymerase. RT-PCR has a number of limitations 
including low sensitivity detection with ethidium bromide, which leads to 
unreliable results. The detection of the RT-PCR samples requires post­
amplification processing, which can increases the cross-contamination of 
the samples. Amplicons can be visualised only after the amplification 
ends.
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required for DNA amplification. These are denaturation, annealing also 
know as hybridisation and extension. (B) Schematic representation of the 
method, from one molecule to hundreds.
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2.4.2 Design of primers
2.4.2.1 Background
Primers are short oligonucleotides (20-30bp) that function as starting 
point for DNA amplification. When designing primers several criteria have 
to be reached. These include designing primers with annealing 
temperature of 60°C for amplification of short products (100-250bp). 
Usage of longer products reduces sensitivity because of increased 
potential for multiple melting domains with complicated melting curve. 
The percentage of GC (guanine and cystosine) in the primers should not 
exceed 50%. This is because the GC interaction has three hydrogen 
bonds and therefore, requires more energy for disruption. Secondary 
structures should also be taken in account because they can affect the 
efficiency of the amplification. Generally, primers with high delta-G values 
produce less secondary structures and are therefore favoured in the 
amplification reaction. Low delta-G values indicate a strong and high level 
of secondary structure and therefore values above -1 are favoured.
2.4.2.2 Procedure
Primers (Sigma-Aldrich, Dorset, UK) were designed for the following 
genes; Beta- (P-) tubulin, /3- actin andGAPDH, which were used as 
loading control (endogenous control), initiator caspase 6, 7, 8 and 9 and 
effector caspase 3. Primers were also designed for several lAPs. These 
included B ird, also known as neuronal IAP (NIAP), Birc2, cellular IAP 1 
(clAP1), Birc3, (also called clAP2), Birc4, also known as X-chromosome 
linked IAP (XIAP), Birc5, also called Survivin, Birc6, also known as Bruce 
and Birc7, also known as Livin. Sequences for all genes were obtained 
from the NCBI (http://www.ncbi.nlm.nih.gov/SNP) or Ensemble database 
(http://www.ensembl.org/index.html). A portion of the Fasta (DNA and 
protein sequence alignment software) sequence was evaluated using 
BLAST (http://www.ensembl.org/Multi/blastview) to identify variation and 
intron-exon boundaries. The Fasta sequence with the least variation was 
copied and pasted in Primer 3 software
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(http://fokker.wi.mit.edu/primer3/input.htm). Primer length (18-27), melting 
temperature (57-63°C) and product size (150-250bp) were selected. 
Primers with lowest percentage GC values were selected for further 
analysis. Secondary structure profiling software 
(http://www.bioinfo.rpi.edu/applications.hybrid/twostate-fold.php) was 
used to determine the secondary structure of both forward and reverse 
primers. The primers with delta-G value greater than -1 were chosen 
(Table 2.1).
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Table 2.1: Primers used in this study
Gene Primer sequence Ta (°C) Cycle no.
Caspase 3 Forward:AGGGGCATGTTTCTGTTTTG 
Reverse: CATTGCAGGCAGTGGTATTG
59 28
Caspase 6 Forward: TGAAGGAGCTGCTTTTCCAT 
Reverse: ATCAAGCAGGCTCGAGTTGT
61 35
Caspase 7 Forward: TACT GT GAGCAT GGCCT CT G 
Reverse: CAACAGCCACCI I I ICCAAT
59 32
Caspase 8 Forward :TAAAAAGCAGCCCAGAGGAA 
Reverse: AT CAAGCAGGCT CG AGTT GT
61 35
Caspase 9 Forward :TCATT CTT GCAAAGCAGT GG 
Reverse: TGGGTGTTTCTGGTGTGAGA
59 28
Birc 1 (NIAP) Forward: AAGGCAGGGCCAAAAGTTAT 
Reverse: GAGCATGCAGCAACTGTGTT
59 30
Birc 2 (clAP1) Forward: AGCTTGCAAGTGCTGGATTT 
Reverse: CTCCTGACCCTTCATCCGTA
59 34
Birc 3 (CIAP2) Forward: TTCCCTCAGACCCTGTGAAC 
Reverse: GCAAAGCAGGCCACTCTATC
59 29
Birc 4 (XIAP) Forward: GACAAAT GT CCCAT GT GCT G 
Reverse: CTAAT GGACT GCG AT GCT GA
59 30
Birc 5 (Survivin) Forward: TGCAAAGGAGACCAACAACA 
Reverse: AAGCTGGGACAAGTGGCTTA
59 34
Birc 6 (Bruce) Forward: GGTCACAGAACACGCTCAGA 
Reverse: CCTGCCTCAAAGAAGCAAAC
59 27
Birc 7 (Livin) Forward: TCTTCTGCTACGGGGGTCTA 
Reverse: TCCTGTTCTTCCCGTTGTTC
59 29
GAPDH Forward: GAAGGGCTCATGACCACAGT 
Reverse: GGAT GCAGGGAT GAT GTT CT
61 35
Beta-Actin Forward: TT GCT GACAGGATT GCAGAAG 59 
Reverse: TAGAGCCACCAATCCACACA
35
Beta tubulin Forward: ACCGAAGCTGAGAGCAACAT 
Reverse :GAAACAAAGGGCAGTT GGAA
59 27
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2.4.3 RNA extraction
RNA was extracted using the Qiagen mini kit (Qiagen, West Sussex, UK) 
according to manufactures’ instructions. Briefly, the retina was 
homogenised in RTL buffer containing 1% p-mecaptoethanol. One 
volume of 70% ethanol was added to the homogenised lysate and the 
sample was mixed well by pippeting up and down. The samples were 
then transferred to a RNase mini column placed in a 2 ml collection tube 
and was centrifuged in a table centrifuge at max speed at 13000rpm 
(Jencons PLS, Leicestershire, UK) for 15 seconds. The flow through was 
discarded and DNASE1 (Qiagen, West Sussex, UK) added to the column 
and incubated at room temperature for 30 minutes.Further centrifugation 
was performed in order to remove the DNASE 1 and RW1 buffer was then 
added to the column. Again the samples were centrifuged and the flow 
through was discarded. RPE buffer containing ethanol was added to the 
column and centrifuged at 2 minutes at max speed. More centrifugation 
was carried out to remove the remaining RPE buffer and RNase-free TE 
Buffer (Invitrogen, Paisley, UK; 30-50pl) was added directly to the column 
and incubated for 1-2 minutes. After incubation, the samples were 
centrifuged for 1 minute in order to elute RNA. The RNA was then stored 
at -20°C.
2.4.4 Quantification of RNA
RNA was quantified using either an Picodrop (3pi sample required; 
Picodrop limited, Saffron Walden, UK) or Nano-drop (1pl sample 
required; Labtech, East Sussex, UK) spectrophotometer. RNA 
concentration (ng/pl) and purity can be obtained using this methodology. 
The spectrometer measures total nucleic acid content at 260 and 280 nm. 
The machine then calculated the 260/280 ratio.A ratio between 1.9 and
2.3 suggested that the RNA is pure, thus no contamination. Unfortunately 
both DNA and RNA have the same wavelength (260nm), which makes it 
difficult to determine whether the RNA is free of DNA in case of 
contamination. Buffer contamination also gives poor 260/280 ratio. An
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example of RNA concentration and purity can be seen in S1 in appendix 
III.
2.4.5 RNA denaturation gel
For assessing the quality and the yield of the RNA, denaturing agarose 
gel electrophoresis of RNA was employed. This system was also used to 
determine RNA secondary structure. Most RNA forms extensive 
secondary structure by intermolecular base pairing. MESA buffer 
containing 20mM MOPS solution, 2mM sodium acetate and 1mM EDTA 
(Sigma-Aldrich, Dorset, UK)were used for making the gel and running 
buffer. Agarose gel (1.2%) containing 37% (2.3M) formaldehyde was 
prepared and equilibrated for 30 minutes in running buffer (MESA buffer 
containing 37% (2.3M) formaldehyde) prior to running the gel. Meanwhile, 
RNA samples were prepared. RNA (5pl) was mixed with 10pl loading 
buffer and heated for 10 minutes at 65°C. The samples were then chilled 
on ice prior to loading. Ethidium bromide (EtBr, Promega, Hampshire, 
UK) is an intercalating agent that is used for staining nucleic acids and 
when exposed to UV light it fluorescence. Intact RNA will give two bands, 
28S rRNA (the heavier band) and 18S rRNA (the smaller band). The 
heavier band should be more intense than the smaller band in a ratio of 
2:1 (28S:18S) if the RNA is intact. In order to visualise the RNA with EtBr, 
at least 200ng of RNA should be loaded. Some RNA preparations such 
as preparation using needle biopsies may result in a low RNA yield. The 
RNA gel was initially run at 40V for 10 min and then at 80V for 30 minand 
visualized under UV light in (UVP-Bio Doc-lt™ Systems, Cambridge, UK). 
Gel images were captured using VisiDoc-it Systems (UVP-Bio Doc-lt™ 
Systems, Cambridge, UK) equipped with a thermal printer (Sony, Japan)
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2.4.6 cDNA synthesis
Total RNA (50ng-1pg) was transcribed using the reverse transcriptase kit 
(BIOLINE, London, UK) according to manufactures’ instruction. Briefly, 
RNA was primed at 65°C for 10 minutes. Reverse-transcription was then 
achieved at 42°C for 30 minutes. Oligo (dt)i8 was used for RT-PCR in 
order to distinguish mRNA from other RNA species. It is possible to use a 
higher temperature i.e. 50°C to increases the yield of cDNA synthesis if 
the sample has a complex RNA secondary structure but the yield of the 
majority of normal RNA molecules is reduced. No RT controls were 
included for all genes in this study.
2.4.7 cDNA amplification
The cDNA was amplified using 0.025 U/pl of Taq polymerase (Qiagen, 
West Sussex, UK). All products were optimized for cycle number to 
ensure a linear signal. All primers were used in a concentration of 
0.25pM, unless indicated. PCR products were separated on a 1.5% 
agarose gel containing EtBr (Promega, Hampshire, UK) and visualized 
under UV light (UVP-Bio Doc-lt™ Systems, Cambridge, UK). Gel images 
were captured using VisiDoc-it Systems (UVP-Bio Doc-lt™ Systems, 
Cambridge, UK) equipped with a thermal printer (Sony, Japan)
2.4.8 Quantification the RT-PCR bands
Quantification was done using the ImageMaster ID prime program 
(Pharmacia Biotechnologies Inc, San Francisco, USA) where the band 
density was measured and normalised to (3-tubulin band intensity.
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2.5 Real-time PCR
2.5.1 Principle
In contrast to conventional RT-PCR, where the product can only be 
visualised after the amplification end, with real-time PCR (also known as 
quantitative PCR (QPCR)), the gene of interest is amplified and quantified 
while the reaction is running. This is accomplished by detection of 
fluorescence emitted by accumulating PCR product at each PCR point. 
The intensity of fluorescence is proportional to the concentration of the 
amplified gene of interest. There are two methods of detecting the 
amplification using real-time PCR. These includes using SYBR green (a 
fluorescent dye), which binds to the amplified cDNA or flourogenic 
probes, which are single stranded oligoneucleotid of 20-26 nucleotides 
and are designed to bind the DNA sequence between the two PCR 
primers. These fluorogenic probes allow only fluorescent signals from 
specific PCR products. The most used amplification detection method is 
uses SYBR green because of its high sensitivity, however it does not 
discriminate between the amplification of target gene and non-specific 
amplification of related sequence and/or primer artefacts.
2.5.2 cDNA synthesis
RNA obtained as described in section 2.3.3 was converted to cDNA. The 
cDNA synthesis was done as described in section 2.3.6, the difference 
here was that random hexamers were used instead of oligodt-
2.5.3 Real-time PCR procedure
The standard curve for the real time PCR was prepared with 6 weeks old 
BN retinae cDNA, which was synthesised as described above. The 
standard curve consisted of consecutive dilutions 1, 1/4, 1/16, 1/64 and 
1/256, in RNase/DNase free water (Qiagen, West Sussex, UK). cDNA 
(2,5|il) was amplified in a 25-pl reaction volume using the SYBR@ Green
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JumpStart™ Taq Readymix™(Sigma-Aldrich, Dorset, UK) kit according to 
manufactures’ instructions. Primers were used at a concentration of 
0.6pM. PCR was performed using a Cobrett PCR machine (Corbett 
research limited, Cambridge, UK) with an initial denaturation step at 95°C 
for 5 minutes and for 45 cycles of 94°C for 30 seconds, 59-61 °C 
depending on the gene being amplified for 1 min, and 72°C for 30 
seconds. Cycling was followed by a 1 minute hold at 65°C. A melting 
curve was obtained to confirm that the SYBR green signal corresponded 
to unique and specific amplicons (Fig 2.4A-B).
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2.5.4 Data analysis
The real-time PCR data were analysed as previously described by 
Vandesompele and collegues (Vandesompele et al, 2002). Briefly, 
threshold cycles (ct) values were obtained using RotorGene 6000 Series 
software (Corbett Research, UK) and these were transformed to 
quantities using comparative ct method (delta ct). Three stable 
housekeeping genes (GAPDH, B-actin and B-tubulin) were then selected. 
The geometric mean of these genes was calculated and used as a 
normalisation factor. The raw expression values of the gene of interest 
were then standardised to the normalisation factor obtained as described 
above. The reason why normalisation factor based on multiple control 
genes was used was to decrease variability in expression of 
housekeeping genes and to ensure accurate and reliable normalisation of 
gene expression data.
2.6 Western blotting
2.6.1 Principle
Western blotting is a method used to detect a protein of interest from a 
mixture of proteins synthesis in vivo or in vitro. This is accomplished by 
employing a high quality antibody, also known as primary antibody 
directed against the protein of interest. The general principle is that a 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) is used to separate 
the protein by size. The proteins are then transferred to a nitrocellulose 
membrane. Since the protein (polypeptide) bands are negatively charged 
they will bind to the positive charged nitrocellulose membrane. The 
results will be a nitrocellulose membrane that is imprinted with the same 
protein bands as the gel. Primary antibody is applied to the membrane 
and the secondary antibody (directed against the primary antibody) with 
an enzyme (e.g. alkaline phosphates or horseradish peroxidase) 
conjugated to it is used to visualise the protein.
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2.6.2 Protein extraction
Protein from retina was extracted using Qiagen Qproteome mammalian 
protein preparation kit (Qiagen, West Sussex, UK). Briefly, the retina was 
homogenised in cold PBS by trituration. The samples were then 
centrifuged for 5 minutes at 4500x g in a pre-cooled (4°C) centrifuge. 
The cell pellet was resuspended in lysis buffer containing 1U benzonase 
nuclease and a protease inhibitor. The samples were then incubated for 
30 minutes at 4°C. After incubation, the suspension was centrifuged at 
4°C for 10 minutes and the supernatant, containing total protein fraction 
transferred into a new tube and stored at -20°C for later analysis. In some 
cases, the retina was homogenised in RIPA lysis buffer (Upstate 
Millipore, Herts, UK) containing phenylmethanesulfonyl fluoride solution 
(PMSF, a protease inhibitor cocktail, Sigma Aldrich, Dorset, UK) using a 
pellet pestle motor (VWR international, Leicestershire, UK). The samples 
were then incubated on ice for 45 minutes, frozen and thawed in liquid 
nitrogen 3 times. The samples were centrifuged at 14000rpm for 15 
minutes and supernatant containing protein was collected. The samples 
were stored at -20°C for further analysis.
2.6.3 Protein quantification
Protein quantification was carried out using the Bio-Rad Protein Assay 
(Bio-Rad, Hemel Hempstead, UK) with bovine serum albumin (BSA, 
Sigma-Aldrich, Dorset, UK) as standard (Table 2.2). The standard 
samples were prepared as shown in table 2.2 and the samples were 
diluted 1:10. The working reagent was prepared by adding 1 part reagent 
B with 50 parts reagent A (10mls reagent A to 200 pi reagent B). Working 
reagent (200pl) was then added to 96-well plate and 25 pi of each 
standard or unknown sample was also added. The mixture was incubated 
at 37°C for 30 minutes. The absorbance was then measured at 540nm 
using the plate reader. An example of protein concentration can be seen 
S2 in appendix III. In some cases, the Nano-drop spectophotometer was 
used to determine protein concentration.
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Table 2.2. BSA standards.
Vial Vol. Diluents (H20) Vol. BSA Final BSA conc.
A 0 pi 300 pi of stock 2000 pg/ ml
B 125 pi 375 pi of stock 1500 pg/ ml
C 325 pi 325 pi of stock 1000 pg/ ml
D 175 pi 175 pi of vial B 750 pg/ ml
E 325 pi 325 pi of vial C 500 pg/ ml
F 325 pi 325 pi of vial E 250 pg/ ml
G 325 pi 325 pi of vial F 125 pg/ ml
H 400 pi 100 pi of vial G 25 pg/ ml
I 400 pi 0 0 pg/ ml
2.6.4 Western blotting procedure
In order to resolve the protein, 12% SDS-PAGE (see appendix II) was 
used and the protein transferred to a nitrocellulose membrane. Protein 
(10pg) was loaded to the immunoblot.The SDS-PAGE blot was run at 
100V, 350mA for 1hour. Successful transfer was determined by 
incubated the nitrocellulose membrane (Amersham biosciences, Bucks, 
UK) with Ponceau S (Sigma-Aldrich, Dorset, UK) to visualise the protein 
bands (Fig. S1 in appendix III). The membrane was then washed in tris 
saline buffer (TBS) containing 0.1% Tween 20 (TBST, see appendixll) 
and blocked in 5% milk (Fluka, Biochemika, Buchs, Swisterland) in TBST 
for 1hour. After blocking, the membrane was washed and incubated in 
TBST with primary antibody (see dilution and incubation time in table 
2.3). Following three washes in TBST, membranes were incubated in 
appropriate peroxidase-linked secondary antibodies (1.5000; Santa Cruz, 
Heidelberg, Germany) for 1h before substrate development using ECL- 
plus (GE Healthcare, Bucks, UK). Rabbit IgG was used as negative
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control for TRAF2, caspase 3 and 9 antibody while clAP1 blocking 
peptide was used as clAP1 negative control. The blocking peptide was 
incubated together with clAP1 primary antibody for 1 h prior to incubation 
with the membrane. Another negative control (secondary antibody alone) 
was also included. The procedure used to detect the protein of interest 
was also used for the controls as well. Laser scanning densitometry was 
performed and bands were quantified using Labworks programme (UV 
Biolmaging Systems, Cambridge, UK).
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Table 2.3.Dilutions and incubation times of antibodies.
Antibody name Antibody type Company Concentration Incubation time
CIAP1 Polyclonal Santa Cruz, 1:200 1 h at room
Heidelberg, temperature
- Germany
Active Caspase 3 Polyclonal Abeam, 1M9 Overnight at
Cambridge, UK 4°C
Caspase 3 Polyclonal Cell Signalling, 1:1000 Overnight at
Hertfordshire, UK 4°C
Caspase 9 Monoclonal Cell Signalling, 1:1000 Overnight at
Hertfordshire, UK 4°C
p53 Polyclonal Santa Cruz, 1:1000 Overnight at
Heidelberg, 4°C
Germany
TRAF2 Polyclonal Santa Cruz, 1:1000 Overnight at
Heidelberg, 4°C
Germany
Chx 10 Polyclonal chemikon, 1:500 Overnight at
Millipore, 4°C
Hertfordshire, UK
Thy 1 Monoclonal Abeam, 1:500 Overnight at
Cambridge, UK 4°C
Actin Polyclonal Santa Cruz, 1:1000 1 h at room
Heidelberg, temperature
- Germany
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2.6.5 Stripping the membranes
Stripping is a term used to describe removal of antibodies from a Western 
blot membrane. This is very useful since it allows investigation of more than 
one protein using the same blot. For example, a protein of interest and a 
loading control can be detected using the same membrane. Stripping has an 
advantage of saving samples, material and time. During the stripping process 
some protein will be lost, however. This is carried out by incubation of 
membrane in stripping buffer (see appendix II), two times, 10 minutes each. 
The membrane is then transferred to PBS and washed twice for 10 minutes 
each. And finally, washed in TBST, again twice for 5 minutes each time.
2.6.6 Quantification of lAPs and caspases protein in the retina
Laser scanning densitometry was performed and bands were quantified 
using Labworks programme (UV Biolmaging Systems, Cambridge, UK). The 
values were normalised to the B-actin band intensity.
2.7 Immunofluorescence
2.7.1 Principle
Immunoflourescence is a technique used to detect the location and the 
abundance of any protein using an antibody. It is very important for the entire 
process to be able to visualise the antibody when looking in through a 
microscope. In order to do this, a fluorescent dye is covalently (this bond is 
achieved when atoms share electrons) linked to the antibody. When the dye 
is illuminated, it absorbs light at the stimulation wavelength and emits a light 
at a longer wavelength, which can be imaged and quantified. In most 
experiments two antibodies are used. A primary antibody that recognise and 
binds to the protein of interest and a secondary antibody with a fluorescent 
dye attached to it that recognise and binds to the primary antibody.
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2.7.2 Preparation of wax embedded retina sections
Eye-cups (anterior segment and lens removed) were dehydrated through a 
series of increasing methylated spirit (IMS, Fisher scientific, Leicestershire, 
UK) concentration (50%, 70%, 90% and 100%) with maximum incubation 
time of 1 h/concentration. The tissue was first immersed in an equal mixture 
of 100% ethanol (Fisher scientific, Leicestershire, UK) and xylene (VWR 
international, Leicestershire, UK) for 10 minutes. Thereafter, they were 
immersed in 100% xylene for 10 minutes and incubated warm wax for 1 h to 
remove xylene. Eye-cups were then transferred into fresh molten wax, 
incubated for 30 minutes and finally embedded in wax and sectioned at 7pm. 
Sections were incubated at 56°C overnight in order to dry.
2.7.3 De-wax the sections
Sections were immersed twice in 100% xylene for 10 minutes each and then 
twice in 100% alcohol for 5 minutes each. The samples were then transferred 
into a series of alcohol (90%, 70% and 50%) and incubated for 5 minute in 
each condition then washed in running water for 5 minutes.
2.7.4 Nuclei staining with Hoeschst 333542
Retinal wholemounts were stained with 3ng/pl Hoechst 33342 (Sigma- 
Aldrich, Dorset, UK) for 20 minutes and mounted in Prolong Gold antifade 
medium (Invitrogen, Paisley, UK).
2.7.5 Citrate buffer antigen retrieval
2.7.5.1 Principle
PFA fixation forms protein cross-links that can mask the epitopes in tissue 
samples. This may results into weak or false negative staining for 
immunohistochemical detection of certain proteins. Antigen unmasking was 
therefore undertaken to break protein cross-links, therefore unmask the 
antigens, which will enhance staining intensity of antibodies.
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2.7.5.2 Procedure
De-waxed sections were washed in PBS and then put in a pressure cooker 
containing citrate buffer (15ml antigen unmasking solution in 1600 ml ddH20 , 
Vector laboratories, Peterborough, UK) and heated to boiling point. Samples 
were removed after 15 minute of boiling, cooled for at least for 30 minutes at 
room temperature and washed in PBS for 5 minutes. In some cases, 
homemade citrate buffer was used (see appendix II). The sections were put 
in the citrate buffer and heated to boiling point using a microwave. The 
samples were then cooled for 5 minutes at room temperature and the 
procedure was repeated 2 more times.
2.7.6 Immunofluoroscence staining procedure
De-waxed sections were washed in PBS and blocked with 5% either rabbit 
(Sigma-Aldrich, Dorset, UK) goat (Sigma-Aldrich, Dorset, UK) or donkey 
(Sigma-Aldrich, Dorset, UK) serum in PBS containing 0.01% Triton x 100 
(Sigma-Aldrich, Dorset, UK) for 1h at room temperature. Tissues were 
incubated overnight at 4°C with primary antibody in 1% blocking solution 
serum (anti-active caspase 3 (1pg, Abeam, Cambridge, UK) and anti-TRAF2 
(1:100; Santa Cruz, Heidelberg, Germany)). After three washes, the sections 
were incubated with appropriate (donkey anti-goat, goat anti-rabbit) Alexa- 
Flour-labeled secondary antibody (1:1000, Invitrogen, Paisley, UK) for 1h at 
room temperature. All sections were counterstained with To-PRO 3 
(Invitrogen, Paisley, UK) and mounted using Hydro-mount solution (National 
Diagnostic, England, UK).Controls (secondary antibody alone) were included 
in all studies.
2.7.7 Imaging
Sections were imaged using an Axioplan Zeiss laser scanning confocal 
microscopy (Zeiss, Heidelberg, Germany) equipped with the following 
absorption /emmision filters (nm); absorption at 494nm and emission 518nm 
filter, absorption at 555 nm and emission 575 filter for Alexa fluor (488nm) 
and (546nm), respectively and absorption 640 nm and emission 690 filter for
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To-PR03. Staining intensity was quantified utilising Adobe Photoshop 
(Adobe Systems Incorporated, Uxbridge, UK) and expressed in percentage 
of the staining intensity of the experimental sections after extracting the 
background staining intensity.
2.8 TUNEL assay
2.8.1 Principle
TUNEL assay is used to detected breakage in DNA strands by enzymatically 
labelling the free 3’ -O H  termini with modified nucleotides. The assay detects 
both single and double stranded DNA associated with apoptosis. Although 
the assay distinguishes apoptosis from necrosis, there are cases where cells 
exhibiting necrotic morphology may also stain lightly.
The underlaying principle is that digoxigenin-nucleotides are enzymatically 
added to DNA by terminal deoxynucleotidyl Transferas (TdT). TdT is then 
used as a catalytic factor to catalyse a templet-independent additional of 
nucleotides triphosphates to the 3’-OH end of double- and single- stranded 
DNA. The incoporated digoxigenin-nucleotides are the allowed to bind anti- 
digoxigenin antibody that is conjugated to a peroxidise reporter nucleotide, 
which can then be visualised (Fig 2.5)
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Indirect 
Figure 1A
Direct 
Figure IB
End result d  apopto*!*: nucleoaome 
sized DNA fragments
End result of apoptosis: noeteosome 
sized DNA fragments
ApopTag* Step 1: Tall with 
dlgoxigonirvdWTP
ApopTag" Step 1:Tai! with fiuoeesceln- 
nuoiootido
ApopTag0 Step 2: Bind antibody
c o n ju g a t e
ApopTag* Step 2: Analyze by flow 
cytometry
ApopTag0 Step 3: Stain with substrate 
and view by microscopy (p*ro».) as 
depicted. Alternatively, analyze by 
microscopy or flow cytomeby (ftuor.)
Figure2.5.ApopTag based TUNEL assay methodology (Figure adapted from 
Chemicon ApopTag Peroxidase In situ Apoptosis Detection Kit booklet).
2.8.2 Procedure
TUNEL assays were carried out according to manufacturer’s instructions. 
Briefly, following three washes in PBS, dewaxed sections were incubated in 
20pg/ml 60pl/5 cm 2 for 15 minutes. The sections were then washed using 
dH20  and the endogenous peroxide blocked by additional of 3% hydrogen 
peroxidise for 5 minutes. Following washes in PBS, the sections were put in 
equilibration buffer for 30 seconds and the TdT enzyme was added to the 
sections. The reaction was stopped by adding working strength stop/wash 
buffer (see appendix II) and incubated to 10 minutes. Subsequently, the 
sections were incubated with anti-digoxignenin conjugate for 30 minutes, 
washed and working strength peroxidise substrate (see appendix II) applied 
to the sections and incubated for 15 minutes. Following washes, the samples
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were counterstained with Hoeschst 3342 (Sigma-Aldrich, Dorset, UK) for 20 
minutes, washed and the mounted using hydromount ((National Diagnostic, 
England, UK). Negative (section with no TdT enzyme) and positive controls 
were included in the experiment. Positive controls were obtained by 
incubating whole mount adult mouse retina in 3pl staurosporine overnight.
2.8.3 TUNEL imaging
TUNEL images were obtainedusinga Leica DMRA2 brightfield microscope 
(Wetzlar, Germany) and Leica QWin v3 software (Wetzlar, Germany). The 
images were taken using 20x and 40x objectives.
2.9 Organotypic retinal explants
2.9.1 Background
The organotypic retinal explant culture technique is a very useful tool to study 
the physiological and pharmacological properties of neurons and neuronal 
circuits. In contrast to dissociated retinal cells cultures, organotypic cultures 
have the advantage of retaining cytoarchitecture and neuronal circuits of the 
retina.
2.9.2 Medium preparation
Culture medium consisted of sterile Neurobasal medium (Gibco, Invitrogen, 
Paisley, UK) supplemented with 2% B27 (Invitrogen, Paisley, UK), 0,8mM L- 
glutamineand 0.1% penicilin/streptomycin (Sigma-Aldrich, Dorset, UK)
2.9.3 Explants cultures
The cultures used in the project were short-time with less than 1h incubation. 
After transferring the dissected retina on to a millicell nitrocellulose insert 
(Millipore, Hertfordshire, UK) with RGC side facing upwards the membrane 
was then inserted in a culture dish containing culture medium (see section
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2.9.2). Explants were incubated at 37°C in the humidified 5% C 0 2 incubator 
(ICN Flow Laboratories, Irvine, CA).
2.9.4 Pre-coating of tubing
Plastic tubing (Bio-Rad, Hertfordshire, UK, catalog number 165-2441) was 
pre-coated with 0.1 mg/ml polyvinyl pyrolidone (PVP, Sigma-Aldrich, Dorset, 
UK). PVP was diluted in 100% ethanol and was freshly prepared each time 
before use. The tube was then hooked to a nitrogen tank (BOC, Bristol, UK) 
and left to dry for 30 minutes minimum.
2.9.5 Coating tungsten particles
1 .T-dioctadecyl-S.S.S’.S’-tetramethylindocarbocyanine perchlorate (Dil, 
25mg/ml, Molecular Probes, Eugene, OR) was dissolved in 400ml methylene 
chloride (Sigma-Aldrich, Dorset, UK). Tungsten particles (1.7pm diameter; 
BioRad, Hertfordshire, UK) were spread evenly on a glass slide. The Dil 
solution was then added to the particles until they were completely corvered 
with the solution. Menthylated choloride evaporated leaving the dye 
precipitated onto the tungsten particles. The particles were scraped from the 
glass slide giving a fine powder. The powder was then transferred into the 
pre-coated plastic tubing. The dye-coated particles were allowed to settle on 
to the wall for 20 minutes. The particle-coated tube was cut into 13mm pieces 
length using a tube cutter (Bio-Rad, Hertfordshire, UK) and stored at room 
temperature for further use.
2.9.6 Delivery of particles
The particles were delivered to the retinal explant using gene gun (Helios 
Gene-gun, BioRad Hercules, CA, USA). A membrane filter of size 11pm 
(black, gridded millipore filters, Millipore, Hertfordshire, UK) was placed 
between the gun and the culture to protect the retina from shock wave. In 
order to deliver the particles, 120psi helium gas pressure was used. The 
higher the pressure the more cells were labelled. Some tissues were shot 
several times (up to 3 times) in order to increase the labelling density but this 
was not preferred since several shooting may lead to tissue injury. Following
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the delivery, the explants were incubated at 37°C in the humidified 5% C 0 2 
incubator for 30 minutes to allow the Dil to spread.
2.9.7 Fixing and counter staining
The explants were fixed overnight at 4°C in 4% paraformaldehyde (see 
appendix II) and counter stained and mounted on glass slides the following 
day as described in section 2.7.4.
2.9.8 Imaging
2.9.8.1 Analysis of RGCs dendrites
Diolistically labelled RGCs were imaged with an Axioplan Zeiss laser 
scanning confocal microscope 24 hours after labelling. Explant wholemounts 
were washed in PBS and mounted, ganglion cell side up on superfrost slides 
(Jencons, VWR International, UK). ProLong Gold (Invitrogen, Paisley, UK) 
was used as an antifade reagent. For every experimental age studied, the 
dendritic organisation of at least 60 neurons was reconstructed and 
analysed. For each RGC, 15 and 30 optical sections were obtained using 20x 
objective. Imaging was done at 565nm, obtaining slice thickness of 0.852pm.
2.9.8.2 Neuron nuclei imaging
Images of the RGCL were captured at 420/40nmin a systematic fashion 
using a fluorescent microscope (Leica 6000B,Wetzlar, Germany) linked to a 
Leica digital camera (Leica DFC350 FX, Wetzlar, Germany) and Stereo 
Investigator software (Microbrightfield, Magdeburg, Germany). Retinal 
specimens were placed on a motorized stage and the cells in the RGCL were 
imaged with a 20x objective in 12 fields (each with an area of 217141.75 
pm2)arranged in a grid centred on the optic disc (OD).
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2.9.8.3 INL and ONL imaging and cell count
De-waxed wax embedded retinal sections (sections crossing the optic nerve 
(ON), see section 2.7.2-3) were stained with Hoeschst 3342 (Sigma-Aldrich, 
Dorset, UK) for 20 minutes. Images were obtained at 420/40nm utilising a 
fluorescent microscope (Leica 6000B, Wetzlar, Germany) linked to a Leica 
digital camera (Leica DFC350 FX, Wetzlar, Germany) and Stereo 
Investigator software (Microbrightfield, Magdeburg, Germany). The sections 
were imaged with a 20x objective in 10 fields per section.
2.9.9 Sholl analysis
Sholl analysis was performed on the Z-projection image of the neurons. The 
Sholl analysis programme is MATLAB based software that creates a series of 
20pm a part concentric circles that were centred on the cell soma. The 
dendrites intersecting each ring were counted and plotted as a function a 
function of radial distance from the cell soma. In this thesis, Fast Sholl 
programme (Gutierrez and Davies, 2007), which is a simplified Sholl 
programme was used (Fig 2.6)
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Figure 2.6.A schematic image of Conventional Sholl (A) and Fast Sholl (B). 
With conventional Sholl analysis, a number of concentric rings with 
increasing radial centred in the cell body are traced and the number Xi of 
neuritis (dendrite and axons) intersecting each ring of increasing radii is 
counted (shown as open circles). The data are then averaged over a 
population of sampled neurons and plotted vs. radial distance result in the 
characteristic Sholl profile (inset). Fast Sholl analysis, on the other hand, the 
entire Sholl profile is derived from the radial distance to bifurcations (‘b’ 
points in image B) and terminal points f t ’ points in image B) and the number 
of processes emerging from the soma (X0). Figure adapted from Gutierres 
and Davies, (2007)
2.9.10 Cell counting
For RGC counting, the number of labelled cells in each image was counted 
manually using the Cell Counter plugin for ImageJ (NIK Images, NIH, USA). 
Approximately 5.2% of 6 week old and 4.2% of 24-52 week old BN retina was 
evaluated to estimate neuronal density. Standard morphologic criteria were 
applied for discriminating non-neuronal cells (endothelial and glial cells) from 
neuronal cellslNL and ONL cell count was also performed manually using the 
Cell Counter plug-in for ImageJ (NIK Images, NIH, USA). Total of 5 sections 
per retina in of 3 animals per study stage were imaged.
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2.10 Experimental glaucoma
2.10.1 Principle
Experimental rat glaucoma model is a valuable tool for studying human 
glaucoma. Experimental glaucoma in animals is achieved by blocking the 
outflow of the aqueous humor produced by ciliary body from the anterior 
chamber. Different reagents have been used, these includes saline 
phosphate buffer, different types of beads among others. The reagents clog 
the trabecular meshwork, which serves as drainage. This leads to elevated 
IOP, which in return results in damage to the optic nerve head and to RGC.
2.10.2 Preparation of polystyrene paramagnetic beads
Ferro-magnetic microspheres (CHI Scientific, Inc., USA, bead diameter 5 
microns) were reconstructed in sterile Balance Salt Solution (BSS, Alcon 
Corp, Hunenberg, Switzerland) resulting in an concentration of 30 mg/ml. 
Microspheres were then sterilised by y-irradiation with a Gammacell 1000 
Elite (Nordon International Inc. 22 TBq Caesium Source, Fleurus, Belgium).
2.10.3 Animal Acclimatisation
Ten retired male breeder BN rats were housed in a constant low-light 
environment (40-60 lux) to minimise diurnal fluctuations in IOP, with food and 
water provided ad libitum. lOPs were measured 3 times before injection 
using a handheld rebound tonometer (Tiolat, Oy, Finland) calibrated for use 
with the rat eye (Levkovitch-Verbin et al., 2002). All measurements were 
made in awake animals (Fig 2.7) in which the cornea was anaesthetised 
using topical 0.4% oxybuprocaine hydrochloride eye drops(Chauvin, UK).
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Figure 2.7.An example of IOP being measured in awake rat. Figure adapted 
from http://www.colmedsupplv.com/ophthalmoloqy.html. Accessed on 15-04- 
2010
2.10.4 Injection of the beads to anterior chamber
Animals were first generally anaesthetised using Isoflurane anaesthesia. 
Topical chloramphenicol (0.5%, Cusi, Herts, UK) was administered pre and 
post injection. Approximately 20 pi of the bead solution was injected into the 
anterior chamber of the left eye, delivering approximately 0.6 mg of beads. 
The right eye served as an unoperated control. Injections were made using a 
sterile 32 (Hamilton) or 33-gauge (WPI Corporation) needle parallel to the 
iris. The 33-gauge needles were bevelled on 3 sides to facilitate injection 
through the cornea. A tunnelled injection was made with the needle running 
parallel to the anterior surface of the iris to minimise the risk of iris trauma. 
Since the beads tended to settle under the influence of gravity, the syringe 
and needle were agitated using a vortex stirrer (IKA® Werke GmbH & co.kg. 
Staufe, Germany), for approximately 10 seconds prior to injection to 
resuspend the beads in BSS.
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Following completion of the injection, the needle was kept in position and the 
beads then drawn away from the injection site using a small hand held 
magnet (0.45 Tesla) which prevented the egress of beads from the injection 
track. The magnet was then used to distribute the microspheres around the 
iridocorneal angle to reduce the outflow of aqueous humour via the 
trabecular meshwork. Immediate increases in IOP could be minimised by 
leakage of aqueous around the injection cannula once the beads had been 
drawn away from the injections site. Injections of microspheres were 
performed up to four times, depending on the required level and duration of 
the IOP elevation.
2.10.5 IOP measurements
lOPs were taken the following days and then every 3 days after injection. 
Again all measurements were made in awake animals in which the cornea 
was anaesthetised using topical 0.4% oxybuprocaine hydrochloride eye 
drops(Chauvin, UK). The IOP were taken as the mean and standard 
deviation of 6 readings. The readings were recorded on online database 
named critter (Fig. S7; critters1.cf.ac.uk)
2.10.6 Staining of the beads in TM
Animals were sacrificed using overdose of CO2. One injected eye was 
dissected removing the anterior chamber and the lens. Both the eye cup and 
the anterior chamber was then fixed in 4% PFA overnight and left in 10% 
sucrose (se appendix II) until it sank. Cryosections (10 pm) of the anterior 
chamber were obtained and put on gelatine-coated slides were stained with 
Haematoxylin and Eosin (H&E) or mounted under DPX (Raymond A Lamb, 
Thermo Fisher Scientific, Basingstoke, UK)for differential interference 
contrast (DIC) also known as Nomarski imaging. Section images were taken 
using a Leica DMRA2 brightfield microscope (Wetzlar, Germany) and Leica 
QWin v3 software (Wetzlar, Germany).
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2.10.7 Retina dissection and RNA extraction
Rats were sacrificed using overdose of CO2. Retina dissection and RNA 
extraction were done as described in sections 2.2.1 and 2.4.3.
2.10.8 cDNA synthesis and real-time PCR
cDNA synthesis and real-time PCR were done as described in sections 2.5.2 
and 2.5.3, respectively.
2.11 Statistical analysis
Data were expressed as mean and standard errors. Following normality 
testing (Shapiro-Wilk test) and homogeneity of variance (Lavene test), group 
comparisons were made using independent student t-test (SPSS16, 
Chicago, Illinois) or one-way ANOVA as appropriate followed by Fisher’s 
Tukey’s post hoc test (SPSS16, Chicago, Illinois) for normal distributed data. 
Nonparametric test, Kruskal-Wallis with post-hoc test (SPSS16, Chicago, 
Illinois) was performed for data that was not normal distributed. Differences 
were considered significant for p< 0. 05.
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Chapter 3
Expression profiling of caspases and lAPs in 
ageing retinas of BN and Wister albino rats 
using Conventional and Real time PCR
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3.1 Introduction
The survival of neurons is a complex balance between pro-survival and pro­
death factors. Vision loss in ageing and diseases has been suggested to be a 
consequence of retinal ganglion cell (RGC) death (Morgan, 2002, Morgan et 
al., 2006, Quigley, 1999). The majority of RGCs are lost by apoptosis. Recent 
reports suggest that upon insult, for example elevated IOP and/or deprivation 
of neurotrophic factors, RGC simultaneously activates both apoptotic and 
survival pathways (Kim and Park, 2005, Levkovitch-Verbin et al., 2006, 
Levkovitch-Verbin et al., 2007, Yang et al., 2007), clearly highlighting cells’ 
struggle for survival.
Moreover, there is evidence indicating that RGCs undergo a prolonged 
period of remodelling in which the dendritic tree is reduced in both extent and 
complexity prior to loss of the cell body (Morgan et al., 2006, Weber et al., 
1998). For example, work carried out in rodents and primates has 
demonstrated dendrite remodelling during ageing and glaucoma both in 
RGCs and other cells of the retina including rod bipolar cell (Xu et al., Liets et 
al., 2006, Morgan et al., 2006, Weber and Harman, 2005). Using the DBA/2J 
mouse glaucoma model, it was shown that there is dendritic loss of RGC and 
the loss is more pronounced in the high order dendrites (A. Koizuma, 2010).
Moreover, dendrite pruning occurs in other CNC neurons (Solis et al., 2007, 
Ferrante et al., 1991, Moolman et al., 2004, Morgan et al., 2006). For 
example, dendrite pruning occurs in striatal neurons in HD, in pyramidal 
neurons in both AD and PD. Also experiments in monkey glaucoma, 
demonstrated reduction in dendritic field of the pyramidal neurons in LGN 
(Yucel et al., 2006, Yucel et al., 2003). Thus, dendrite pruning is a common 
theme in neurogenerative diseases.
In primate and murine RGCs, the changes in the dendritic tree have shown to 
have functional consequences. For instant, generation of action potential is 
more stochastic (Jakobs et al., 2005, Weber and Harman, 2005) and contrast 
sensitivity and receptive field size are reduced. Although these cells are 
compromised they are still functional and it is important to determine the
76
Chapter 3 Caspases and lAPs expression profile
molecular mechanisms that governs dendrite pruning in ageing and disease 
in order to rescue these cells. It will be a challenge to determine these 
changes before the cells reach the “point of no return” defined by activation 
of caspase 3 in apoptotic pathway.
Although it is known that during ageing and neurodegenerative diseases 
cells are eliminated by apoptotic mechanisms, it is still not clear whether 
apoptotic mechanisms are responsible for dendrite remodelling. Work carried 
out in developing neurons, has suggested the involvement of the apoptotic 
pathway in dendrite pruning. There have been suggestions that apoptotic 
activity might be occurring at the dendrite level prior to the activation of cell 
death at the level of soma. Williams and colleagues demonstrated that during 
development of Drosophila Melanogaster sensory neurons, local caspase 
activity directs the engulfment of dendrites (Williams et al., 2006).
There are different methods of detecting gene expression. These include 
Northern Blotting, RNAse Protection Assay (RPA), In situ hybridisation, 
microarray and PCR (RT-PCR and quantitative, also known as real-time 
PCR). Northern blotting can be used to detect alternative splicing products 
and to evaluate transcript size. However, the methodology is limited by RNA 
degradation and low sensitivity (Streit et al., 2009). RNAse Protection Assay, 
on the other hand, is a single-stranded RNA based technique that allows 
simultaneous analysis of multiple mRNAs in the same total RNA sample 
(Burton et al., 1999). The major limitation of RPA is that it does not provide 
information on transcript size (Qu and Boutjdir, 2007). In situ hybridisation is 
utilised to localise DNA and RNA of the gene of interest to specific regions 
and cells within the regions (Montgomery, 2009). Thus, it allows analysis of 
the macroscopic distribution and cellular localisation of DNA and/or RNA 
sequence in heterogeneous cell populations. The disadvantage of this 
technique is that it is not very sensitive and also proper controls are essential 
for interpreting the results obtained.
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For the past decade, microarrays have shown to be a powerful technology 
that allows parallel evaluation of thousands of genes in a short period of time 
(Schena et al., 1995).Microarrays can analyse up to 20000 genes. There are 
different types commercially available including microarrays or gene chip 
cDNA and oligo-nucleotide type (Pfaffl, 2003). The degree of the pitfalls of 
microarray made it unsuitable methodology for the screening of the genes of 
interest in this study. These pitfalls include, high variability, low sensitivity for 
low abundant expressed genes, inconsistent fidelity, discrepancy in “fold- 
changes calculations” and lack of specificity for differentially expressed 
genes and different isoforms (Bustin, 2000, DeRisi and Iyer, 1999, Harrington 
et al., 2000, Schena et al., 1995).AIso, the methodology was economical 
unfavourable for tis study.
However, PCR-based screening of expression profile of the apoptotic 
pathway was a favourable methodology for this study because of its exquisite 
sensitivity. The PCR technique has been shown to be the most specific and 
sensitive for quantative analysis of gene expression (Pfaffl, 2003, Horikoshi 
et al., 1992, Livak and Schmittgen, 2001, Murphy et al., 1990). In fact, PCR 
has up to a 100-fold detection limit compared to other gene expression 
methods such as Northern hybridisation and RNA-Protection Assay (Bustin, 
2000, Lockey et al., 1998, Orlando et al., 1998, Pfaffl, 2003). Thus, PCR is 
more powerful for the analysis of gene expression because it is rapid, simple, 
has a high sensitivity and reproducibility.
3.2 Aim
The aim of the experiments carried out in this chapter was to characterise the 
expression patterns of caspases and lAPs during maturation and ageing of 
BN and wistar albino rat retinae. This was done in order to identify molecules 
that can be of importance in maturation and maintenance of a healthy retina.
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3.3 Experimental design
RNA was extracted from 6, 10, 16 and 24-52 weeks old BN and from 16-24 
and 88 weeks old Wistar albino rats retinae as described in section 2.3.3. 
Following RNA quantification, purification and integrity evaluation (see 
sections 2.4.3 and 2.4.4), cDNA synthesis was carried out as describe in 
chapter 2.
RT-PCR was performed as described in chapter 2 section 2.4.7 on samples 
from 6 and 24-52 week retinae. Following optimisation of PCR conditions 
(cycle number and annealing temperature, Table 2.1), amplification of 
capsases 3,6,7,8 and 9 and lAPs, namely NIAP, clAP1&2, XIAP, Survivin, 
Bruce and Livin was carried out. The products were then separated on a 
1.5% agarose gel containing EtBr and visualized under UV light. Gel images 
were captured using VisiDoc-it Systems and the bands quantified using 
ImageMaster ID prime program.
Following, determination of housekeeping genes stability, the real-time 
method was carried out as described in chapter 2. Three housekeeping 
genes, GAPHD, Beta actin and Beta III tubulin were used for normalisation of 
the expression of genes of interest, caspase 3,6,7,8 and 9 and lAPs, NIAP, 
CIAP1&2, XIAP, Survivin, Bruce and Livin. RNA was extracted, quantified, 
and purity and integrity evaluated (see details of the methods in chapter 2). 
Real-time PCR was performed, using appropriate annealing temperature for 
each gene (Table 2.1) running 45-50 cycles using Corbett machine (see 
section 2.5.3). A melting curve was obtained for every run to ensure only one 
product was amplified (Fig. S6-8 in appendix III)
Threshold values (ct) obtained from Corbett machine were transformed to 
quantities. Geometric mean of the three housekeeping genes was calculated 
and was used as a normalisation factor for normalisation of relative 
expression of the genes of interest.
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Following evaluation of normal distribution and homogeneity of the variance 
of the data, parametric (student t-test and ANOVA) and nonparametric 
(Kruskal-Wallis test) were performed. Data are shown as mean ± standard 
errors. Differences were considered significant when p< 0.05.
3.4 Results
3.4.1 RNA integrity
Following RNA isolation, quantification and purity evaluation, integrity was 
confirmed utilising RNA denaturation gel. Intact rat RNA should give two 
bands, the heavier band correspond to 28S and the smaller band 
corresponding to 18S ribosomal bands. The denaturation gel showed only 
two band indicating that the RNA was intact (Fig. 3.1). If the RNA samples 
were degraded there would have been a smear on the gel, which was not the 
case.
3.4.2 RT-PCR optimisation
Initial PCR reactions were performed to determine the annealing 
temperatures and duration of product elongation. All products were optimized 
for cycle number. The conditions were chosen so that all of the genes 
(housekeeping gene, caspases and lAPs) analysed were in the exponential 
phase of amplification (Fig. 3.2A-F and Fig. 3.3A-G).
3.4.3 Expression of caspases and lAPs in BN retina
No statistical significant change in mRNA levels of caspases 3,6,7,8 and 9 
(Fig. 3.4A) or lAPs (NIAP, clAP2, XIAP, Survivin, Bruce and Livin) were 
identified between 6 and 24-52 weeks old retinae with the exception of clAP1 
(Fig. 3.4B) using RT-PCR. clAP1 mRNA levels were significantly down- 
regulated in mature retinae when compared to younger retinae (p<0.001, Fig. 
3.4B).Real-time PCR confirmed the down-regulation of clAP1 in mature 
compared to younger retina and this reduction was shown to be gradual (Fig. 
3.5).
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Figure 3.1. An example of an denaturing gel. Samples run on the gel were 
isolated from whole BN rat retina. Samples 3,5,6 and 8 are from 6 and 
samples 9,11 and 12 were isolated from 24-52 weeks old BN rat retina
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Figure 3.2. Optimisation of PCR conditions for p-tubulin (A), caspase 
3 (B), 7 ( C) and 9 (D) primers. The optimal cycle number was chosen 
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Figure 3.4. RT-PCR reveals expression profiles of caspases (A) and lAPs (B) 
in the ageing BN rat retina between 6 and 24-52 weeks of age. Samples were 
taken from total retinal extraction (6 eyes, 3 animals per group). Bands were 
normalized relative to p-tubulin mRNA. Mean and standard errors are shown 
(*** indicates p <0.01, statistical comparison between the two ages, 
independent student’s test)
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Figure 3.5. Gradual down-regulation of clAP1 mRNA during maturation of BN 
retina. The mRNA quantity was normalized to three endogenous genes 
(GAPDH, p-actin and p-tubulin). Mean and standard errors of data from three 
experimental repeats for each animal (n=6 per age) are shown (*** indicates p 
<0.01, statistical comparison between the groups, Kruskal Wallis test)
Chapter 3 Caspases and lAPs expression profile
3.4.4 Evaluation of housekeeping gene costistency
Housekeeping gene expression was determined by plotting the ct values. 
The results show a trend towards a lower expression in older Wistar retinae 
(n = 5) but the difference was marginal indicating that their expression is not 
altered as a consequence of ageing (Fig. 3.6).
3.4.5 Expression of caspases and lAPs in Wistar albino rat retinae
Caspses 3,6,7,8 and 9 did not show alteration in their expression during 
ageing of Wistar albino rat retinae (Fig. 3.7A). Caspase 3 and 6 showed a 
trend towards increase in older (88 weeks) compared to younger (16-24 
weeks) retinae but this was not statistical significant. NIAP, clAP2 and XIAP 
were dramatically decreased in older compared to younger Wistar retinae 
(Fig 3.7B). clAP1 was marginal decreased (Fig 3.7B). Survivin, Bruce and 
Livin showed a trend towards an increased but this was marginal (Fig 3.7B)
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Figure 3.6. Stability of housekeeping genes (GAPDH, beta-actin and beta-ill 
tubulin) in ageing wistar albino rat retinae. Determination of housekeeping genes 
in the two stages studied by plotting their ct-values.
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Figure 3.7. Real-time PCR on expression profiles of caspases (A) and lAPs (B) 
in the ageing wistar albino rat retina between 16-24 and 88 weeks of age. 
Samples were taken from total retinal extraction (4 and 5 animals for younger 
and older, respectively). The levels of mRNAs were calculated relative to three 
endogenous genes, namely, GAPHD, P-actin and p-tubulin mRNA. Mean and 
standard errors are shown.
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3.5 Discussion
Understanding the expression pattern of genes is prerequisite for determining 
and elucidation of their function. The work reported in this chapter started by 
looking at the expression profile of caspases and lAPs utilising conventional 
PCR. This was carried out because it was unclear of what would be found 
and also to reduce experimental costs. The profile expressions were initially 
performed in BN rats.
Firstly, RNA integrity was determined, which showed that the RNA used to 
for cDNA was intact. This is important since fragmented RNA may introduce 
errors in cDNA generation, which in turn will affect the amplification of cDNA.
In order to eliminate false negative or positive signals during cDNA 
amplification, it is important to determine an optimal cell cycle. This was only 
done once and before the main experiments. Since the optimal cycle number 
was chosen in the exponential part of the curve, it is clear that the signal that 
obtained reflects the expression of the genes of our interest. All primers were 
designed to give a product of 150-250 base pair. A weight marker was used 
in the initial experiments just to confirm that the products obtained are of the 
correct size.
Using conventional PCR, caspase expression remained similar in the two 
stages studied. Densitometry quantification confirmed no statistically 
significant changes in caspase expression in mature compared to younger 
retinae. These data are not in line with observations made by McKernan and 
colleagues where they reported that caspase 3 and 9 expression is 
significantly reduced during ageing of the mouse retina between p6 and p60 
(McKernan et al., 2006). This contradicting data could have several 
explanations. It is possible that species-specific difference in caspase 3 and 
9 expression could be responsible for this apparent difference. A more likely 
explanation is that the differences is due to the different ages examined in 
the two studies; this study examined animals at 6 weeks at the earliest stage 
and did not include animals as young as P6 where one would expect to see
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changes in caspase activity arising during development (Silver and Hughes, 
1973, Silver and Robb, 1979).
Another possible explanation is that McKernan et al worked on cultured 
retinal tissue to determine expression of caspases, whereas the present 
study the expression was performed on freshly isolated tissue. The retinae in 
culture are traumatised and may not necessary reflect in vivo processes. 
During trauma, the cells respond by activating apoptotic/necrotic processes 
(Edinger and Thompson, 2004, Kerr et al., 1972). This includes activation of 
caspases. Additional explanation could be that BN rats have a high genetic 
variation despite inbreeding attempts (Gibbs et al., 2004) while genetic 
variation is absent in inbreed mice.
On the other hand, lAPs showed a general reduction in 24-52 compared to 6 
weeks retinae in BN rat. IAP expression was generally decreased in mature 
compared to younger retinae suggesting that inhibition of apoptosis is 
compromised during ageing which could explain why neuronal degeneration 
is a common feature during ageing. In particular, clAP1 is significantly down- 
regulated in mature compared to younger BN retinae. The data were 
validated using real-time PCR, which not only demonstrated a reduction in 
mature compared to younger retina but also showed that the reduction was 
gradual.
clAP1 together with clAP2 have been shown to control apoptosis triggered by 
multiple stimuli when introduce into mammalian cells (Eckelman and 
Salvesen, 2006). These two proteins are unusual among the BIR family 
proteins in their ability to bind to TRAF-family adapter proteins that have a 
role in TNF-receptor signaling (Li et al., 2002, Rothe et al., 1995, Shu et al., 
1996). The TRAF-family consists of 6 members, TRAF1-6, but clAPs only 
binds to TRAF1 and 2 through the BIR domain (Chung et al., 2002, Samuel 
et al., 2006). Although clAPs bind to effector caspase 3 and 7 and initiator 
caspase 9 they are incapable of directly inhibiting their proteolytic activity 
(Eckelman and Salvesen, 2006). An emerging theory is that these two
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proteins regulate apoptosis indirectly by inhibiting activation of survival 
pathways (Varfolomeev et al., 2006), which would be interesting to confirm in 
the retinal samples.
The majority of investigations on clAP1 protein have mainly focus on tumour 
cells where it is highly expressed. Recently, it was shown that kockdown of 
clAP1 either by an antagonist antibody or a knockout, leads to NF-kB 
activation and increased TNF- alpha expression, which result in cell survival. 
NF-kB is a transcriptional factor that is ubiquitously expressed (Vince et al., 
2007). NF-kB is involved in different cellular processes including the stress 
response, innate and adaptive immune responses and cell survival and 
proliferation (Baldwin, 1996, Karin, 1996). Gutierrez and colleagues 
demonstrated that NF-kB signaling is involved in growth of neuronal 
processes in the developing PNS and CNS (Gutierrez et al., 2005). They 
observed reduced size and complexity of the neurite arbours of sensory 
neurons through inhibiting NF-kB activation. The hypothesis here is that the 
neurons of older animals have a less complex dendritic tree compared to 
younger animals. The suggestion put forward here is that the absence of 
clAP1 may lead to reduced activation of NF-kB signaling. This in turn, 
contributes to decreased complexity of the dendritic tree.
There are two different methods for quantifying expression of genes using 
real-time PCR; absolute and relative quantification. Absolute quantification is 
critically dependent on the external standard material. The problem with 
external standard is that it lacks internal control for real-time and PCR 
inhibitors. Real-time PCR works on the basis that all samples are amplified 
with similar efficiency (Bustin, 2000, Livak and Schmittgen, 2001), which 
does not hold true for unknown samples. Relative quantification, which is the 
most commonly used method, evaluated the changes in steady-state mRNA 
of the gene and provides a result relative to the levels of the internal control 
(housekeeping gene; (Pfaffl, 2003).
Living cells are subject to fluctuation in their environments, which, in turn, 
influences the level of gene expression. Therefore, it is important to identify
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genes whose expression remains constant in the tissue or cells under 
investigation, or in response to experimental treatment, that can be used as 
housekeeping genes in order to produce accuracy of RNA transcription 
analysis that real-rime PCR offers (Radonic et al., 2004). There have been 
suggestions that the expression of commonly used genes varies in different 
cell types, tissues, in diseases and during development and senescence 
(Spanakis, 1993, Suzuki et al., 2000, Bustin, 2000, Ishii et al., 2006, Thellin 
et al., 1999, Warrington et al., 2000)indicating that the use of single control 
gene is not suitable for evaluation expression of the target gene. Therefore, 
the use of multiple housekeeping genes as used in this chapter for analysis is 
advisable (De Boever et al., 2008). 18s and 28s rRNA have also been used 
as internal controls. These are not proper controls because of the imbalance 
between rRNA and mRNA. Also, they are absent in the highly purified mRNA 
samples (Vandesompele et al., 2002).
lAPs and caspase expression profile was also determined in very old (88 
weeks) Wistar albino rat retina. Caspase expression remain similar in the two 
ages studied with the exception of caspase 6, which was up-regulated in 
older compared to younger retinae. NIAP, clAP2 and XIAP were significantly 
down-regulated, whilst the expression of the rest of lAPs was not altered with 
age.
The pattern of expression was different in Wistar albino compared to the 
pattern observed in BN rat retinae. This could be owing to strain difference, 
but the more likely explanation is the different ages of the animals. The oldest 
BN rats used for the study were 52 weeks while the oldest Wistar rats were 
88 weeks. The degree of apoptotic activity in senescence has been suggest 
to be more pronounced in 88 compared to 24 weeks retinae. Thus, the age 
difference could be the determining factor in the difference between 
caspases and lAPs expression in the two rodents strains used in this study.
Although Wistar albino rats have been used for glaucoma studies, are not 
favorable model for studying glaucoma. This is because they have other 
natural complications that occur as a result of ageing. These complications
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include elevated cell death in the retina (Ricci et al., 1988, Neufeld and 
Gachie, 2003). For example, it was reported that neuronal loss during ageing 
in the retina is more pronounced in Wistar albino rats compared to pigmented 
rat strains (Weisse, 1995). In addition they show an increase in ultrastructural 
detrimental changes in the RPE (Adams, 1987). Although we did not 
observed any changes in caspase expression this does not exclude that 
there were changes in apoptotic activity in the two groups that were studied.
Caspases are stored in the cell as zymogens and are activated upon 
apoptotic signals (Kisiswa et al., 2009). It will be interesting to examine 
caspase and lAPs protein levels in order to determine whether the mRNA 
levels correlated with protein levels. Also it remains a challenge to evaluate 
activation in apoptotic pathway in Wistar albino rat retinae.
In summary, caspase expression, both in BN and Wistar albino rat retina is 
not significantly altered during maturation and senescence. lAPs expression, 
on the other hand, in BN rat retina show a general down-regulation in mature 
compared to younger retina with an exception of clAP1, which was 
statistically significantly down-regulated in older mature compared to younger 
retina. lAPs expression pattern in wistar albino rat retina differs from the 
pattern observed in BN rat retina. NIAP, clAP2 and XIAP significantly 
decreased in older compared to younger Wistar retinae. clAP1 expression 
remained similar in the two ages studied. Survivin, Bruce and Livin showed a 
trend towards an increased but this was not significant. This suggests that 
the cell may respond differently to different stimuli.
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4.1 Introduction
Age-related loss of retinal ganglion cells (RGCs) is a consistent feature of the 
ageing mammalian visual system (Harman et al., 2000, Jonas et al., 1990, 
Jonas et al., 1989, Morrison et al., 1990, Neufeld and Gachie, 2003, Sanchez 
et al., 1986, Sohl et al., 1998).This non-pathological loss of RGCs is thought 
to contribute to the age-related decline in visual function (Neufeld and 
Gachie, 2003, Spear, 1993). Although the involvement of apoptosis in the 
elimination of RGCs in development, ageing and retinal pathology has been 
well documented (Cecconi et al., 1998, Neufeld and Gachie, 2003, Quigley et 
al., 1995, Spear, 1993), it is still unclear whether apoptosis is the main 
pathway of RGCs elimination during ageing (Kisiswa et al., 2009). Other 
modes of cell death namely, autoghagy and casapase-independent cell 
death, have been suggested to occur in glaucoma (Whitmore et al., 2005). 
The key regulators of apoptosis are caspases. Although essential for cell 
death, caspases have also been shown to participate in non-apoptotic 
processes including cell proliferation (Sadowski-Debbing et al., 2002, 
Schwerk and Schulze-Osthoff, 2003), differentiation (Carlile et al., 2004, 
Ishizaki et al., 1998, Okuyama et al., 2004, Oliver and Vallette, 2005, Wride, 
2000, Wride et al., 2006, Wride et al., 1999) and maturation (Sordet et al., 
2002). There is evidence that caspase expression in the retina is reduced 
following early post-natal development (McKernan et al., 2006).
Inhibitors of apoptosis (lAPs) comprise a family of proteins characterised by 
the presence of a variable number of Baculoviral IAP Repeats (BIR) domain 
(Clem, 2001). Early work showed that lAPs are involved in the inhibition of 
apoptosis by binding directly to caspases through their BIR domains and 
preventing their activation and activity (Liston et al., 2003). Recent evidence 
demonstrate that lAPs are involved in other cellular processes including cell 
division, morphogenesis, nuclear factor-kB (NF-kB) activation and mitogen- 
activated proteins (MAP) kinase signalling (Srinivasula and Ashwell, 2008). 
Substantial evidence indicates that clAP1 and 2 form a multicomplex with 
tumor necrosis factor receptor associated factor 2 and 3 (TRAF2 and 3), 
resulting in the activation of NF-kB (Chu et al., 1997, Rothe et al., 1995, Tang 
et al., 2003). TRAF2 is an adaptor protein involved in signal transduction by
95
I\
Chapter 4 Impaired activation of survival pathway
most members of the tumour necrosis factor receptor (TNFR) family (Wajant 
et al., 2003). The binding of clAP1 to TRAF2 leads to ubiquitin-dependent 
degradation of TRAF2 as a feedback signal for NF-kB activation (Li et al., 
2002).
Work in the ageing and age related diseases such as glaucoma suggest that 
RGCs undergo a prolonged process of degeneration prior to cell death, 
manifest as a reduction in the complexity of the dendritic tree and the 
elimination of terminal processes (Kisiswa et al., 2009, Watts et al., 2003, 
Whitmore et al., 2005, Williams et al., 2006). These observations are 
consistent with those in other neuronal systems where parts of the neuron 
degenerate at different rates raising the possibility that the early stages of 
degeneration, neuronal damage is associated with partial activation of 
programmed cell death (Whitmore et al., 2005).
It has been hypothesis that these chronic changes in neuronal morphology 
indicating a balance between the factors that initiate program cell death and 
those that inhibit the process (Kisiswa et al., 2009). In support of this theory 
there is evidence that caspase activation, which is a consistent trigger to 
apoptosis is countered by lAPs, whose expression and activation increases 
in the cells that are entering into the apoptosis process (Kisiswa et al., 2009).
4.2 Aims
To clarify the relationship between caspase activation and inhibition in the 
maturation process, the expression of clAP1 protein was measured in 
healthy young adult and mature BN rat retina. This was done since there was 
a significant reduction in clAP1 expression at mRNA levels in BN retinae as 
shown in previous work (see chapter 3 for details). The involvement of clAP1 
in maintenance of the cells in BN RGCL was also determined. The analysis 
was performed in the whole retina and in isolated RGCL preparation. The 
clAP1-dependent regulation of TRAF2 was also exploited.
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4.3 Experimental design
Retinae was dissected from eyes of 6 and 24-52 weeks animals for protein 
isolation as described in chapter 2, section 2.2.2. Protein was isolated and its 
concentration determined.
Protein samples (10pg) were resolved using a 12% SDS-PAGE 
electrophoresis followed by transfer onto a nitrocellulose membrane. 
Membranes were blocked for 1 h in 5% dried milk in Tris buffered saline- 
Tween 20 (TBST). The blocked membranes were then incubated in either 
anti-clAP1 or anti-actin at room temperature for 1h, anti-caspase 3, anti- 
caspase 9, anti-TRAF2, anti-Thy 1, anti-Chx 10 at 4°G overnight. Following 
washes in TBST, membranes were incubated in appropriate peroxidase- 
linked secondary antibodies (anti-goat or anti-rabbit depending on the source 
of primary antibody) for 1hour before substrate development using the ECL- 
plus Kit according to manufactures instruction. Laser scanning densitometry 
was performed and bands were quantified using Labworks programme.
For immunofluorescence analysis, eye-cups (anterior segment and lens 
removed; see section 2,2,2) were wax embedded (see details in chapter 2) 
and serially sectioned at 7 pm. They were then de-waxed, washed in PBS 
and blocked with 5% BSA in PBS containing 0.01% Triton x 100 for 1h at 
room temperature. The clAP1 staining, dewaxed sections were subjected to 
antigen retrival (see section 2.7.5). Tissues were incubated overnight at 4°C  
with primary antibody in 1% blocking solutions and anti-TRAF2. After three 
washes, the sections were incubated with Alexa-Fluor-labeled secondary 
antibody for 1 h at room temperature. All sections were counterstained with 
To-PRO 3 and mounted using Hydro-mount solution. Sections were imaged 
using an Axioplan Zeiss laser scanning confocal microscopy. Staining 
intensity was quantified utilising Adobe Photoshop and expressed in 
percentage of the staining intensity of the experimental sections after 
extracting the background staining intensity.
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Subsequently, dewaxed sections were washed in PBS and subjected to 
TUNEL assay analysis as described 2.8.3. The samples were imaged using 
Leica bright field microscopy.
Following normality testing, group comparisons were made using 
independent student t-test or one-way ANOVA as appropriate followed by 
Fisher’s Tukey’s post hoc test.
4.4 Results
4.4.1 clAPi protein level in the whole BN retina
Investigation of clAP1 protein levels in the whole retina revealed reduction of 
clAP1 protein in mature BN retinae. Levels of clAP1 protein in whole retinal 
lysate were statistically significantly (p=0.040) reduced in mature compared 
to younger retinae (Fig. 4.1A-B; n=3).
4.4.2 Enrichment of RGCL cells
Cells in RGCL were enriched employing retinal shaving technique described 
in chapter 2. The purity of the RGCL shaves was confirmed by 
immunoblotting for the RGC marker (Thy 1) and bipolar marker (Chx 10). 
Staining for Thy-1 was more intense and the Chx 10 was below the level of 
detection in the RGCL lysate compared to the non-GCL lysate (Fig.4.2A) 
confirming precise isolation of the cells in RGCL. Chx 10 staining was absent 
in the RGCL sample (Fig.4.2B) confirming that there was no bipolar cell 
contamination.
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Figure 4.1. Reduced clAP1 protein levels in the whole retina in 24-52 
compared to 6 weeks animals. (A) shows the bands for individual animals (R1- 
3 at 6 weeks and R4-6 and 24-52 weeks). (B) shows the densitometry data for 
clPA1 as a ratio value relative to actin levels (mean and standard errors, n-3 
for each group (3 readings were taken for each animal; * indicates p <0.04, 
statistical comparison between the two ages, independent student’s test). 
Abbreviations: R1-6, rat 1-6.
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Figure 4.2. Enrichment of cells in the RGCL. The RGCL samples were 
obtained from retinal shavings and the purity was confirmed by staining 
for a RGC marker Thy1 (A) and Chx 10 (B), a bipolar marker (absent in 
RGCL).
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4.4.3 Comparison of clAP1 protein expression in RGCL and non-RGCL 
of BN rat retinae
Expression of clAP1 protein in the non-RGCL remained constant (Fig. 4.3A- 
B; n=6) while clAP1 protein amounts were statistically significantly (p <0.004) 
decreased (Fig. 4.3C-D, n=6) in the mature compared to younger animals in 
the RGCL.
4.4.4 Localisation of clAP1 expression in the retina
Immunofluoroscence analysis showed that there was staining of clAP1 in the 
RGCL but none in the rest of the retina (Fig. 4.4 A-B). The staining was more 
visible in the younger compared to mature retinae (Fig. 4.4 A-B).
4.4.5 Caspase 3 and 9 activity in 6 and 24-52 weeks BN retinae
Caspase 9 activity was not altered in BN retinae studied. Inactive caspase 9 
(50kDa) showed a marginal decrease in mature BN retinae but this did not 
reach statistical significance (Fig. 4.5A-B). The cleaved caspase 9 (37kDa) 
remained similar during BN retina maturation (Fig.4.5 A, C). Western blotting 
of caspase 3 in whole retinal lysate suggested that there was a trend for up- 
regulation of both the cleaved (active) and uncleaved (inactive) forms in 
mature compared to younger retina, but this did not reach statistical 
significance (Fig. 4.6A-B). Immunohistochemical analysis confirmed that 
there was a slight increase of cleaved caspase 3 expression in 24-52 weeks 
old RGCL (Fig. 4.6C).
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Figure 4.3. clAP1 down-regulation is restricted for cells in the RGCL. No changes 
were observed in clAP1 protein levels in non-RGCL (A-B) but there was a 
significant (p <0.02377) reduction in RGCL (C-D) in 24-52 compared 6 weeks. 
Densitometry data reflect the expression level for clAP1 as a ratio value relative to 
actin levels (mean and standard errors, n=6 for non-RGCL and n=9 for RGCL (3 
readings were carried out for each animal; ** indicates p <0.02 statistical 
comparison between the two ages, independent student’s test). Abbreviations: R1- 
6, rat 1-6; RGCL, retinal ganglion cell layer; ns, non significant.
Figure 4.4. Expression of clAP1 in RGCL. Immunofluoroscence 
analysis showed staining of clAP1 in RGCL of 6 weeks retinae (A) 
and almost none in 24-52 weeks retinae (B). Negative (C, secondary 
antibody only) and positive (D, clAP1 expression in pO CD1 mouse 
brain controls were included in the study, Representative sections are 
shown (3 sections crossing the optic nerve per animal per age; n=3). 
Abbreviations; ONL, outer nuclear layer; INL, inner nuclear layer; 
RGCL, retinal ganglion cell layer. Scale bar: 100pm
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Figure 4.5. Western blotting reveal no changes in expression of in caspase 
9 activity during ageing of BN retina. (A) an example of western blots. Both 
uncleaved (B) and cleaved (C) caspase 9 expression was not altered. The 
densitometry data reflect the expression level for cleaved and uncleaved 
forms of caspase 9 as a ratio value relative to actin levels (mean and 
standard errors, n=3 for each group: 3 readings were taken for each 
animal). Abbreviations; R1-6, rat 1-6; ns, non significant.
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Figure 4.6. Western blotting (A-B) and immunofluroscence analysis (C-F) 
reveal no changes in expression of in caspase 3 activity during ageing of BN 
retina. The densitometry data reflect the expression level for cleaved and 
uncleaved forms of caspase 3 as a ratio value relative to actin levels (mean 
and standard errors, n=3 for each group: 3 readings were taken for each 
animal). Representative sections are shown (3 sections per animal per age 
(total 18 sections)). Images were taken with 20x objective. Arrows indicate 
nucleai that are positive for active caspase 3. Abbreviations; R1-6, rat 1-6; 
ONL, outer nuclear layer; INL, inner nuclear layer; RGCL, retinal ganglion cell 
layer; ns, non significant.
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4.4.6 TUNEL assay analysis
TUNEL assay analysis did not show any TUNEL-positive cells in the retinae 
of 6 and 24-52 healthy retinae (Fig 4.7A-D).
4.4.7 TRAF2 protein levels in mature RGCL
Immunoblotting for TRAF2 using whole retina lysate revealed retinae with 
reduced clAP1 had accumulation of TRAF2 protein (Fig. 4.8A-B), but this did 
not reach statistical significance. The trend indicating an increase in TRAF2 
protein was confirmed with immunofluoroscence analysis, which revealed 
statistically significant (p=0.018) accumulation of TRAF2 in mature retinae 
(Fig. 4.8C). Comparison in TRAF2 expression between non-RGCL and 
RGCL showed consistent TRAF2 expression in non-RGCL lysate (Fig. 4.9A- 
B). TRAF2 expression in RGCL lysate was significantly (p<0.001) elevated 
confirming the results obtained using immunoflouroscence analysis (Fig. 
4.9C-D).
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Figure 4.7. TUNEL assay analysis of 6 and 24-52 weeks BN rat retinae. 
There were no TUNEL positive cells in 6 (A-B) and 24-52 weeks (C-D) 
retinae. Negative (E) and positive (F: whole amount retina treated with 
staurosporine overnight) were included in the experiment. Representative 
sections are shown (3 sections crossing the optic nerve per animal per age; 
n=3). Abbreviations; ONL, outer nuclear layer; INL, inner nuclear layer; 
RGCL, retinal ganglion cell layer.
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Figure 4.8. Western blotting (A-B) and immunofluoroscence analysis (C) reveal 
accumulation of TRAF2 in 24-52 compared to 6 weeks retinae. 
Immunofluoroscence data revealed a statistically significant (p=0.018) 
accumulation of TRAF2 in the RGCL. The densitometry data reflect the 
expression level for TRAF2 as a ratio value relative to actin levels (mean and 
standard errors, n=3 for each group: 3 readings were taken for each animal). 
Representative sections are shown (3 sections per animal per age (total 18 
sections)). Abbreviations; R1-6, rat 1-6; ONL, outer nuclear layer; INL, inner 
nuclear layer; RGCL, retinal ganglion cell layer; ns, non significant
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Figure 4.9. A slight reduction of TRAF2 in non-RGCL (A) and accumulation in 
RGCL (B) in mature compared to younger retina. The densitometry data reflect 
the expression level for TRAF2 as a ratio value relative to actin levels (mean and 
standard errors, n=6 per age; ** indicates p <0.02 statistical comparison 
between the two ages, independent student’s test). Abbreviations: R1-6, rat 1-6, 
RGCL, retinal ganglion cell layer; ns, non significant.
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4.5 Discussion
The present study has focused on understanding the molecular mechanisms 
underlying cell death in ageing and neurodegenerative disease including 
retinal degeneration in order to elucidate molecules that can be target for 
therapeutic intervention. There is evidence indicating that the involvement of 
apoptotic factors and expression of these factors is altered in diseases and 
are differentially expressed during retinal development and ageing. Here, 
evidence on impairment in survival pathway occurs in mature retina has been 
presented. clAP1 expression is decreased in mature retina and this is 
specific for the output neurons of the retina which was shown by both 
Western blot analysis on retinal shaving and localisation of clAP1 expression 
utilising immunofluoroscence analysis. Furthermore, retinae with reduced 
clAP1 showed accumulation of TRAF2. Both clAP1 and TRAF2 are important 
for activation of NF-kB. Lastly, evidence of intact caspase 3 and 9 activity 
during maturation is provided.
Investigation of clAP1 protein levels revealed that significant down-regulation 
was specific for cells in RGCL, suggesting impairment in the activation of 
survival pathways in these cells. This, in return, may enhance the sensitivity 
of cells in RGCL to apoptotic stimuli encouraging cells death leading to 
impaired visual abilities in mature subjects. It was shown that cells in 
glaucoma undergo apoptosis as a result of increased intra-ocular pressure 
(Quigley et al., 1995).Taken together, RGCs seems to be particularly 
susceptible to elevated IOP possibly because of the decreased lAPs, but 
most importantly, clAP1, which leads to impairment in activation of survival 
pathways.
In this study, the involvement of clAP1 in both the intrinsic and extrinsic 
apoptotic pathway was investigated by evaluating capsase 3 and 9 
(representative to intrinsic pathway). Evidence on that the expression of 
caspase 3 and 9 protein, both the active and inactive form, remains constant 
during ageing of BN rat retina has been provided. The data are not consistent 
with reports showing that caspase 3 expression is significantly reduced 
during ageing of the mouse retina between p6 and p60 (McKernan et al.,
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2006). This could be explained by that fact that the model used for the study 
was mouse while in this study rat retina was utilised for the investigation, 
suggesting caspase expression pattern varies between different species. 
This raises an interesting question to whether lAPs and caspase expression 
in the central and peripheral nervous system vary during human lifespan. 
However, a more likely explanation is that the difference is due to the 
different ages examined in the two studies; our study examined animals at 6 
weeks at the earliest stage and did not include animals as young as P6 
where we would expect to see changes in caspase expression arising during 
development (Silver and Hughes, 1973, Silver and Robb, 1979).
There was no alteration in caspase 3 and 9 activity as a consequence of 
reduced clAP1. Thus, there was no alteration in activation of caspase 3 and 
9. Early reports on clAP1 and 2, which are homologous, suggest that these 
proteins protect cells against apoptotic signals (Orth and Dixit, 1997, Roy et 
al., 1997) through direct binding to caspases via their BIR domains. Protein 
structure analysis of caspase 3, 7 and 9 revealed that these proteins have a 
binding site for clAP1 and 2 (Roy et al., 1997, Santoro et al., 2007). However, 
recent work demonstrates that although clAP1 is capable of binding 
caspases, it does not inhibit their activity (Eckelman and Salvesen, 2006), 
suggesting that the clAP1 BIR domains that interact with caspase have 
evolutionary lost their protease inhibition sequence that is found in other 
lAPs such as XIAP. Consistent with this, data obtained in this study support 
the notion that clAPs inhibits apoptosis by enhancing activation of survival 
pathways. There are substantial reports emphasising the importance of 
clAP1 in NF-kB activation (Mahoney et al., 2008, Varfolomeev et al., 2007, 
Varfolomeev and Vucic, 2008, Dupoux et al., 2009, Shu et al., 1996, 
Zamegar et al., 2008). For example, it was shown that clAP1 regulates NF- 
kB activation in endothelial cells, which, in turn, regulates vascular 
homeostatis in zebrafish (Santoro et al., 2007). Zamegar and collegues 
demonstrated that activation of non-canonical NF-kB requires assembly of a 
regulatory complex, in which clAP1 is a member of the complex (Zarnegar et 
al., 2008).
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Upon activation of TNFR1 and 2, TRAF 2 builds a multicomplex with clAP1, 2 
and TRAF3 leading to activation of NF~kB and JNK pathways (Eckelman and 
Salvesen, 2006, Rothe et al., 1995). Furthermore, TRAF2 interact with 
TRADD leading to NF-kB activation (Hsu et al., 1996, Hsu et al., 1995, Shu 
et al., 1996), suggesting that TRAF2 is involved in both TNF-R1 and TNF-R2- 
mediated NF-kB activation. In this study there was an increase in TRAF2 
protein levels in RGCL where clAP1 was significantly reduced. This increase 
might be caused by impairment in clAP1-dependent ubiquitination of TRAF2 
upon survival signal activation. Thus, the reduction of clAP1 might lead to 
inhibition of survival pathways depriving cells with death protection 
mechanism and enhancing apoptotic activity.
TRAF2 has been linked to other neurodegenerative disease such as 
Alzeimer’s diseases (AD). Interestingly, TRAF2 is increased in neurons of 
AD patients and is associated with neuritic plaques and neurofibrary tangles, 
suggesting either a continual recruitment of TRAF2 due to persistent in NF- 
kB activation pathway or lack of proteosomal degradation of TRAF2 leading 
to accumulation of TRAF2 in these neurons (Culpan et al., 2009). It would be 
interesting to evaluated clAP1 expression in AD brain and determine whether 
there is alteration in clAP1 expression in these neurons and if the alterations 
are in line with the data obtained in this study. Interestingly, TRAF2 has been 
suggested to be involved in inhibition of seizures in rodent (Balosso et al., 
2005) but the molecular mechanisms underlying this inhibition are yet to be 
elucidated.
Although there was no alteration in caspase activity, it is reasonable to 
postulate that caspase-independent apoptosis may occur in RGCs. Several 
groups have shown that caspase-independent apoptosis occurs in adult 
neurons (Okuno et al., 1998, Selznick et al., 2000, Zhang et al., 2002). Bcl-2 
family proteins are known to regulated apoptosis by inhibiting capsase 
activation (Merry and Korsmeyer, 1997), there is evidence indicating that this 
family of proteins is capable of preventing cell death via a caspase- 
independent mechanism (Okuno et al., 1998). Moreover, other forms of cell 
death have been suggested to occur in neurodegenerative disease.
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Autophagy is one of these cell death modalities that has been largely studied 
in neurodegeneration. Autophagy has been shown to occur in AD (Moreira et 
al., 2007, Nixon, 2007), PD (Pan et al., 2008, Xilouri et al., 2009) and HD 
(Kegel et al., 2000, Ravikumar et al., 2004, Sarkar et al., 2007). Furthermore, 
autohpagic bodies have been reported to increase with age in mice (White et 
al., 2009). Taken these findings together with data shown here, this suggests 
that caspases may play a limited role in neuronal cell death in ageing rat 
retina.
The negative results obtained in this study using TUN EL assay analysis 
emphasise that other forms of cell death may play an important role during 
retinal maturation and ageing. It is important to note that even in human 
glaucoma, very few TUNEL-positive cells are detected (Kerrigan et al., 1997). 
Another explanation to these negative results could be that the cells were 
already dead or at a very early stage of cell death that it was impossible to 
detected using TUNEL assay. However, according to the manufactures’ 
instruction, these cells should be detectable with TUNEL kit.
Whilst this study demonstrates reduction of clAP1 in the RGCL of mature BN 
retina, it remains still unclear at present to what extend clAP1 contribute to 
death of the cells in RGCL. The precise point when the cells in RGCL start to 
be eliminated and whether the death correlates with reduction of clAP1 are 
still to be elucidated. Determining the magnitude of clAP1 contribution to 
RGC cell death is of high interest. As already demonstrated by several 
groups, clAP1 seems to be a common player in facilitating cell death and 
activation of survival pathways (Eckelman and Salvesen, 2006, Hsu et al., 
1996, Hsu et al., 1995, Rothe et al., 1995, Shu et al., 1996). Furthermore, 
there is evidence that exogenous lAPs may protect neurons during 
glaucoma. Gene therapy delivery of XIAP/BIRC4 to the retinae of chronical 
ocular hypertensive (COH) model of rat glaucoma significantly promoted 
optic nerve axon survival (Kugler et al., 1999, Kugler et al., 2000, McKinnon 
et al., 2002).
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The limitation of this study is that it has not clarified whether the clAP1 
reduction occurs as early as 24 weeks. The age range in the mature sample 
is too big to draw any definitive conclusions. The reason that the age range 
was used is because the company (Charles River, UK) where the animals 
were purchased from could not provide the specific age of the animals
At present, what determines the balance between cell death and activation is 
still unknown. Further investigation into the subject will highlight the 
molecules that may be targeted for therapeutic intervention in order to arrest 
RGC cell death. Thus, it remains a challenge to determine the specific 
contribution of clAP1 to cell death of ageing and diseased RGCs.
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5.1 Introduction
Age-related functional changes in mammalian CNS vary between different 
regions of the brain, as reflected by the decline in motor, sensory and 
cognitive functions associated with senescence (Hofer et al., 2003, Mattson 
and Magnus, 2006). These changes include modification and/or loss of 
neuronal structure, function, cell loss of a specific neuronal population and/or 
loss of cells that support neurons such as glial cells (Adams, 1987, Ball, 
1977, Coleman and Flood, 1987, Morgan et al., 1999b, Morrison and Hof, 
1997, Nakamura et al., 1985, Poe et al., 2001, Wong et al., 1998).
Neuronal loss during normal ageing is a universal phenomenal, which is 
associated with cognitive function decline (McArdle et al., 2002, Finch, 2009). 
Recently, it was suggested that cognitive function decline start in early 
adulthood (Coleman et al., 1990, Finch, 2009, Li et al., 2001, McArdle et al., 
2002). There have been reports indicating that neuronal loss start at middle- 
age, at 25 years in humans (Salthouse, 2009) and at 3 months for rodents 
(Severson and Finch, 1980). Severson and Finch showed a well defined 
decline in dopamine D2, Serotonin 2A and other binding sites in striatum and 
cortex in middle-aged rodents (Severson and Finch, 1980). Although there is 
substantial evidence of neuronal loss at early adulthood in different regions of 
the brain, it is still unclear whether this is the course of decline of motor, 
sensory and cognitive function associated with senescence.
Vision is one of the first functions that are affected by age (Dandona and 
Dandona, 2006). Although there are reports indicating that there is a 
neuronal loss in the retina with age (Neufeld and Gachie, 2003, Spear, 
1993), it has also been suggested that the loss is subtle (Harman et al., 
2000, Mann, 1996). Work carried out on human wholemounted or sectioned 
retina demonstrated a decrease in neuronal density with age in the retina 
(Gao and Hollyfield 1992). Similarly, reduction in cell density in retinal 
ganglion cell layer (RGCL) in rat (Katz and Robison, 1986), quokka wallaby 
and the horse has been demonstrated (Harman et al., 2000, Harman et al., 
2003, Harman et al., 1999). In rats the reduction was up to 60% in RGCL, 27- 
30% in INL and 38-50% in ONL. Although there have been many reports
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suggesting that cell loss in the retina occurs in aged rodents and humans, 
very little investigation has been carried out to determine the time of onset of 
cell loss. Thus, it is important to elucidate when the decline begins because 
this may indicate to which period in adulthood is likely to be informative for 
learning about the causes of, not only age-related visual impairment, but also 
age-related motor and cognitive function impairment.
5.2 Aims
The aim of this study was to investigate whether there is any alteration in 
retinal cell density during retina maturation of BN rat. The BN rat is a valuable 
model to study normal ageing since it has a low incidence of age-related 
pathologies (Sprott and Austad, 1995). The second goal of this study was to 
determine when dendrite pruning starts and the extent in which dendrite 
pruning occurs in adult rat retina.
5.3 Experimental design
Eyes from 6 and 24-52 weeks animals were removed immediately after 
sacrificing the animal. The anterior segment and vitreous were removed and 
retina carefully dissected as described in chapter 2, section 2.2.3. Once the 
retina was out of the eye-cup, four cuts were made in order to open up the 
retina. Dissection was carried out quickly and under cold conditions. The 
retina was then transferred to a nitrocellulose membrane with RGC side 
facing up and then inserted in a culture dish containing culture medium (see 
section 2.9.2)
The retina was incubated at 37°C under humidified 5% CO2 for 20 minutes in 
order to allow the adjustment of the retina to dissection stress. Following 
diolistic labelling using BioRad gene gun, the retina was incubated for 
maximum 30 minutes at 37°C in the humidified 5% C 0 2 incubator in order to 
allow the Dil dye to spread. Before incubation, the retina was visualised with 
Ziess confocal microscope to evaluated transfection success. Following 30 
minutes incubation, the retina was fixed in 4% PFA overnight at 4°C, washed
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and then transfared to a glass slide, again with the RGC side facing up and 
mounted using ProLong Gold antifade reagent. Imaging was carried out 
using Zeiss confocal microscope and images stack of the retina were 
obtained for cells of interest.
Following imaging, the retina was carefully removed from the slide washed in 
PBS and counter stained for Hoeschst 3342 for 20 minutes. Subsequently, 
three washes in PBS were carried out and the retina was mounted once 
again on glass slide with RGC side facing up and mounted with ProLong 
Gold antifade reagent. Imaging was carried out utilising Leica fluoroscence 
microscope. Cells were counted using Cell Counter plugin for ImageJ (see 
Chapter 2, section 2.9.8).
For determining the cell density in the INL and ONL, the anterior segment 
was removed and the eye-cup was fixed overnight in 4% PFA. Following 
standard paraffin embedding of the eye-cups, 7 pm sections were obtained. 
Following dewax, the sections were stained for Hoeschst 3342 for 20 
minutes. The sections were washed and mounted on glass slide and 
mounted with ProLong Gold antifade reagent. Leica fluoroscence microscope 
was used to obtain images. Nuclei were counted using a Cell Counter plugin 
for ImageJ.
Data in this chapter are expressed as mean and standard error. Normality 
test was carried out for all data before performing any statistical test. 
Statistical analysis was done using SPSS program. For comparison between 
two groups, independent student test was utilised. Comparison among 
multiple groups was performed using one-way ANOVA followed by Fisher’s 
Tukey’s post hoc test. Differences were considered significant for p<0.05.
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5.4 Results
5.4.1 Decreased RGC density in 24-52 week old retinae
Systematic imaging of RGCs in the whole retinal mount (Fig 1A-C) revealed 
that there was a significant decrease in cell number (n = 4; per studied group; 
p>0.001; Fig 5.2A) and density (p>0.001) in the whole retina (Fig 5.3A). 
Percentage-wise, RGCL cell loss was 16% in the whole retina (Fig 5.2A). 
When the different areas of the retina were investigated, there was a 
significant reduction in the central (1mm from the OD, p>0.001, Fig 5.2B and 
5.3B). This reduction was up to 24%. The density of the peripheral (2mm and 
3mm from the OD) retina remained similar during retinal maturation (Fig 5.2B 
and 5.3B).
5.4.2 Decreased cell density in INL and ONL 24-52 week old retinae
Evaluation of cell number and density revealed that there was a statistically 
significant decreased cell number in the INL and ONL cells (n = 4; p>0.001, 
and p>0.001, respectively) counted from the retinal slices crossing the optic 
nerve (Fig 5.4A-C). These corresponded to 25% decrease in INL and 20%  
decrease in ONL (Fig 5.4A-C).
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Figure 5.1. Hoeschst 3342 stained retinal ganglion cells. (A) 
Schematic picture of the imaging areas. (B) RCGs in 6 weeks 
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Figure 5.2. Decreased RGC number in the central but not peripheral BN retina during 
ageing. (A) The total RGC number in the whole retina was statistical significantly 
reduced. (B) RGC cell in three different areas of the retina in the two studied stages. 
There was a statistical significant reduction of RGC number in the central area (1mm 
from the Optic disc) of the retina of 24-52 compared to 6 week old retina. Mean and 
standard errors are shown on data from 4 animals per age (total 8 retinae per age) to 
produce the results (*** indicates p <0.001 statistical comparison between the two 
ages, independent student’s test).
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Figure 5.3. Decreased RGC density in the central but not peripheral BN retina during 
ageing. (A) RGC cell in three different areas of the retina in the two studied stages. 
There was a statistical significant reduction of RGC density in the central area (1mm 
from the Optic disc) of the retina of 24-52 compared to 6 week old retina. (B) The total 
RGC density in the whole retina was statistical significantly reduced. Mean and 
standard errors are shown on data from 4 animals per age (total 8 retinae per age) to 
produce the results (*** indicates p <0.001 statistical comparison between the two 
ages, independent student’s test).
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Figure 5.4. Reduced cell number of the cell in the inner and outer nuclear layer. 
Retinal sections stained for Hoeschst 3342 (A) . The INL (B) and ONL (C) cell 
number was statistical significant decreased during ageing. Mean and standard 
errors are shown on data from 5 sections per retina (n=6 eyes per age; total 30 
sections per age) to produce the results (*** indicates p <0.001 statistical 
comparison between the two ages, independent student’s test). Abbreviations: 
INL, inner nuclear layer; ONL outer nuclear layer. Scale bar: 50pm
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5.4.3 Retinal expansion during maturation
The next step was to investigate whether the decrease was due to cell death 
or some other unknown factor. In chapter 4, the levels of active caspase 3 
were shown to remain similar between retinae of 6 to 24-52 week old (data 
shown in Fig. 4.4A-C in chapter 4) and no TUNEL-positive cells were 
detected in these retinae (Fig4.7A-F in chapter 4). This led to investigation of 
other factors such as retinal expansion. Measurements of retina area 
demonstrated that 24-52 week old rats had a significantly (p>0.001) 
increased retina area corresponding to 23% increase (n = 5 for 6 and n = 4 
for 24-52 week old rats; Fig 5.5).
5.4.4 Decreased dendrite complexity in 24-52 compared to 6 week old 
retinae
Diolistic Dil labelling of RGC ex vivo revealed the cell soma, axon and the 
entire dendritic field. These cells were the divided into four groups 
corresponding to percentile 25, 50, 75 and 100 of the sampled population in 
terms of the total dendritic complexity, thus in terms of bifurcations (Fig 5.6). 
Sholl analysis quantifying the dendrite abours demonstrated a reduction in 
dendritic intersections in mature compared to younger animals (n = 5 animals 
per stage, 60 neurons for young and 64 neurons for mature animals; Fig 
5.7A). Analysis of individual parameters revealed a significant reduction 
(p=0.0071) in bifurcations in mature animals (Fig 5.7B). The total length of 
the dendrites also showed a significant (p=0.0098) reduction in mature 
compared to young retinae (Fig 5.7C).
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Figure 5.5. increased retinal area in 24-52 weeks compared to 6 
weeks. There was a statistical significant retinal expansion in 24-52 
compared to 6 week old BN rat. The data represent mean and standard 
errors of 10 young and 8 mature retinae from 4-5 animals per stage (*** 
indicates p <0.001, statistical comparison between the two ages, 
independent student’s test).
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Figure 5.6 Schematic representation of the BN RGC. The figure illustrated 
morphology variety of the neurons in ages studied. RGC dendrite complexity is 
reduced in 24-52 (right panel) compared to 6 weeks (left panel) animals. The 
neurons shown correspond to percentiles 25, 50, 75 and 100 of the sampled 
population in terms of bifurcations. Scale bar: 20pm
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Figure 5.7. Reduced dendrite complexity in mature RGCs. (A) 
Photomicrographic of typical diolistically (Dil) labelled RGC. (B) Sholl analysis of 
RGCs dendrites morphology. (C) Number of birfucation was significantly (p< 
0.0071) reduced in RGCs 24-52 weeks RGCs. (D) Total length of RGCs 
dendrites was also significantly (p< 0.0098) reduced in mature compared to 
younger RGC. The data represent mean and standard errors of 60 young and 64 
mature neurons from 5 animals per stage (**indicates p <0.020, statistical 
comparison between the two ages, independent student’s test).
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5.4.5 Soma and dendritic field area
Mean percentage soma size showed a trend towards increase during retina 
maturation (Fig 5.8A), but this did not reach statistical significance. Mean 
dendritic field area showed a marginal increase in 24-52 weeks retina (Fig 
5.8B).
5.4.6 Dendritic density
Since there was a significant reduction in dendritic complexity, investigation 
of dendritic density was carried out. Calculation of dendritic density revealed 
this to be significantly (p=0.027) reduced in 24-52 compared to 6 weeks old 
RGCs (Fig 5.9).
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Figure 5.8. RGC soma remains similar during retina maturation. Both 
dendritic field (A) and percentage soma size (B) show a slight increase in 
mature compared to younger animals but this did not reach statistical 
differences. The data represent mean and standard errors of 50 young 
and 53 mature neurons from 5 animals per stage. Abbreviations; ns, non 
significant.
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Figure 5.9. RGC dendrite density was significant decreased (p< 0.025) 
in 24-52 compared to 6 weeks retinae. The data represent mean and 
standard errors of 50 young and 53 mature neurons from 5 animals per 
stage (** indicates p <0.020, statistical comparison between the two 
ages, independent student’s test).
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5.5 Discussion
The age-related decline in cognitive function has been well documented. 
Although there has been a large body of reports in the literature suggesting 
cognitive function decline with increase age, it is still unclear when these 
changes start occurring. The current study, explores the changes in the 
retinal cell population, along with number, density and architectural structure 
of neurons in young adult and mature BN rat retina. Furthermore, cell number 
in INL and ONL were determined. All retinal cell populations show a 
significant decrease in cell number and density with increasing age. Several 
groups have also reported reduction in retinal cell population as a function of 
age. For example, it was reported that there isan inherited age-related loss of 
RGCs in monkey (Sanchez et al., 1986, Jonas and Hayreh, 2000, Morrison 
and Hof, 1997) and human (Harman et al., 2000, Jonas et al., 1990, 
Kenrigan-Baumrind et al., 2000), but this loss in human differs from region to 
region.
The reduction in RGC density observed in this study confirms that cell 
reduction is more pronounced in the central compared to peripheral retina. 
These results corroborate that of other investigators showing that the 
distribution of RGCs in the rat is not homogenous (Urcola et al., 2006). 
Neuronal loss has been shown to also occur in the brain. A half of the 
neurons in somatosensory cortex are lost during ageing (Henderson et al., 
1980). This effect is also seen in hippocampus (West et al., 1993) and visual 
cortex (Devaney and Johnson, 1980), where there is up to 50% of neuronal 
loss over the lifetime.Thus, the general understanding is that there is 
neuronal loss in CNS in human, primate and rodents (Flood and Coleman, 
1993).
While the apparent cell loss observed in this study could reflect the degree of 
cell death changes, retinal area could also generate similar changes in cell 
density. In this study, there was an increased retinal area in the mature 
compared to younger animals studied here. These data are in line with a 
report suggesting that there is retinal expansion during adulthood (Harman et 
al., 2000). There were no TUNEL-positive cells detected in the present study.
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In development, where 50% RGC undergo developmental apoptosis, usually 
less than 1% of TUNEL-positive is detected (Perry et al., 1983). The 
explanation for this could be that the phagocytosis of dead retinal cells has a 
clearance time of only a few hours suggesting that the negative results in this 
work observed by TUNEL could be a consequence of wrong 
timing.Investigation of human glaucomatous eyes by Kerrigan and 
colleagues revealed TUNEL-positive cells but DNA fragmentation was not 
detected and also the frequency of TUNEL-positive cells was very low 
(1/10000 celts; (Kerrigan et al., 1997). The data obtained in this work and 
data from other groups (Harman et al., 2000) strongly suggest that the 
decrease neuronal density in the retina is coursed by a small but continuous 
increase in retinal area and not cell death.
Interestingly, 0.3% axons loss occurs in the optic nerve per year in healthy 
humans (Jonas et al., 1990). The same observation has been made in 
human photoreceptors and pigment epithelium (Panda-Jonas et al., 1995). 
Progressive axonal loss occurs also in rodents. For instance, Wistars albino 
rats show over a third axonal loss during ageing process (Ricci et al., 1988). 
In contrast to this, relatively mild axonal loss in BN rats is observed, where 
just 12% by 30 months and none by 24 months (Cepuma et al., 2005) 
suggesting non-linear neuronal loss with age in BN rats. Clearly, the effect of 
age on retinal cell population, not only varies between species but also within 
species.
The work carried out here showed that neuronal network complexity is 
significantly reduced in mature compared to younger retinae. Taking in 
account retinal expansion and ceil spreading out, in order to cover the 
increasing area, the likely hypothesis would be that neurons will extend there 
processes in order to maintain synaptic contact. However, this was not the 
case, suggesting that there is a reduction in synaptic contacts with age, 
which may be owing to visual impairment during the ageing process. 
Dendrites remain subjected to structural changes throughout adulthood 
(Johnston and Narayanan, 2008).
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Thus, any alteration in dendrite geometry will significantly alter the 
physiological properties of any given neuron, even if the total number of 
synaptic input is stable thereby contributing to the cognitive changes that 
often accompany senescence (Barnes, 1979, Markowska et al., 1998). 
Nevertheless, it has been reported that similar changes occur in the brains of 
different species, where there is age-related decrease in dendrites stability, 
lengthening and regression (Grill and Riddle, 2002).
Dendrite growth has been suggested to terminate by age of 5 years in human 
prefrontal cortex (Koenderink and Uylings, 1995, Uylings and de Brabander,
2002) and by one month in rat visual cortex (Juraska, 1982). This could 
partially explain the observation obtained in the current work. Interestingly, 
there are some reports suggesting increasing dendritic extent between 3 and 
12 months in rats supraoptic (Flood and Coleman, 1993) and in pyramidal 
neurons of macaca mulatta (Cupp and Uemura, 1980). Grill and Riddle 
showed an ongoing dendritic growth after 2 months and regression after 18 
months in pyramidal neurons of BN rats (Grill and Riddle, 2002). This 
conflicting data could be owing to experimental set up. For example, housing 
condition has been shown to have an effect on the dendritic tree. Animals 
housed in more complex environment have a bigger and more elaborated 
dendritic field compared to those housed in less complex environment 
(Green et al., 1983).
The data provided here is informative for the effects of ageing on the 
development of glaucoma. BN rats are preferred models for experimental 
glaucoma, where RGC death occurs as early as two weeks after induction of 
glaucoma (Samsel et al., 2010). Since the RGCs are already “sick”, this 
facilitates their death. This points out the importance of taking the animal’s 
age in to consideration when evaluating the pathophysiology of 
glaucomatous eyes in animal models. Thus, BN are not susceptible to 
glaucoma as other rat strains such as Wistars due to neuronal death 
accompanying senescence but as a consequence of compromised RGC 
architectural structure.
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Taken together, the results provided here suggest that neuronal cell loss that 
occurs as a result of the ageing process appears to be more marginal than it 
has been generally assumed. Although neuronal cells are subjected to 
ageing process it does not mean that the cell undergoes cell death (Harman 
et al., 2000).The architectural structural changes of the neurons may leave 
the cell viable with impaired physiological function. The changes are reflected 
in visual decline that is seen during ageing. The data provided here provide 
insights concerning the onset of these changes suggesting appropriate 
intervals for the use of therapeuric intervention the mitigation of RGC loss. It 
is clear that architectural structural changes of the CNS neurons occurs as 
early as middle age across all species. Also with animal models, it is 
important to have this information in order to correctly evaluate 
pathophysiology of a certain diseases.
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Chapter 6
Expression of caspases and lAPs in the 
microbead model of experimental rat glaucoma
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6.1 Introduction
Glaucoma is a neurodegenerative disease that leads to irreversible 
blindness. It is characterised by detrimental changes in the optic nerve and 
RGC death (Quigley et al., 1995, Kerrigan et al., 1997). The course of these 
detrimental effects is partially due to elevated intraocular pressure (IOP). 
Although glaucoma has been studied extensively for the past 30 years, 
molecular mechanism that governs RGC death has not been fully 
understood. The use of experimental glaucoma model has facilitated 
progress in this research field.
The development of an experimental rat glaucoma model has allowed the 
identification of genes and protein involved in glaucoma pathogenesis and 
disease progression (Johnson et al., 2000, Morrison, 2005, Morrison et al., 
2005, Levkovitch-Verbin, 2004, McKinnon et al., 2002, Neufeld and Gachie,
2003). Different methods have been used to induce elevated IOP in rats. 
These include injection of phosphate buffer saline (Morrison et al., 1997), 
cauterisation of the episcleral vien (Kim and Park, 2005), laser energy 
delivery to the trabecular meshwork (Levkovitch-Verbin et al., 2006), injection 
of hypertonic saline into the limbal venous plexus (McKinnon et al., 2002) 
and injection of paramagnetic beads to the anterior chamber (Samsel et al., 
2010). All these models strive to increase IOP by blocking outflow of the 
aqueous humor from the anterior chamber.
It is well documented that RGCs undergo apoptosis in glaucoma (Garcia- 
Valenzuela et al., 1995, Vrabec and Levin, 2007, Guerin et al., 2006, Quigley 
et al., 1995). Both human and animal model glaucoma shows TUNEL 
positivity in the RGCL (Kim and Park, 2005, Kerrigan et al., 1997). Moreover, 
activation of initiator caspase 8 and effector caspase 3 activation has been 
shown to occur in experimental glaucoma (McKinnon et al., 2002).
Discovery of IAP genes, which are conserved in viruses, insects and 
vertebrates and investigation of their function, has lead to a novel approach 
of caspase inhibition for neuroprotection in the retina (Liston et al., 2003). 
Furthermore, these molecules have shown capability to modulate activation
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of survival pathways (Zarnegar et al., 2008). For instant, clAP1 is involved in 
activation of nuclear factor kappa B (NF-kB) pathway (Zarnegar et al., 2008). 
Furthermore, it was demonstrated that overexpression of XIAP protects optic 
nerve (ON) axons of hypertension rat glaucoma model (McKinnon et al., 
2002). Although extensive work has been performed to elucidate the function 
of IAP proteins, their roles in modulating glaucoma pathophysiology are still 
unclear.
Interestingly, both apoptotic and survival pathways are simultaneously 
activated in experimental glaucoma (Kim and Park, 2005, Levkovitch-Verbin 
et al., 2006, Levkovitch-Verbin et al., 2007, Yang et al., 2007), indicating that 
there is a delay in RGC death. It was shown that the proapoptotic genes from 
the p53 pathway Gadd45a and Ei24 were up-regulated in a photocoagulation 
model for experimental glaucoma (Levkovitch-Verbin et al., 2006). The MAP- 
kinase pathway was altered in experimental glaucoma (Levkovitch-Verbin et 
al., 2007).
6.2 Aim
The aim of the current study was to characterise the expression profile of 
pro-apoptotic and survival pathway molecules in glaucomatous eyes in order 
to identify molecules that can be targeted for therapeutic purposes in order to 
rescue RGC death. Since the apoptotic pathway has previously been shown 
to be the main mechanism of RGC death, molecules of apoptotic pathway 
were quantitatively investigated.
6.3 Experimental design
Elevated IOP was induced in 14 male BN rats by injecting paramagnetic 
microbeads into the anterior chamber of the left eye. The beads contain an 
Iron (II,III) oxide (Fe3 0 4) core, which is ferromagnetic, encapsulate by a 
polysterene with a carboxyl group (-COOH) link to it via a polyethylene glycol 
(PEG). The right (non-injected) eye was used as a control. IOP was
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measured 24h after injection and every three days thereafter. Sustained 
elevated IOP for at least 14 days was desired, but some animals did not have 
increased IOP even after the injections therefore, up to 3 injections were 
required in some cases. Moreover, a minor number of animals did not have a 
sustained IOP elevation after multiple injections. These animals were not 
included in the protein analysis experiments.
After, at least 14 days of increased IOP, the animals were sacrificed by C 0 2 
inhilation. The retina was immediately dissected as described in section 2.2.1 
for RNA analysis and 2.2.2 for protein isolation.
RNA extraction, quantification and cDNA synthesis was carried out as 
described in sections 2.4.3, 2.4.4 and 2.4.6 respectively.
Following evaluation of stability of the housekeeping genes, namely 
glyceraldehydes 3-phosphate dehydrogenase (GAPDH), beta-actin and beta- 
ill tubulin in experimental and control eyes, real-time PCR was run as 
described in the methods and chapter 3. Caspase 3, 7 and 9 and lAPs 
genes, namely, NIAP, clAP1, clAP2, XIAP, Survivin, Bruce and Livin 
expression was evaluated.
Subsequently, caspase 3 activity was determined in glaucomatous eyes by 
Western blotting as described in section 2.6. The p53 pathway, which is 
involved in regulation of both pro- and anti- survival molecules pathway was 
evaluated by quantifying p53 protein levels in glaucomatous eyes.
Finally, statistical analysis between experimental and control eyes was 
performed using parametric analysis independent student t-test (SPSS16, 
Chicago, Illinois) after determining normal distribution (Shapiro-Wilk test) and 
equal variance (Lavene test) between the groups. All data are presented as 
means ± standard errors. Differences were considered significant for p<0.05.
138
Chapter 6 Microbead model of experimental rat glaucoma
6.4 Results
6.4.1 IOP profile
Injected paramagnetic beads can be seen in the live animal eye (Fig. 61A-B) 
and post-mortem H&E staining of the TM two weeks after injection (Fig 6.1C- 
F). The beads clearly blocked the outflow of the aqueous humour. Injection of 
the paramagnetic beads into the anterior chamber of the BN rats resulted in 
sustained elevated IOP in <50% of the injected animals for the period of 
investigation (£ 30 days; Fig. 6.2, and 6.5). The remaining animals had 
fluctuating IOP (Fig. 6.2, and 6.5), but these animals were also included in 
the study since they all had an increase of IOP at some point. Previous work 
by our group has demonstrated that animals with fluctuating IOP also show 
RGC loss (Samsel et al., 2010). Mean lOPs of all animals are shown in table 
6.1. The IOP increase was highly significant 1day post injection. At day 8 
post injection the animals showed an increase in IOP but the statistical 
significance were modest. At day 16 and £ 30 days post injection the 
increase was significant but not as strong as 1day post injection (Table 6.1). 
lOP-integral differences were averaged for each animal and compared. The 
mean integral IOP was 326.14± 49.53, range 57.7-607.25 (±SEM).
Table 6.1. Intraocular pressure (IOP) history in rats with experimental 
glaucoma
Time point Mean IOP (mmHa) 
Glaucoma Control* p-values
1 day 34.95±11.2 19.05±4.56 P <  0.0114
8 days 31.29±12.83 21.5513.31 P < 0.0540
16 days 32.35±12.17 22.7713.40 P < 0.0467
£ 30 days 31.21±10.59 23.3412.07 P <  0.0413
Results are given as mean ±SD 
*The animal’s fellow eye
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6.4.2 Evaluation of housekeeping genes stability
IOP profiles of the animals used for quantitative PCR are shown in figure 6.2 
(n = 6). Animals in figures 6.2A, C and D had fluctuating IOP profiles whilst 
animals in figures 6.2B, D and F had sustained IOP profiles. Housekeeping 
gene expression was evaluated by plotting the ct values. The results show a 
trend towards a higher expression in glaucomatous eyes (n = 6) but the 
difference was marginal indicating that the expression of these housekeeping 
genes was not significantly altered following IOP elevation (Fig. 6.3).
6.4.3 mRNA expression of caspases and lAPs in glaucoma
Caspases 3,7 and 9 showed no alteration in their expression at the mRNA 
level (Fig. 6.4A, n = 6). By contrast, the majority of lAPs showed a trend 
towards an increased in expression (n = 6). These include NIAP, clAP2, 
Survivin and Livin (Fig. 6.4B). NIAP and Livin were significantly up-regulated 
(p<0.0001 for both), up to 5-fold increase in glaucomatous compared to 
control eyes. Bruce was significantly down-regulated (p<0.0001; 2.5 fold) in 
experimental eyes while clAP1 and XIAP remain similar between control and 
experimental eye (Fig. 6.4B).
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Figure 6.1. Paramagnetic beads in the trabecular meshwork (TM). A 
picture of he paramagnetic beads that were used to induce increased 
IOP in BN eyes (A). Beads in the iridocorneal angle as indicated by 
the arrow (B). Immunohistochemical analysis confirmed presence of 
the beads in the trabecular meshwork (C-F). Figure 6.1B is adapted 
from Samsel P, Kisiswa L et al., IOVS 2010, In press.. Abbreviations; 
TM, trebecular meshwork; PMB, paramagnetic beads.
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Figure 6.2. IOP profile of animals used for real-time PCR on expression profiles 
of caspases and lAPs in experimental rat glaucoma model. Some animals had 
sustained increased IOP (B,D-F) while other had fluctuation in IOP (A and C). 
Several animals required multiple injection (A and C)
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Figure 6.3. Stability of housekeeping genes (GAPDH, beta-actin and beta-ill 
tubulin). Evaluation of the stability of housekeeping genes by plotting their ct- 
values.
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Figure 6.4. Real-time PCR on expression profiles of caspases (A) and lAPs (B) 
in experimental rat glaucoma model. Samples were taken from total retinal 
extraction (6 right (control) and 6 left (experimental) eyes, total 6 animals). The 
levels of mRNAs were calculated relative to three endogenous genes, namely, 
GAPHD, p-actin and P-tubulin mRNA. Mean and standard errors are shown.
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6.4.3 Active caspase 3 in experimental eyes
Previously, it was reported that active caspase 3 is present in glaucomatous 
eyes using immunohistochemisty analysis. Western blotting analysis was 
performed to quantify active caspase 3 protein in the experimental glaucoma 
bead model. Thisese animals had a variable IOP profile (Fig. 6.5). Western 
blotting analysis demonstrated the presence of both inactive and active 
caspase 3 in the two groups (n = 7) studied (Fig 6.6A). Densitometric 
quantification revealed a significant (p<0.001) decrease in inactive caspase 3 
in experimental (3.8 ± 1.8-fold; n = 7) compared to control (n = 7) eyes (Fig. 
6.6B). The active form of caspase 3 also showed a trend towards reduction 
(2.3 ± 1.5-fold; n = 7; Fig. 6.6B) but this did not reach statistical significance.
6.4.3 Analysis of p53 protein levels in glaucomatous eyes
Although p53 gene expression was altered in experimental glaucoma by 
gene array analysis (Levkovitch-Verben et al. 2006), evaluation of p53 
protein levels were measured here since mRNA levels of a particular gene do 
not always provide a consisten correlatation with protein levels. Protein levels 
of p53 in this study were statistically significantly (p=0.02, n=7) higher in the 
experimental eye of the bead model compared to the control eye (Fig. 6.7A- 
B).
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Figure 6.5. IOP profile (representative IOP profiles) of animals used for 
evaluating casapse 3 (pro-apoptotic), and p53 protein levels in experimental rat 
glaucoma model. Some animals had sustained increased IOP (B.D-F) while 
other had fluctuation in IOP (A and C). Several animals require multiple injection 
(A and C)
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Figure 6.6. Increased active caspase 3 protein levels in experimental rat glaucoma 
model. (A) Blots showing reduction in levels of inactive caspase 3 in the left 
(experimental) compared to right (control) eye. (B) Quantification of the band 
density revealed a significant (p<0.001) reduction of inactive caspase 3 but active 
caspase 3 remained the same in both groups. The densitometry data reflect the 
expression level for each protein for each examined as a ratio value relative to actin 
levels (mean and standard errors, n=7 for each group (3 readings were taken for 
each animal; *** indicates p <0.001, statistical comparison between the two ages, 
independent student’s test).
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Figure 6.7. Increased p53 protein levels in experimental rat glaucoma model. (A) 
Blots showing an increased levels of p53 in the left (experimental) compared to right 
(control) eye. (B) Quantification of the band density revealed an increased in p53 
protein levels. The densitometry data reflect the expression level for each protein 
for each examined as a ratio value relative to actin levels. Mean and standard 
errors, n=7 for each group (3 readings were recorded for each animal; **p=0.02).
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6.5 Discussion
Susceptibility of getting glaucoma increases with age (Carter, 1994). Current 
work has focused on elucidating the molecular mechanisms that are involved 
in the genesis and progression of glaucoma. The majority of RGCs are lost 
by apoptosis, but recent evidence suggests that RGCs undergo a prolonged 
period in which the architectural structure of the neuron alters, which includes 
reduction of dendritic tree extent and complexity prior to loss of the cell body 
(Morgan, 2002, Quigley, 1999). Apoptotic pathways are involved in dendrite 
remodelling in development and inhibitory pathways are activated that retard 
the onset of apoptotic cell death (Williams et al., 2006).
In this study, a novel rat glaucoma model was developed by injecting 
magnetic microbeads into the anterior chamber. To ensure occlusion, a hand 
held magnet was used to draw the beads into the TM giving an increase in 
IOP 24 hours later and this was sustained for over a month. This bead model 
is a model for human chronic closed angle glaucoma. The model is 
considered chronic as the elevated IOP is sustained for a period longer than 
24 hours.
In the present study, examination of the apoptotic pathway, concentrating on 
the inhibitors of apoptosis molecules has been carried out. The data provided 
here demonstrates that clAP1, clAP2, XIAP and Survivin expression on 
mRNA level remained similar in glaucomatous and normal eyes. 
Interestingly, Levkovitch-Verbin and colleagues showed clAP1 (named IAP1 
in the paper) and clAP2 (named IAP2 in the paper) were up-regulated on the 
gene array but could only confirm the up-regulation for clAP1 which was up- 
regulated 1.5-fold (Levkovitch-Verbin et al., 2006). These contradicting 
results may be owing to the fact that different rodent models were used in the 
two experiment and also that the method of inducing elevated IOP also 
differs between the experiments.
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NIAP and Livin expression were increased 5-fold in glaucomatous compared 
to control eyes. Although, NIAP and Livin are structurally different, they have 
been suggested to bind caspase 3 and 9 (Liston et al., 2003). NIAP 
containing three BIR and Nucleotide Binding Domains (NBD) binds capsase 
3 and 7 and hinders activation of these proteases (Liston et al., 2003). NIAP 
has been suggested to have a modulating function in spinal mascular atropy 
(SMA), a disease characterised by progressive loss of motor neurons 
(Gendron and MacKenzie, 1999, Xu et al., Liston et al., 2003). NIAP-deficient 
mice do not exhibit developmental malfunction or spinal mascular atrophy 
(Roy N et al., 1995; Holcik M, et al., 2000) suggesting that the mutation is not 
the primary cause of the disease (Gendron and MacKenzie, 1999). Taken 
together, the increase in the levels of NIAP shown in this study suggests that 
it may have a modulatory effect in glaucoma, possible by delaying RGC 
death.
By contrast, Livin contains only one BIR domain and a RING domain. The 
RING domain function is to encode ubiquitin protease activity. Thus, the 
RING domain is responsible for the transfer of ubiqutin into target proteins 
(Yang et al., 2000). There are two isoforms of Livin, the alpha (a) and the 
beta (P). Although they are structurally very similar, the two isoforms exhibit 
different cellular and tissue distribution and antiapoptotic characteristics 
(Wang et al., 2008b). Only the alpha isoform is expressed in the CNS 
(Ashhab et al., 2001).
Initially, Livin was suggested to inhibit caspase 3,7 and 9 showing a broader 
range of activity than any other IAP considering the fact that it has only one 
BIR domain (Kasof and Gomes, 2001, Liston et al., 2003). However, the 
inhibition has shown to be weak compared to XIAP (Vucic D et al., 2005) 
suggesting that Livin might bind to the proteases but has no or little effect on 
inhibiting their activity. Recent work reported that similarly to XIAP and 
clAP1, Livin is involved in non-apoptotic pathway (Sanna et al., 2002, 
Dupoux et al., 2009, Li et al., 2002, Santoro et al., 2007, Rothe et al., 1995). 
Livin is capable of activating Jun NH2-terminal kinase 1 (JNK1) and 
activation of this molecule protects the cell from extrinsic apoptotic signals
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(Sanna et al., 2002).
The linker region in XIAP between BIR1 and BIR2 has been suggested to be 
more important than BIR domain itself (Liston et al., 2003). The linker region 
spans the entire active site of caspase 3 and 7, hindering substrate entry 
(Liston et al., 2003). Also, XIAP has been suggested to inhibit directly and 
indirectly caspase 8. Activation of JNK1 has been implied to be the second 
role of XIAP (Sanna et al., 1998).Interestingly, overexpression of XIAP 
showed a protective effect of the optic nerve axons in rat glaucoma model 
(McKinnon et al., 2002).
But the group also observed expression of XIAP by cilliary bodies suggesting 
that overexpressing XIAP could have a protective effect in glaucoma by 
preventing pressure elevation by regulating production of aqueous humour 
(McKinnon et al., 2002). Thus, considering the fact that Livin and XIAP share 
50% homology and function (activation of JKN1 and inhibition of caspase 3 
and 7), it will be interesting to investigate whether the increase expression of 
Livin in glaucomatous eyes has a similar effect as XIAP and also to 
determine whether the expression is restricted to RCGL.
Interestingly, Bruce expression was decreased in glaucomatous eyes 
compared to control. Bruce, together with Survivin belongs to a group of lAPs 
with “Survivin like” BIR domain (Verhagen et al., 2001). Proteins with 
“Survivin like” BIR domains can also be found in Caenorhabditis elegans (C. 
Elegance) and yeast Schizosaccharomyces pombe (S pombe) indicating in 
evolutionary terms that these lAPs are older compared to the rest.
Furthermore, in these systems, the BIR domain in Bruce does not inhibit 
apoptosis but has been shown to modulate cell division (Silke and Vaux, 
2001, Uren et al., 1996). Other reports suggest that Bruce promotes cell 
survival by inhibiting apoptosis by spontaneous release of second 
mitochondrial-derived activator of caspase (Smac) (Hao et al., 2004). For 
instance, Bruce has been shown to regulate apoptosis in mice (Hao et al., 
2004, Ren et al., 2005) and in Drosophilamelanogastedyernooy et al., 2002). 
Recent work demonstrated that loss of Bruce function leads to up-regulation
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of p53 (Ren et al., 2005). This work is line the work reported here. Although, 
no evidence of alterations in Bruce protein has been provided here, it is fair 
to postulate that down-regulation of gene expression seen in this work might 
contribute to the up-regulation/stabilisation of p53 as shown here.
Thus, Livin and NIAP up-regulation suggest that the cell is struggling to 
escape apoptosis while stabilisation of p53 as a consequence of down- 
regulation of Bruce indicates that apoptotic activity is taking place in 
glaucomatous eyes. But other forms of cell death such as autophagy cannot 
be ruled out.
In this work, p53 protein levels were increased in glaucomatous compared to 
control eyes. p53 is a transcriptional factor that positively and negatively 
regulates transcription of various genes (Laptenko and Prives, 2006). These 
genes include those that are essential for mediating apoptosis, senescence, 
and cell-cycle arrest (Vousden and Lane, 2007). These are the well 
understood activities of p53. However, recent work has demonstrated that 
p53 also regulates glycolysis (Bensaad et al., 2006, Matoba et al., 2006), the 
repair of genotoxic damage (Gatz and Wiesmuller, 2006), invasion and 
motility (Roger et al., 2006), angiongenesis (Teodoro et al., 2006) 
differentiation (Murray-Zmijewski et al., 2006), cellular senescence (Kortlever 
et al., 2006) and autophagy (Crighton et al., 2006).
Although a mechanistic basis of p53 in glaucoma has not been provided 
here, it can be speculated that the increase in p53 observed contributes to 
RGC death by apoptosis or autophagy. Although apoptosis has been shown 
to occur in glaucoma it is still debatable whether it is the only cell death 
mechanism that occurs in glaucoma. The evidence of p53 elevation hints that 
autophagy may be occurring in glaucoma. Since little is know to what extend 
the autophagy plays a role in glaucoma, it will be interesting to elucidate a 
role of p53 and autopaghy in glaucoma.
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In summary, the present study has revealed up-regulation of two lAPs (NIAP 
and Livin) in an experimental rat glaucoma model (the bead model), of which 
one was previously shown to be up-regulated in a laser photocoagulation 
model for experimental glaucoma. Bruce, on the other hand, was down- 
regulated in the glaucomatous eyes. p53 protein levels were shown to be 
higher in the experimental eye suggesting that the down-regulation of Bruce 
might play a role in stabilisation of p53 protein in glaucoma. This in turn could 
lead to increased apoptosis activity and /or increased pro-survival activity in 
glaucoma.
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7.1 General discussion
The overall aim of the present study was to elucidate factors and mechanism 
that governs the maintenance and remodelling of RGC dendrites, as well as 
neuronal cell death in ageing and neurodegenerative diseases. Using PCR 
techniques, the expression pattern of molecules of the apoptotic pathway on 
mRNA level was determined in young adult, mature and diseased retinae. 
Furthermore, validation of the expression of these molecules on protein level 
was carried out using western blotting and immunoflouroscence techniques.
Rodent retinae were used in this study, which provide an excellent model 
because of its relative short lifespan enables ageing studies. Due to the 
availability of the ageing animals wistar albino rats were used for mRNA 
expression screening at late stage of the rat lifespan.
Using conventional PCR, caspases 3,6,7,8 and 9 expression in BN retina 
remain similar in two stages studied. lAPs expression, on the other hand, 
was generally decreased in mature compared to younger retina with an 
exception of clAP1. clAP1 was significantly down-regulated in mature retina 
compared to younger retina (Chapter 3). Real time PCR revealed a different 
expression pattern of the apoptotic pathway in ageing Wistar albino rats. 
Caspases 3,6,7,8 and 9 expressions were not altered during Wistar albino 
retina. NIAP, clAP2 and XIAP and clAP1 were decreased in older compared 
to younger Wistar albino retinae, while Survivin, Bruce and Livin we slightly 
increased with age (Chapter 3).
Correlation of clAP1 mRNA levels, which showed a significant reduction in 
expression in BN rat, with protein was carried out. In deed, clAP1 mRNA 
levels correlated with protein levels in the whole retina lysate. Using enriched 
RGCL cell sample, clAP1 down-regulation was shown to be specific for 
RGCL. This was validated by immunoflouroscence. Reduction of clAP1 did 
not alter caspase activity, which was shown using immunoflouroscence 
analysis and TUNEL assay. Impair survival pathway in retinae absent of 
clAP1 was shown by quantifying TRAF2 using immuno blotting and 
fluroscence (Chapter 4).
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Subsequently, dendrite pruning was determined in maturing BN rat retina 
revealing a reduction in dendrite complexity in what could be considered as 
middle-aged animals. The assessment of retinal cell loss demonstrated that 
there was reduction in cell density (unit per area) in all retinal layers but this 
was an offset of the retinal expansion (Chapter 5).
During this study, a new model of glaucoma was developed, where the 
injection of magnetic beads in the anterior chamber of the BN rat eyes was 
carried out. This lead to a sustained elevated IOP resulting in RGC cell death 
(Samsel et al., 2010). Once again, there was no alteration in caspase 
expression upon induction of glaucoma. Caspase 3 activity was slightly 
increased in the glaucomatous eyes. NIAP, clAP2, Survivin and Livin were 
up-regulated, while Bruce was down-regulated in glaucomatous eyes. clAP1 
and XIAP expression remain similar between control and experimental eye 
(Chapter 6).
A summary of the results presented in this thesis is provided above. The 
following discussion offers general observations as to the importance of the 
differently expressed genes during ageing and neurodegenerative diseases 
and the consequences accompanying the alteration in expression of these 
identified molecules in this study. The outcome of compromising neuronal 
morphology and the importance of maintaining a complex dendritic tree in 
health and disease will also be discussed.
Two rat strain, namely BN and Wistar albino have been used in this study for 
several reasons. Firstly the availability of the rat in the group was a 
determining factor. Initial lAPs and caspases expression pattern was 
determined in both strains in order to evaluate whether the changes in 
expression was specific to the species or differed also within the species. BN 
were the favourable model for further studies commonly used and more 
representative of the human glaucoma. With this in mind it was logic to use 
the BN for the ageing study, which facilitated extrapolation of the aging 
studies with glaucoma studies.
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Reduction in clAP1 does not lead to cell death. Age-related cell loss in the 
CNS is well documented for the past decades. This was first reported by 
Brody back in 1955, where reduction in brain weight as a consiquence of 
scenescence was suggest to be coursed by cell loss (Brody, 1955). Since 
then, neuronal loss has been shown to occur in ageing human, non-human 
primate and rodent brain (Ball, 1977; Brizzee et al., 1980) and retina (Cano et 
al., 1986, Cavallotti et al., 2001, Curcio and Allen, 1990, Gao and Hollyfield, 
1992, Katz and Robison, 1986, Weisse, 1995). Recent reports, including 
results provided in this thesis (Chapter 5) revealed no age-related neuronal 
cell loss occurs in rodent, human and non-human primates (Harman et al., 
2000, Harman et al., 2003, Harman et al., 1999, Kim et al., 1996).
Earlier reports on cell death during ageing faced various technical and 
methodological difficulties, such as species and strain difference, tissue 
processing and sampling design. The stereological method used for this early 
studies were measuring neuronal density (unit per area) but not total 
neuronal number (Morrison and Hof, 1997). This type of measurements did 
not take in account developmental expansion and volume of the tissue.
The development of new stereological principles has greatly improved 
sampling strategy and also eliminates the confounding factors of the previous 
studies (Burke and Barnes, 2006). The principles consist of collection of rules 
that enables counting of the number of items in a three-dimensional structure 
independent of the size of the object (Burke and Barnes, 2006).
There are several issues that accompany the cell density data provided here. 
For instant, RGC density in the central part of the retina was reduced but this 
did not apply to the peripheral retinal areas. One explaination is that it reflects 
the uneven distribution of the retinal cells. For example, there are no cells at 
the optic disk and photoreceptors cells are contracted in the fovea and 
macula (Feng et al., 2007).
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Moreover, the 7pm sections used in the study may result in overestimation of 
the number of cell (see chapter 2, section 2.7.2).The optical dissector method 
would have been better for sampling. The optical dissector, optically sections 
the sample area and directly estimates the cell number in each nuclear layer 
(Oorschot, 1994). The counting carried out here did not discriminate the 
amacrine cells. Amacrine cells make up to 50% of the cells in the RGCL 
(Perry et al., 1983). Thus, the data provided here show no changes in all 
retinal cell rather than retinal neuronal cells. Another limitation of the cell loss 
assessment carried out here is that the estimation of cell density did not 
account for the thickness of individual retina. Changes in retinal volume may 
vary topographically.
The advantage of this study is that the neuronal density measured took 
retinal expansion in account to estimate cells loss. For example the reduction 
in RGCL cell density was 16% whilst retinal expansion was 23%. Subtraction 
of percentage density reduction from percentage expansion showed no 
reduction. Thus neuronal loss is not a characteristic of normal ageing 
process in rodent retina to a certain age.
The clAP1 reduction leads to accumulation of TRAF2, which suggest 
impaired survival pathway in the retina, specifically in the RGCL. TRAF2 is a 
key player in activation of NF-kB. In neurons activation of NF-kB leads to 
expression of NF-kB targeted genes (Table 7.1). The genes encodes for cell 
survival (Bcl-2 and Mn-SOD;), inhibition of apoptosis (lAPs), cell death (Bcl- 
x(S) and Bax), regulation of ion homeostasis (subunits of NMDAR, calbindin, 
calcium binding protein and voltage dependent calcium channels; 
(Camandola and Mattson, 2000, Camandola et al., 2000b, Camandola et al., 
2000a, Chu et al., 1997, Furukawa and Mattson, 1998, Shou et al., 2002).
Although the clAP1 expression data shown here do not exclude other cells 
such as glial cell, the suggestion put forward is that the reduction is mainly in
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the neurons (amacrine and RGCs) since these cells form the major cell 
component of the RGCL (Perry et al., 1983).
Assessment of RGC dendrite complexity showed a reduction in dendritic 
complexity and this might be caused by a reduction in the survival response. 
Since the activation of survival pathway is impaired the cells are vulnerable to 
all kind of stress including deprivation of nutrients and more. Dendrites are 
more vulnerable to environmental changes, either intrinsic or extrinsic. As a 
consiquence to impaired survival pathway, in response to stress, they will be 
the first to go and that might explain the reduction in dendrite complexity 
seen here.
Impairment in activation of NF-kB also lead to reduced transcription of the 
genes that encode for cytoskeleton proteins including various filament 
proteins (Komine et al., 2000, Radoja et al., 2004, Wu et al., 2001, Wu et al., 
1994). Reduction in the cytoskeletal genes might facilitate retraction of the 
dendrites.
The reductions in dendritic architecture may contribute to decline vision 
ability with age. Alterations in neuronal morphology have been suggested to 
be the main course of decline motor, sensory and cognitive function (Hofer et 
al., 2003, Mattson and Magnus, 2006). Although reduction in dendrite 
complexity is more pronounced in disease, these changes in the ageing rat 
retina are less marked and therefore likely to have comparably reduced 
physiological effects.
Similar changes have been reported in other parts of the CNS. In the 
hippocampus, CA1 pyramidal neurons demonstrate elevated Ca2+ 
conductance as a result of age-related dendritic pruning, which might result 
in alteration in Ca2+ homeostasis (Thibault and Landfield, 1996, Toescu et al., 
2004), contributing to plasticity impairment accompanying scenescence 
(Foster and Norris, 1997, Landfield, 1988). The elevated Ca2+ result in 
prolonged depolarisation suggesting a decrease in the number of fired action
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potential (Burke and Barnes, 2006). Indeed, using in vitro hippocampal slice 
cultures, CA1 neurons showed to be less excitable (Moyer et al., 1992).
The retina, as part of the CNS, is a good model for studying the CNS 
because of its easy access. The highly multilayered organisation of the retina 
facilitated enrichment of a particular neuronal population. Work carried out 
on retinal neurons can be extrapolated for other neuronal populations in the 
CNS and also in PNS. For example, impairment in NF-kB activation has been 
shown to inhibit dendrite growth in developing sympathetic neurons (Gavalda 
et al., 2009, Gutierrez et al., 2008). Furthermore, on the behavioural level, it 
was shown that mice lacking a subunit of NF-kB have a learning deficit 
(Meffert and Baltimore, 2005).
The animals used for induction of glaucoma in this study were 24-52 weeks 
old, which corresponds to the age range when reduction in dendrite 
complexity was observed. Thus, retinae of these animals have already 
compromised neurons. These neurons are clearly susceptible to insults such 
as increased IOP and this might explain why glaucoma is associated with 
age. Few studies have addressed the physiological impacts of these changes 
in the retina. In glaucoma, dendritic pruning has been reported as a 
consistent early feature (Morgan et al., 2006, Weber and Harman, 2005, 
Weber et al., 1998). In the primate glaucoma model, electrophysiological 
studies of RGC with dendritic pruning demonstrated a reduced response rate 
and changes consistent with impaired spatial summation (Weber and 
Harman, 2005).
The findings here contribute to the general knowledge to the change that 
might underlie the reduction in retinal sensitivity as a function of age. These 
observations are important in the study of neurodegenerative diseases such 
as glaucoma in which the retinal ganglion cell population is selectively 
damage. Investigations into the pathophysiology of these diseases and into 
the assessment of therapeutic measures should be conducted on age 
appropriate animals. It seems likely that neurons with age related
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changes/degeneration would be more susceptible to damage compared with 
younger neurons.
For instant, RCG axons of older animals are more susceptible to increased 
intraocular (IOP) damage as a result of age-dependent decline of metabolic 
capacity in these retina (Baltan et al., 2006). Also, in contrast to young optic 
nerve, white matter in older optic nerves shows a higher vulnerability when 
subject to ischemic injury (Baltan et al., 2006). This clearly suggests that 
changes in experimental glaucoma in young animals may not reflect changes 
that would be seen in ageing eyes.
In conclusion, reduction in clAP1, which leads to impairment in survival 
pathway might be the underlaying course of reduction in dendrite complexity 
observed in this study (Fig. 7.1). Compromised dendrite complexity could be 
the key factor in age-related visual decline. Compromised RGC morphology 
makes a preparatory platform for neurodegenerative process observed in 
glaucoma disease where age is a major risk factor.
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7.2 Future work
Although this study shows a decrease in dendrite complexity, the extent to 
which these changes apply to all RGCs remains unclear. Thus, it will be of 
high interest to determine which type of RGC show a higher/less degree of 
dendrite remodelling during ageing.
Manipulation of clAP1 in order to determine to what extend it is involved in 
dendrite pruning during retina maturation process should be carried out. For 
example down-regulation of clAP1 in 6 weeks old retina using siRNA and 
measurement of RGC dendritic field will show whether clAP1 is directly 
involved in dendritic pruning or whether the dendrite pruning observed during 
retinal maturation is a result of a collection of factors where reduction of 
clAP1 is one of the factors.
Further work is needed to correlate lAPs mRNA levels observed in 
glaucomatous eyes with protein levels. This will give a better handle on the 
role of lAPs in glaucoma disease etiology.
The cell death has been well documented in glaucoma with the principal 
placed on events in the apoptototic pathways. In other neurodegenerative 
diseases such AD, recent report have suggest other cell death modes are 
involved in elimination of the neurons. It will be interesting to explore whether 
other cell death i.e. autophagy is responsible for cell death in glaucoma.
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Table 7.1. NF-kB-responsive genes in the nervous system
Gene
Mn-SOD1 and 2
Cu/Zn-SOD
Bcl-2
Bax
Bcl-xL
Bim
lAPs
TRAF1
TRAF2
TRAF2 binding protein 
(Carp)
BDNF
NMDA receptor
VDCC
Calbidin
Inducible NO-synthesis 
(Cano et al.)
Function
Manganese superoxides 
dismutase
superoxides dismutase 
Pro-survival factor 
Pro-apoptotic Bcl-2
homologue
Pro-apoptotic Bcl-2
homologue
Pro-apoptotic Bcl-2
homolog
Inhibitors of apoptosis
TNF-receptor associated
factor
TNF-receptor associated
factor
TRAF2 binding protein
Brain derived neurotrophic 
factor
Neural receptor for N- 
methyl-D aspartate 
Voltage-dependent 
calcium chanel 
Calcium binding protein 
Nitric oxide synthesis
References
Das et al, 1995; Xu et al., 
2007
Rojo et al., 2004;
Catz and Johnson, 2001 
Grimm et al., 2004
Chen et al., 1999; Lee et 
al., 1999
Wang et al., 2008
You et al., 1997; Stehlik et 
al., 1998a and 1998b; 
Turner et al., 2007 
Schwenzer et al., 1999
Wang et al., 1998
Chang et al.,2005
Saha et al., 2007
Ritcher et al., 2002; Begni 
et al., 2003
Cheng et al., 1994; 
Furukawa et al., 1998
Geller et al., 1993; Morris 
et al., 2003; Guo et al., 
2006; Hudges et al., 2008 
Nakata et al., 2006; Li et 
al., 2007
Baines et al., 2002; 
Haddad, 2005
Nueronal nitric oxide Nitric oxide synthesis 
synthesis (nNOS)
Amiloride-sensitive Sodium channel
sodium channel
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Figure 7.1. Schematic picture summarising clAP1 role in neuronal 
plasticity. The traced neurons, represent 75% of dendrite complexity in 
respective populations. Scale bar, 20pm
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Appendix II 
RT-PCR/REAL-TIME PCR
10x MOPS electrophoresis buffer
50mM sodium acetat,
0.2 4-Morpholinepropanesulfonic acid (MOPS) 
1mM EDTA.
Adjust to pH7.0 with NaOH
RNA denaturing gel M 00mII
18ml formaldehyde 
10ml 10x MOPS 
72ml ddH20  
1.5g agarose
RNA running buffer MLl
83ml formaldehyde 
100ml 10x MOPS 
817ml ddH20
Working RTL
10pl p-Mecarptoethanol 
1ml RTL buffer
Working RPE
4 volumes of 100% ethanol 
RPE
EDTA (0.5M)
93.05g EDTA (FW-372.2)
500ml ddH20  
NaOH to pH 8.5
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TAE (50x1 Buffer
242g Tris base (FW=121.14) 
100ml 0.5M EDTA (pH8.0) 
57.1ml Glacial acid 
750ml ddH20 .
HISTOLOGY/HISTOCHEMISTRY
10X PBS MLl
80g NaCI 
2g KCI
14.4g Na2P0 4  
2.4g KH2PO4 
HCI to pH 7.4 
1000ml dH20
4% Paraformaldehyde (PFA1 solution MOOmll
4 g PFA 
99ml 1x PBS.
1 ml 1M NaOH
Peroxidase sunstrate r5ml1
1 tablet of DAB/Cobalt [0.5 mg/m I]
1 tablet of Urea Hydrogen Peroxidase/Tris Buffer 
5ml dH20
DNasel foer slide!
100pl1x Reaction Buffer 
100pl DNasel stock
Inactive caspase 3 blocking solution
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1XPBS
0.1% Tween 20 
5% donkey serum.
WESTERN BLOTTING
10X TBS pH 7.6 MU
12.1g 10mM Tris 
8.7g 150mM NaCI 
1000ml dH20  
HCL to pH 7.6
1x TBS/Tween 20 MLl
100ml 10x TBS 
900ml dH20  
1 ml Tween 20 
pH 7.4
10% APS nOmll
10g Ammonium persulphate 
10ml dH20
10x SDS
10g SDS 
100ml dH20
1.5M Tris-HCL pH 8.8 n50ml1
27,23g Tris base 
150 dH20  
HCL to pH 8.8
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0.5M Tris-HCL pH 6.8 nOOmll
6g Tris base 
100ml dH20  
HCL to pH 6.8
Working sample buffer MOOuH
95pl Laemlli buffer 
5pl P-Mecarptoethanol
Running buffer MLl
100ml 10xTris/glycin/SDS 
900ml dH20
1X Transfer buffer (1L)
100mlTris/glycine buffer (Bio-Rad)
200ml Methanol 
700ml dH20
Mild stripping buffer. 1L
15g glycine
1g sodium deocyl sulphate (SDS)
10ml Tween 20 
HCL to pH 2.2 
1000ml dH20
Antigen retrival solution T1L1
1.92 Citric acid anhydrous 
1000ml dH20
SDS-PAGE
1. Resolving Gel to a final volume of 10ml
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Final % 
Gel
6% 6.5% 7% 7.5% 8% 10% 12% 15%
Range
(Mw)
70-
200
20-
100
10-70 8-50
Acrylamide
(30%)
2.0 2.2 2.3 2.5 2.7 3.3 4.0 5.0
Water 5.3 5.1 5 4.8 4.6 4 3.3 2.3
1.5M Tris 
pH8.8
2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
10% SDS 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
10% APS 100pl 100pl 100pl 100pl 100pi 100pl 100pl 100pl
TEMED 20|jI 20 pi 20pl 20 pi 20pl 20pl 20pl 20pl
2. Stacking Gel to a final volume of 10ml
Acrylamide (30%) 1.67
Water 5.83
0.5M Tris pH 6.6 2.5
10% SDS 0.1
10% APS 50pl
TEMED 10pl
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COMPOSITIONS OF SOLUTIONS PROVIDED WITH KITS
ApopTag® Peroxidase in situ Apoptosis Detection Kit, Chemicon
Equlibration buffer: contains potassium cacodylate (dimethylarsinic acid) 
Reaction buffer: contains potassium cacodylate (dimethylarsinic acid)
BCA™ Protein Assay, Pierce
Reagent A: Sodium carbonate, sodium bicarbonate, bicinchonic acid and 
sodium tartrate in 0.1 M sodium hydroxide 
Reagent B: 4% cupric sulphate
Albumin Standard Ampluse 2 mg/ml: bovine serum albumin at 2.0mg/ml in 
0.9% saline and 0.05% sodium azide
cDNA kit, BIOLINE
Oligo (dT)i8
Random Hexamers
2.5 mM dNTP
5x RT buffer
30Units RNase inhibitors
150 units Reverse trascriptase
1 pg/pl Control RNA templet
ECL Plus. Amersham
Solution A: ECL Plus substrate solution containing tris buffer 
Solution B. Stock Acridam solution in Dioxane and Ethenol
RNeasy® Mini Kit, Qiagen
RTL buffer: containing guanidinium thicyanate
RPE buffer: containing ethanol
RW1 buffer: containing guanidinium thicyanate, ethanol
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VECTASTAIN® Elite® ABC KIT, Vector Laboratories
Reagent A: Avadin 
Reagent B: Biotinylated enzyme
QPCR Kit, Sigma
Master mix containing 20 mM Tris-HCI, pH 8.3, 100 mM KCI, 7 mM MgCI2, 
0.4 mM each dNTP (dATP, dCTP, dGTP, TTP), stabilizers, 0.05 unit/ml Taq 
DNA Polymerase, JumpStart Taq antibody, and SYBR Green I.
Internal Reference Dye
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Ladder
Ladder
Figure S1. Visualisation of successful transfer utilising Ponceau S. Ladder (Bio Rad)
A B
Figure S2. Exampes of negative controls used in the study. A. 
Pre-incubation of clAP1 antibody together with clAP1 blocking 
peptide showed no staining of clAP1 on the membrane 
confirming specificity of primary antibody. B. Rabbit 
immunoglobulins (IgG) control. C. Secondary antibody omission.
Table S1. Concentration and purity of RNA. YR1, young (6 weeks) rat 1 and 
OR1 is old (retired breeders of ages 24-52 weeks).
Animal Sample nr. Cone, [ng/ pi] Final amount [pg] 260/280 ratio
YR1 1 28.05 7.0 1.95
2 25.85 6.0 1.94
YR2 3 22.14 5.0 1.99
4 27.34 6.8 2.05
YR3 5 23.12 5.78 2.09
6 10.45 2.6 2.27
OR1 7 17.75 4.4 1.81
8 11.50 2.86 2.35
OR2 9 10.65 2.66 1.91
10 21.95 5.5 2.05
OR3 11 9.22 2.3 2.18
12 6.18 1.54 2.07
Table S2. An example of protein quantification. Absorbance and 
concentration of the unknown samples. The concentrations were calculated 
using the equation (y = 0.0008x + 0.135) obtained from the standard curve 
(Fig. 10).
Sample Absorbance Conc.(pg/ml) Conc.(pg/ml) x 10 Conc.(mg/ml)
(dilution factor)
YR1 0.789 817.5 8175 8.175
YR2 0.8985 954.375 9543.75 9.544
YR3 0.596 576.25 5762.5 5.763
OR1 0.872 921.25 9212.5 9.213
OR2 0.9345 999.375 9993.75 10
OR3 0.9055 963.125 9631.25 9.631
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Figure S3. Standard curve. Abbreviations: y, Absorbance: x, concentration.
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Figure S4: Amplification plot, melting curve and Standard curve of beta actin (A- 
C). Beta III tubulin (D-F) and GAPDH (G-l)
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Figure S5: Amplification plot, melting curve and Standard curve of Caspase 
3 (A-C). 6 (D-F), 7 (G-l). 8 (J-L) and 9 (M-N).
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Figure S6: Amplification plot, melting curve and Standard curve of 
NIAP (A-C). clAP1 (D-F), clAP2 (G-l). XIAP (J-L), Survivin (M-N), 
Bruce (P-R) and Livin (S-U)
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Figure S7. An example of critter database for IOP records. Image taken from 
critter1.cf.ac.uk. Accessed on 6.7.10
